ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count,Ontology
GO:0007059,chromosome segregation,81/198,373/12185,1.25E-71,1.62E-68,1.23E-68,CDCA8/CDC20/KIF2C/STIL/GPSM2/PSRC1/NUF2/ASPM/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF11/MKI67/KIF18A/INCENP/NCAPD2/RACGAP1/ESPL1/SKA3/DLGAP5/BUB1B/KNL1/OIP5/NUSAP1/CCNB2/ZWILCH/KIF23/PRC1/RMI2/NDE1/PLK1/CDT1/AURKB/SPAG5/CDC6/TOP2A/KIF18B/BRIP1/BIRC5/NDC80/SKA1/SPC24/CENPO/NCAPH/BUB1/SPC25/SGO2/HJURP/TPX2/DSN1/FAM83D/MYBL2/UBE2C/AURKA/CHEK2/CENPM/FANCD2/SGO1/SMC4/ECT2/TACC3/NCAPG/CENPE/MAD2L1/MND1/CENPU/TRIP13/CENPK/CCNB1/CENPH/PTTG1/KIFC1/TTK/CENPW/NCAPG2/CDCA2/ESCO2/KIF4A/CENPI,81,BP
GO:0000280,nuclear division,73/198,350/12185,1.45E-62,9.32E-60,7.10E-60,CDCA8/CDC20/KIF2C/RAD54L/PSRC1/NUF2/ASPM/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF20B/KIF11/MKI67/KIF18A/INCENP/RAD51AP1/NCAPD2/RACGAP1/ESPL1/BRCA2/BORA/DLGAP5/BUB1B/KNL1/RAD51/NUSAP1/CCNB2/ZWILCH/KIF23/PRC1/PKMYT1/NDE1/PLK1/CDT1/AURKB/SPAG5/TOP2A/KIF18B/BRIP1/BIRC5/NDC80/SPC24/UBE2S/NCAPH/BUB1/SPC25/TPX2/DSN1/MYBL2/UBE2C/AURKA/CHEK2/FANCD2/SGO1/SMC4/NCAPG/CENPE/MAD2L1/MND1/TRIP13/CENPK/CCNB1/CDC25C/PTTG1/KIFC1/TTK/ANLN/NCAPG2/CDCA2/KIF4A/CENPI,73,BP
GO:0098813,nuclear chromosome segregation,65/198,268/12185,7.72E-60,3.32E-57,2.53E-57,CDCA8/CDC20/KIF2C/PSRC1/NUF2/ASPM/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF11/KIF18A/INCENP/NCAPD2/RACGAP1/ESPL1/DLGAP5/BUB1B/KNL1/NUSAP1/CCNB2/ZWILCH/KIF23/PRC1/RMI2/PLK1/CDT1/AURKB/SPAG5/CDC6/TOP2A/KIF18B/BRIP1/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/TPX2/DSN1/FAM83D/MYBL2/UBE2C/AURKA/CHEK2/FANCD2/SGO1/SMC4/ECT2/TACC3/NCAPG/CENPE/MAD2L1/MND1/TRIP13/CENPK/CCNB1/PTTG1/KIFC1/TTK/NCAPG2/KIF4A/CENPI,65,BP
GO:0048285,organelle fission,73/198,393/12185,1.12E-58,3.61E-56,2.75E-56,CDCA8/CDC20/KIF2C/RAD54L/PSRC1/NUF2/ASPM/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF20B/KIF11/MKI67/KIF18A/INCENP/RAD51AP1/NCAPD2/RACGAP1/ESPL1/BRCA2/BORA/DLGAP5/BUB1B/KNL1/RAD51/NUSAP1/CCNB2/ZWILCH/KIF23/PRC1/PKMYT1/NDE1/PLK1/CDT1/AURKB/SPAG5/TOP2A/KIF18B/BRIP1/BIRC5/NDC80/SPC24/UBE2S/NCAPH/BUB1/SPC25/TPX2/DSN1/MYBL2/UBE2C/AURKA/CHEK2/FANCD2/SGO1/SMC4/NCAPG/CENPE/MAD2L1/MND1/TRIP13/CENPK/CCNB1/CDC25C/PTTG1/KIFC1/TTK/ANLN/NCAPG2/CDCA2/KIF4A/CENPI,73,BP
GO:0140014,mitotic nuclear division,61/198,250/12185,3.97E-56,1.03E-53,7.81E-54,CDCA8/CDC20/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF20B/KIF11/MKI67/KIF18A/INCENP/NCAPD2/RACGAP1/ESPL1/BORA/DLGAP5/BUB1B/KNL1/NUSAP1/ZWILCH/KIF23/PRC1/PKMYT1/NDE1/PLK1/CDT1/AURKB/SPAG5/KIF18B/BIRC5/NDC80/SPC24/UBE2S/NCAPH/BUB1/SPC25/TPX2/DSN1/MYBL2/UBE2C/AURKA/CHEK2/SMC4/NCAPG/CENPE/MAD2L1/TRIP13/CENPK/CCNB1/CDC25C/KIFC1/TTK/ANLN/NCAPG2/CDCA2/KIF4A/CENPI,61,BP
GO:0000819,sister chromatid segregation,55/198,215/12185,1.31E-51,2.83E-49,2.15E-49,CDCA8/CDC20/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF11/KIF18A/INCENP/NCAPD2/RACGAP1/ESPL1/DLGAP5/BUB1B/KNL1/NUSAP1/ZWILCH/KIF23/PRC1/RMI2/PLK1/CDT1/AURKB/SPAG5/CDC6/TOP2A/KIF18B/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/TPX2/DSN1/MYBL2/UBE2C/CHEK2/SMC4/TACC3/NCAPG/CENPE/MAD2L1/TRIP13/CENPK/CCNB1/KIFC1/TTK/NCAPG2/KIF4A/CENPI,55,BP
GO:0000070,mitotic sister chromatid segregation,51/198,176/12185,8.07E-51,1.49E-48,1.13E-48,CDCA8/CDC20/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/ZWINT/CDK1/KIF11/KIF18A/INCENP/NCAPD2/RACGAP1/ESPL1/DLGAP5/BUB1B/KNL1/NUSAP1/ZWILCH/KIF23/PRC1/PLK1/CDT1/AURKB/SPAG5/KIF18B/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/TPX2/DSN1/MYBL2/UBE2C/CHEK2/SMC4/NCAPG/CENPE/MAD2L1/TRIP13/CENPK/CCNB1/KIFC1/TTK/NCAPG2/KIF4A/CENPI,51,BP
GO:0044770,cell cycle phase transition,61/198,496/12185,2.11E-37,3.41E-35,2.60E-35,E2F2/CLSPN/CDCA8/CDC20/STIL/ORC1/CDC7/IQGAP3/NUF2/KIF14/DTL/CENPF/ZWINT/CDK1/RRM1/INCENP/H2AX/FOXM1/ESPL1/TIMELESS/BRCA2/CDKN3/DLGAP5/BUB1B/KNL1/RAD51/WDR76/CCNB2/ZWILCH/TICRR/BLM/PKMYT1/PLK1/CDT1/AURKB/CDC6/BRIP1/BIRC5/NDC80/SPC24/UBE2S/RRM2/BUB1/SPC25/FAM83D/UBE2C/AURKA/CDC45/CHEK2/GTSE1/FANCD2/TACC3/CENPE/MAD2L1/CCNA2/TRIP13/CCNB1/CDC25C/TTK/ANLN/MELK,61,BP
GO:0006260,DNA replication,47/198,260/12185,2.45E-36,3.52E-34,2.68E-34,NASP/ORC1/CDC7/DTL/MCM10/CDK1/RRM1/FAM111B/POLA2/POLD3/TIMELESS/PRIM1/RFC5/BRCA2/RFC3/POLE2/WDHD1/RAD51/PCLAF/PIF1/TICRR/BLM/RMI2/GINS2/CDT1/CDC6/TK1/CHAF1A/RNASEH2A/RRM2/MCM6/GINS1/CHAF1B/CDC45/MCM5/TRAIP/POLQ/MCM2/RFC4/CCNA2/GMNN/MCM3/MMS22L/RFC2/ESCO2/MCM4/DSCC1,47,BP
GO:0051983,regulation of chromosome segregation,36/198,122/12185,4.90E-36,6.32E-34,4.82E-34,CDCA8/CDC20/KIF2C/NUF2/CENPF/ZWINT/CDK1/MKI67/INCENP/NCAPD2/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/RMI2/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/UBE2C/SMC4/TACC3/NCAPG/CENPE/MAD2L1/TRIP13/CCNB1/TTK/NCAPG2/CDCA2,36,BP
GO:1901987,regulation of cell cycle phase transition,52/198,388/12185,1.64E-33,1.92E-31,1.46E-31,CLSPN/CDCA8/CDC20/STIL/ORC1/CDC7/NUF2/KIF14/DTL/CENPF/ZWINT/CDK1/RRM1/INCENP/H2AX/ESPL1/TIMELESS/BRCA2/DLGAP5/BUB1B/KNL1/RAD51/WDR76/ZWILCH/TICRR/BLM/PKMYT1/PLK1/CDT1/AURKB/CDC6/BRIP1/BIRC5/NDC80/SPC24/RRM2/BUB1/SPC25/FAM83D/UBE2C/AURKA/CDC45/CHEK2/GTSE1/FANCD2/CENPE/MAD2L1/TRIP13/CCNB1/CDC25C/TTK/ANLN,52,BP
GO:1902850,microtubule cytoskeleton organization involved in mitosis,37/198,154/12185,2.26E-33,2.43E-31,1.85E-31,CDCA8/CDC20/STIL/GPSM2/PSRC1/NUF2/NEK2/CDK1/KIF11/INCENP/RACGAP1/ESPL1/BORA/DLGAP5/NUSAP1/KIF23/PRC1/NDE1/PLK1/AURKB/BIRC5/NDC80/CENPA/SPC25/TPX2/MYBL2/AURKA/CHEK2/TACC3/CENPE/MAD2L1/CCNB1/CENPH/KIFC1/TTK/SAPCD2/KIF4A,37,BP
GO:0007088,regulation of mitotic nuclear division,32/198,102/12185,4.92E-33,4.88E-31,3.72E-31,CDCA8/CDC20/NUF2/NEK2/CENPF/ZWINT/KIF20B/MKI67/INCENP/ESPL1/BORA/DLGAP5/BUB1B/KNL1/NUSAP1/ZWILCH/PKMYT1/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/AURKA/MAD2L1/TRIP13/CCNB1/CDC25C/TTK/CDCA2,32,BP
GO:1905818,regulation of chromosome separation,28/198,71/12185,2.86E-32,2.64E-30,2.01E-30,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/NCAPD2/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/UBE2C/SMC4/NCAPG/MAD2L1/TRIP13/CCNB1/TTK/NCAPG2,28,BP
GO:0051783,regulation of nuclear division,33/198,118/12185,3.47E-32,2.98E-30,2.27E-30,CDCA8/CDC20/NUF2/NEK2/CENPF/ZWINT/KIF20B/MKI67/INCENP/RAD51AP1/ESPL1/BORA/DLGAP5/BUB1B/KNL1/NUSAP1/ZWILCH/PKMYT1/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/AURKA/MAD2L1/TRIP13/CCNB1/CDC25C/TTK/CDCA2,33,BP
GO:0000075,cell cycle checkpoint signaling,38/198,185/12185,1.65E-31,1.33E-29,1.01E-29,CLSPN/CDCA8/CDC20/ORC1/NUF2/DTL/CENPF/ZWINT/CDK1/INCENP/H2AX/TIMELESS/BRCA2/BUB1B/KNL1/RAD51/WDR76/ZWILCH/TICRR/BLM/PLK1/CDT1/AURKB/CDC6/BRIP1/BIRC5/NDC80/SPC24/BUB1/SPC25/CDC45/CHEK2/GTSE1/FANCD2/MAD2L1/TRIP13/CCNB1/TTK,38,BP
GO:0044772,mitotic cell cycle phase transition,51/198,409/12185,2.74E-31,2.08E-29,1.58E-29,E2F2/CLSPN/CDCA8/CDC20/STIL/ORC1/CDC7/IQGAP3/NUF2/KIF14/DTL/CENPF/ZWINT/CDK1/RRM1/INCENP/FOXM1/ESPL1/CDKN3/DLGAP5/BUB1B/KNL1/CCNB2/ZWILCH/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/UBE2S/RRM2/BUB1/SPC25/UBE2C/AURKA/CHEK2/GTSE1/TACC3/CENPE/MAD2L1/CCNA2/TRIP13/CCNB1/CDC25C/TTK/ANLN/MELK,51,BP
GO:0051304,chromosome separation,28/198,77/12185,4.47E-31,3.21E-29,2.44E-29,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/NCAPD2/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/UBE2C/SMC4/NCAPG/MAD2L1/TRIP13/CCNB1/TTK/NCAPG2,28,BP
GO:0007346,regulation of mitotic cell cycle,51/198,439/12185,8.83E-30,5.99E-28,4.56E-28,CLSPN/CDCA8/CDC20/STIL/ORC1/CDC7/NUF2/KIF14/NEK2/DTL/CENPF/ZWINT/CDK1/KIF20B/MKI67/RRM1/INCENP/ESPL1/BRCA2/BORA/DLGAP5/BUB1B/KNL1/NUSAP1/ZWILCH/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/RRM2/BUB1/SPC25/UBE2C/AURKA/CHEK2/GTSE1/FANCD2/CENPE/MAD2L1/TRIP13/CCNB1/CDC25C/GMNN/TTK/ANLN/CDCA2,51,BP
GO:0090068,positive regulation of cell cycle process,38/198,208/12185,1.70E-29,1.10E-27,8.35E-28,CDCA8/CDC20/STIL/CDC7/GPSM2/KIF14/DTL/CDK1/KIF20B/RRM1/INCENP/RAD51AP1/NCAPD2/RACGAP1/ESPL1/CIT/DLGAP5/NUSAP1/KIF23/AURKB/SPAG5/CDC6/BIRC5/NDC80/RRM2/NCAPH/BUB1/FAM83D/UBE2C/AURKA/SMC4/ECT2/NCAPG/MAD2L1/PLK4/CCNB1/CDC25C/NCAPG2,38,BP
GO:0006261,DNA-templated DNA replication,34/198,153/12185,1.92E-29,1.18E-27,8.98E-28,ORC1/CDC7/MCM10/RRM1/POLA2/POLD3/TIMELESS/PRIM1/RFC5/BRCA2/RFC3/POLE2/WDHD1/RAD51/TICRR/BLM/GINS2/CDT1/CDC6/TK1/MCM6/GINS1/CDC45/MCM5/TRAIP/POLQ/MCM2/RFC4/GMNN/MCM3/MMS22L/RFC2/MCM4/DSCC1,34,BP
GO:1901988,negative regulation of cell cycle phase transition,39/198,236/12185,1.55E-28,9.07E-27,6.91E-27,CLSPN/CDCA8/CDC20/ORC1/NUF2/DTL/CENPF/ZWINT/CDK1/INCENP/H2AX/TIMELESS/BRCA2/BUB1B/KNL1/RAD51/WDR76/ZWILCH/TICRR/BLM/PKMYT1/PLK1/CDT1/AURKB/CDC6/BRIP1/BIRC5/NDC80/SPC24/BUB1/SPC25/CDC45/CHEK2/GTSE1/FANCD2/MAD2L1/TRIP13/CCNB1/TTK,39,BP
GO:0010948,negative regulation of cell cycle process,41/198,273/12185,2.70E-28,1.51E-26,1.15E-26,CLSPN/CDCA8/CDC20/ORC1/NUF2/NEK2/DTL/CENPF/ZWINT/CDK1/INCENP/H2AX/ESPL1/TIMELESS/BRCA2/BUB1B/KNL1/RAD51/WDR76/ZWILCH/TICRR/BLM/PKMYT1/PLK1/CDT1/AURKB/CDC6/BRIP1/BIRC5/NDC80/SPC24/BUB1/SPC25/CDC45/CHEK2/GTSE1/FANCD2/MAD2L1/TRIP13/CCNB1/TTK,41,BP
GO:0045787,positive regulation of cell cycle,40/198,265/12185,1.09E-27,5.85E-26,4.45E-26,CDCA8/CDC20/STIL/CDC7/GPSM2/PSRC1/KIF14/DTL/CDK1/KIF20B/RRM1/INCENP/RAD51AP1/NCAPD2/RACGAP1/ESPL1/CIT/BRCA2/DLGAP5/NUSAP1/KIF23/AURKB/SPAG5/CDC6/BIRC5/NDC80/RRM2/NCAPH/BUB1/FAM83D/UBE2C/AURKA/SMC4/ECT2/NCAPG/MAD2L1/PLK4/CCNB1/CDC25C/NCAPG2,40,BP
GO:0033045,regulation of sister chromatid segregation,28/198,100/12185,2.09E-27,1.08E-25,8.20E-26,CDCA8/CDC20/NUF2/CENPF/ZWINT/CDK1/INCENP/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/RMI2/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/TACC3/CENPE/MAD2L1/TRIP13/CCNB1/TTK,28,BP
GO:0007052,mitotic spindle organization,30/198,125/12185,4.12E-27,2.04E-25,1.56E-25,CDCA8/CDC20/STIL/GPSM2/PSRC1/NUF2/NEK2/KIF11/INCENP/RACGAP1/BORA/DLGAP5/KIF23/PRC1/PLK1/AURKB/BIRC5/NDC80/SPC25/TPX2/MYBL2/AURKA/CHEK2/TACC3/CENPE/CCNB1/CENPH/KIFC1/TTK/KIF4A,30,BP
GO:0010965,regulation of mitotic sister chromatid separation,23/198,57/12185,6.32E-27,3.02E-25,2.30E-25,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/MAD2L1/TRIP13/CCNB1/TTK,23,BP
GO:0050000,chromosome localization,28/198,106/12185,1.28E-26,5.88E-25,4.48E-25,CDCA8/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/KIF18A/INCENP/RACGAP1/DLGAP5/KNL1/ZWILCH/NDE1/CDT1/AURKB/SPAG5/BIRC5/NDC80/SPC24/SPC25/DSN1/FAM83D/SGO1/ECT2/CENPE/CCNB1/KIFC1,28,BP
GO:1901990,regulation of mitotic cell cycle phase transition,41/198,303/12185,1.83E-26,8.14E-25,6.19E-25,CLSPN/CDCA8/CDC20/STIL/ORC1/CDC7/NUF2/KIF14/DTL/CENPF/ZWINT/CDK1/RRM1/INCENP/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/TICRR/BLM/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/RRM2/BUB1/SPC25/UBE2C/AURKA/CHEK2/GTSE1/CENPE/MAD2L1/TRIP13/CCNB1/CDC25C/TTK/ANLN,41,BP
GO:0051306,mitotic sister chromatid separation,23/198,60/12185,2.67E-26,1.15E-24,8.74E-25,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/MAD2L1/TRIP13/CCNB1/TTK,23,BP
GO:0051303,establishment of chromosome localization,27/198,98/12185,3.05E-26,1.27E-24,9.66E-25,CDCA8/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/KIF18A/INCENP/RACGAP1/KNL1/ZWILCH/NDE1/CDT1/AURKB/SPAG5/BIRC5/NDC80/SPC24/SPC25/DSN1/FAM83D/SGO1/ECT2/CENPE/CCNB1/KIFC1,27,BP
GO:0007051,spindle organization,34/198,189/12185,3.51E-26,1.42E-24,1.08E-24,CDCA8/CDC20/STIL/GPSM2/PSRC1/NUF2/ASPM/NEK2/KIF11/INCENP/RACGAP1/ESPL1/BORA/DLGAP5/CCNB2/KIF23/PRC1/PLK1/AURKB/SPAG5/BIRC5/NDC80/SPC25/TPX2/MYBL2/AURKA/CHEK2/TACC3/CENPE/CCNB1/CENPH/KIFC1/TTK/KIF4A,34,BP
GO:0045786,negative regulation of cell cycle,42/198,334/12185,8.16E-26,3.19E-24,2.43E-24,CLSPN/CDCA8/CDC20/ORC1/NUF2/NEK2/DTL/CENPF/ZWINT/CDK1/INCENP/H2AX/ESPL1/TIMELESS/BRCA2/BUB1B/KNL1/RAD51/WDR76/ZWILCH/TICRR/BLM/PKMYT1/PLK1/CDT1/AURKB/CDC6/BRIP1/BIRC5/NDC80/SPC24/BUB1/SPC25/CDC45/CHEK2/GTSE1/FANCD2/MAD2L1/TRIP13/CCNB1/GMNN/TTK,42,BP
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,26/198,91/12185,9.31E-26,3.53E-24,2.69E-24,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/TACC3/CENPE/MAD2L1/TRIP13/CCNB1/TTK,26,BP
GO:0007093,mitotic cell cycle checkpoint signaling,30/198,138/12185,9.90E-26,3.65E-24,2.78E-24,CLSPN/CDCA8/CDC20/ORC1/NUF2/DTL/CENPF/ZWINT/CDK1/INCENP/BUB1B/KNL1/ZWILCH/TICRR/BLM/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/CHEK2/GTSE1/FANCD2/MAD2L1/TRIP13/CCNB1/TTK,30,BP
GO:0051310,metaphase chromosome alignment,26/198,92/12185,1.28E-25,4.59E-24,3.49E-24,CDCA8/KIF2C/PSRC1/NUF2/KIF14/NEK2/CENPF/KIF18A/INCENP/RACGAP1/KNL1/ZWILCH/CDT1/AURKB/SPAG5/BIRC5/NDC80/SPC24/SPC25/DSN1/FAM83D/SGO1/ECT2/CENPE/CCNB1/KIFC1,26,BP
GO:0044784,metaphase/anaphase transition of cell cycle,26/198,93/12185,1.75E-25,6.11E-24,4.65E-24,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/TACC3/CENPE/MAD2L1/TRIP13/CCNB1/TTK,26,BP
GO:0033044,regulation of chromosome organization,36/198,237/12185,4.96E-25,1.68E-23,1.28E-23,CDCA8/CDC20/NUF2/NEK2/CENPF/ZWINT/CDK1/INCENP/NCAPD2/ESPL1/DLGAP5/BUB1B/KNL1/PIF1/ZWILCH/RMI2/PLK1/AURKB/CDC6/TOP2A/BIRC5/NDC80/SPC24/NCAPH/BUB1/SPC25/UBE2C/SMC4/TACC3/NCAPG/CENPE/MAD2L1/TRIP13/CCNB1/TTK/NCAPG2,36,BP
GO:0030071,regulation of mitotic metaphase/anaphase transition,25/198,87/12185,7.22E-25,2.39E-23,1.82E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/CENPE/MAD2L1/TRIP13/CCNB1/TTK,25,BP
GO:0007094,mitotic spindle assembly checkpoint signaling,20/198,44/12185,7.80E-25,2.39E-23,1.82E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:0071173,spindle assembly checkpoint signaling,20/198,44/12185,7.80E-25,2.39E-23,1.82E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:0071174,mitotic spindle checkpoint signaling,20/198,44/12185,7.80E-25,2.39E-23,1.82E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:0033047,regulation of mitotic sister chromatid segregation,21/198,52/12185,1.13E-24,3.39E-23,2.58E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/CDK1/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,21,BP
GO:1902099,regulation of metaphase/anaphase transition of cell cycle,25/198,89/12185,1.36E-24,3.97E-23,3.02E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/DLGAP5/BUB1B/KNL1/ZWILCH/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/UBE2C/CENPE/MAD2L1/TRIP13/CCNB1/TTK,25,BP
GO:0031577,spindle checkpoint signaling,20/198,45/12185,1.38E-24,3.97E-23,3.02E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:0033046,negative regulation of sister chromatid segregation,20/198,46/12185,2.41E-24,6.35E-23,4.84E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:0033048,negative regulation of mitotic sister chromatid segregation,20/198,46/12185,2.41E-24,6.35E-23,4.84E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:0045841,negative regulation of mitotic metaphase/anaphase transition,20/198,46/12185,2.41E-24,6.35E-23,4.84E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:2000816,negative regulation of mitotic sister chromatid separation,20/198,46/12185,2.41E-24,6.35E-23,4.84E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:0051985,negative regulation of chromosome segregation,20/198,47/12185,4.14E-24,1.03E-22,7.83E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,20/198,47/12185,4.14E-24,1.03E-22,7.83E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:1905819,negative regulation of chromosome separation,20/198,47/12185,4.14E-24,1.03E-22,7.83E-23,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:0008608,attachment of spindle microtubules to kinetochore,20/198,48/12185,7.00E-24,1.70E-22,1.30E-22,CDCA8/KIF2C/NUF2/NEK2/INCENP/RACGAP1/KNL1/ZWILCH/CDT1/AURKB/SPAG5/BIRC5/NDC80/SPC24/SPC25/DSN1/SGO1/ECT2/CENPE/CCNB1,20,BP
GO:0051321,meiotic cell cycle,32/198,189/12185,8.27E-24,1.98E-22,1.50E-22,CDC20/RAD54L/NUF2/ASPM/NEK2/EXO1/KIF18A/INCENP/H2AX/RAD51AP1/NCAPD2/ESPL1/BRCA2/RAD51/CCNB2/PKMYT1/PLK1/TOP2A/BRIP1/NDC80/NCAPH/SGO2/AURKA/FANCD2/SGO1/SMC4/MND1/TRIP13/CDC25C/PTTG1/TTK/XRCC2,32,BP
GO:0045839,negative regulation of mitotic nuclear division,20/198,54/12185,1.24E-22,2.90E-21,2.21E-21,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:1901991,negative regulation of mitotic cell cycle phase transition,29/198,165/12185,4.11E-22,9.47E-21,7.21E-21,CLSPN/CDCA8/CDC20/ORC1/NUF2/DTL/CENPF/ZWINT/CDK1/INCENP/BUB1B/KNL1/ZWILCH/TICRR/BLM/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/CHEK2/GTSE1/MAD2L1/TRIP13/CCNB1/TTK,29,BP
GO:0051784,negative regulation of nuclear division,20/198,57/12185,4.46E-22,1.01E-20,7.69E-21,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/BUB1B/KNL1/ZWILCH/PLK1/AURKB/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,20,BP
GO:1903046,meiotic cell cycle process,27/198,138/12185,6.23E-22,1.39E-20,1.06E-20,CDC20/RAD54L/NUF2/ASPM/KIF18A/INCENP/RAD51AP1/NCAPD2/ESPL1/BRCA2/RAD51/CCNB2/PKMYT1/PLK1/TOP2A/BRIP1/NDC80/NCAPH/AURKA/FANCD2/SGO1/SMC4/MND1/TRIP13/CDC25C/PTTG1/TTK,27,BP
GO:2001251,negative regulation of chromosome organization,23/198,90/12185,1.19E-21,2.59E-20,1.97E-20,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/BUB1B/KNL1/PIF1/ZWILCH/PLK1/AURKB/TOP2A/BIRC5/NDC80/SPC24/BUB1/SPC25/MAD2L1/TRIP13/CCNB1/TTK,23,BP
GO:0045930,negative regulation of mitotic cell cycle,30/198,209/12185,3.26E-20,7.01E-19,5.34E-19,CLSPN/CDCA8/CDC20/ORC1/NUF2/DTL/CENPF/ZWINT/CDK1/INCENP/BUB1B/KNL1/ZWILCH/TICRR/BLM/PLK1/AURKB/CDC6/BIRC5/NDC80/SPC24/BUB1/SPC25/CHEK2/GTSE1/FANCD2/MAD2L1/TRIP13/CCNB1/TTK,30,BP
GO:0032392,DNA geometric change,21/198,83/12185,9.34E-20,1.98E-18,1.50E-18,RFC5/RFC3/RAD51/PIF1/BLM/GINS2/TOP2A/BRIP1/MCM6/GINS1/CDC45/MCM5/POLQ/MCM2/RFC4/HMGB2/MCM3/RFC2/MCM4/DSCC1/HMGB3,21,BP
GO:0140013,meiotic nuclear division,24/198,123/12185,1.46E-19,3.04E-18,2.31E-18,CDC20/RAD54L/NUF2/ASPM/KIF18A/INCENP/RAD51AP1/ESPL1/BRCA2/RAD51/CCNB2/PLK1/TOP2A/BRIP1/NDC80/NCAPH/AURKA/FANCD2/SGO1/SMC4/MND1/TRIP13/PTTG1/TTK,24,BP
GO:0071103,DNA conformation change,21/198,89/12185,4.56E-19,9.34E-18,7.11E-18,RFC5/RFC3/RAD51/PIF1/BLM/GINS2/TOP2A/BRIP1/MCM6/GINS1/CDC45/MCM5/POLQ/MCM2/RFC4/HMGB2/MCM3/RFC2/MCM4/DSCC1/HMGB3,21,BP
GO:0090329,regulation of DNA-templated DNA replication,16/198,43/12185,2.32E-18,4.67E-17,3.55E-17,CDC7/TIMELESS/RFC5/RFC3/TICRR/BLM/CDT1/MCM6/MCM5/MCM2/RFC4/GMNN/MCM3/RFC2/MCM4/DSCC1,16,BP
GO:0051225,spindle assembly,23/198,123/12185,2.39E-18,4.74E-17,3.61E-17,CDCA8/CDC20/STIL/GPSM2/ASPM/NEK2/KIF11/INCENP/RACGAP1/CCNB2/KIF23/PRC1/PLK1/AURKB/SPAG5/BIRC5/NDC80/TPX2/MYBL2/AURKA/CHEK2/KIFC1/KIF4A,23,BP
GO:0006310,DNA recombination,31/198,268/12185,4.56E-18,8.91E-17,6.79E-17,RAD54L/CDC7/EXO1/H2AX/RAD51AP1/TIMELESS/PARPBP/BRCA2/RAD51/PIF1/BLM/RMI2/GINS2/TOP2A/BRIP1/KPNA2/UHRF1/MCM6/CDC45/MCM5/FANCD2/POLQ/MCM2/MND1/HMGB2/TRIP13/MCM3/MMS22L/XRCC2/MCM4/HMGB3,31,BP
GO:0032508,DNA duplex unwinding,19/198,77/12185,9.45E-18,1.82E-16,1.39E-16,RFC5/RFC3/RAD51/PIF1/BLM/GINS2/TOP2A/BRIP1/MCM6/GINS1/CDC45/MCM5/POLQ/MCM2/RFC4/MCM3/RFC2/MCM4/DSCC1,19,BP
GO:0051656,establishment of organelle localization,36/198,402/12185,3.29E-17,6.24E-16,4.75E-16,CDCA8/KIF2C/GPSM2/PSRC1/NUF2/KIF14/NEK2/CENPF/KIF18A/INCENP/RACGAP1/ESPL1/KNL1/NUSAP1/ZWILCH/NDE1/PLK1/CDT1/AURKB/SPAG5/BIRC5/NDC80/LMNB2/SPC24/CENPA/SPC25/DSN1/FAM83D/SGO1/ECT2/CENPE/MAD2L1/CCNB1/LMNB1/KIFC1/SAPCD2,36,BP
GO:0006270,DNA replication initiation,14/198,35/12185,9.70E-17,1.81E-15,1.38E-15,ORC1/MCM10/POLA2/PRIM1/TICRR/CDT1/CDC6/MCM6/CDC45/MCM5/MCM2/GMNN/MCM3/MCM4,14,BP
GO:1905820,positive regulation of chromosome separation,13/198,28/12185,1.12E-16,2.07E-15,1.57E-15,CDCA8/CDC20/INCENP/NCAPD2/ESPL1/DLGAP5/AURKB/BIRC5/NCAPH/UBE2C/SMC4/NCAPG/NCAPG2,13,BP
GO:0044839,cell cycle G2/M phase transition,23/198,146/12185,1.29E-16,2.34E-15,1.78E-15,CLSPN/ORC1/CDC7/KIF14/DTL/CENPF/CDK1/RRM1/FOXM1/CCNB2/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6/NDC80/AURKA/CHEK2/CCNA2/CCNB1/CDC25C/MELK,23,BP
GO:0045132,meiotic chromosome segregation,16/198,57/12185,4.14E-16,7.43E-15,5.65E-15,NUF2/ASPM/ESPL1/CCNB2/PLK1/BRIP1/NDC80/NCAPH/AURKA/FANCD2/SGO1/SMC4/MND1/TRIP13/PTTG1/TTK,16,BP
GO:0061982,meiosis I cell cycle process,18/198,81/12185,5.34E-16,9.44E-15,7.19E-15,CDC20/RAD54L/RAD51AP1/ESPL1/BRCA2/RAD51/CCNB2/PKMYT1/PLK1/TOP2A/BRIP1/NDC80/AURKA/FANCD2/MND1/TRIP13/CDC25C/PTTG1,18,BP
GO:0006275,regulation of DNA replication,20/198,111/12185,9.24E-16,1.61E-14,1.23E-14,CDC7/CDK1/TIMELESS/RFC5/RFC3/TICRR/BLM/CDT1/CDC6/MCM6/MCM5/MCM2/RFC4/CCNA2/GMNN/MCM3/RFC2/ESCO2/MCM4/DSCC1,20,BP
GO:0006302,double-strand break repair,29/198,278/12185,9.80E-16,1.68E-14,1.28E-14,RAD54L/CDC7/H2AX/FOXM1/RAD51AP1/TIMELESS/PARPBP/BRCA2/RAD51/BLM/RMI2/GINS2/BRIP1/UHRF1/MCM6/CDC45/CHEK2/MCM5/FANCD2/POLQ/MCM2/HMGB2/TRIP13/DEK/MCM3/MMS22L/XRCC2/ESCO2/MCM4,29,BP
GO:0000281,mitotic cytokinesis,18/198,84/12185,1.07E-15,1.81E-14,1.38E-14,CDCA8/IQGAP3/KIF20B/CEP55/INCENP/RACGAP1/ESPL1/CIT/NUSAP1/KIF23/PLK1/AURKB/BIRC5/CENPA/ECT2/KIF20A/ANLN/KIF4A,18,BP
GO:0051984,positive regulation of chromosome segregation,12/198,26/12185,1.92E-15,3.22E-14,2.45E-14,CDCA8/CDK1/INCENP/NCAPD2/AURKB/CDC6/BIRC5/NCAPH/SMC4/NCAPG/CCNB1/NCAPG2,12,BP
GO:0000910,cytokinesis,23/198,166/12185,2.35E-15,3.88E-14,2.95E-14,CDCA8/IQGAP3/KIF14/KIF20B/CEP55/INCENP/RACGAP1/ESPL1/CIT/BRCA2/NUSAP1/KIF23/PRC1/PLK1/AURKB/CDC6/BIRC5/CENPA/AURKA/ECT2/KIF20A/ANLN/KIF4A,23,BP
GO:0000086,G2/M transition of mitotic cell cycle,21/198,132/12185,2.37E-15,3.88E-14,2.95E-14,CLSPN/ORC1/CDC7/KIF14/DTL/CENPF/CDK1/RRM1/FOXM1/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6/AURKA/CHEK2/CCNA2/CCNB1/CDC25C/MELK,21,BP
GO:0090307,mitotic spindle assembly,16/198,67/12185,6.98E-15,1.13E-13,8.57E-14,CDCA8/CDC20/NEK2/KIF11/INCENP/RACGAP1/KIF23/PRC1/PLK1/AURKB/BIRC5/TPX2/MYBL2/CHEK2/KIFC1/KIF4A,16,BP
GO:0140694,non-membrane-bounded organelle assembly,32/198,375/12185,9.17E-15,1.46E-13,1.11E-13,CDCA8/CDC20/STIL/GPSM2/ASPM/NEK2/CENPF/KIF11/INCENP/RACGAP1/DLGAP5/CCNB2/KIF23/PRC1/PLK1/AURKB/SPAG5/BIRC5/NDC80/CENPA/TPX2/MYBL2/AURKA/CHEK2/CENPE/PLK4/CENPK/CENPH/KIFC1/CENPW/ANLN/KIF4A,32,BP
GO:0051231,spindle elongation,9/198,12/12185,1.39E-14,2.19E-13,1.66E-13,CDCA8/KIF11/INCENP/RACGAP1/KIF23/PRC1/AURKB/BIRC5/KIF4A,9,BP
GO:0033260,nuclear DNA replication,13/198,38/12185,1.41E-14,2.19E-13,1.66E-13,CDC7/BRCA2/RAD51/BLM/CDT1/TK1/MCM6/GINS1/CDC45/MCM2/GMNN/MCM3/MCM4,13,BP
GO:0034508,centromere complex assembly,12/198,30/12185,1.62E-14,2.49E-13,1.90E-13,NASP/CENPF/DLGAP5/OIP5/CENPO/CENPA/HJURP/CENPE/CENPK/CENPH/CENPW/CENPI,12,BP
GO:0044786,cell cycle DNA replication,13/198,42/12185,6.26E-14,9.50E-13,7.24E-13,CDC7/BRCA2/RAD51/BLM/CDT1/TK1/MCM6/GINS1/CDC45/MCM2/GMNN/MCM3/MCM4,13,BP
GO:0000724,double-strand break repair via homologous recombination,21/198,157/12185,8.44E-14,1.27E-12,9.64E-13,RAD54L/CDC7/H2AX/RAD51AP1/TIMELESS/PARPBP/BRCA2/RAD51/BLM/RMI2/GINS2/UHRF1/MCM6/CDC45/MCM5/POLQ/MCM2/MCM3/MMS22L/XRCC2/MCM4,21,BP
GO:0032465,regulation of cytokinesis,16/198,78/12185,9.14E-14,1.35E-12,1.03E-12,CDCA8/KIF14/KIF20B/INCENP/RACGAP1/CIT/BRCA2/KIF23/PRC1/PLK1/AURKB/CDC6/BIRC5/AURKA/ECT2/KIF20A,16,BP
GO:0061640,cytoskeleton-dependent cytokinesis,18/198,108/12185,1.11E-13,1.63E-12,1.24E-12,CDCA8/IQGAP3/KIF20B/CEP55/INCENP/RACGAP1/ESPL1/CIT/NUSAP1/KIF23/PLK1/AURKB/BIRC5/CENPA/ECT2/KIF20A/ANLN/KIF4A,18,BP
GO:0007080,mitotic metaphase chromosome alignment,14/198,55/12185,1.37E-13,1.98E-12,1.51E-12,CDCA8/KIF2C/PSRC1/NUF2/KIF14/KIF18A/INCENP/CDT1/AURKB/BIRC5/NDC80/CENPE/CCNB1/KIFC1,14,BP
GO:0000725,recombinational repair,21/198,161/12185,1.40E-13,2.01E-12,1.53E-12,RAD54L/CDC7/H2AX/RAD51AP1/TIMELESS/PARPBP/BRCA2/RAD51/BLM/RMI2/GINS2/UHRF1/MCM6/CDC45/MCM5/POLQ/MCM2/MCM3/MMS22L/XRCC2/MCM4,21,BP
GO:0000022,mitotic spindle elongation,8/198,10/12185,1.85E-13,2.62E-12,1.99E-12,CDCA8/INCENP/RACGAP1/KIF23/PRC1/AURKB/BIRC5/KIF4A,8,BP
GO:0031570,DNA integrity checkpoint signaling,19/198,130/12185,2.65E-13,3.72E-12,2.83E-12,CLSPN/ORC1/DTL/CDK1/H2AX/TIMELESS/BRCA2/RAD51/WDR76/TICRR/BLM/PLK1/CDT1/CDC6/BRIP1/CDC45/CHEK2/GTSE1/FANCD2,19,BP
GO:0006268,DNA unwinding involved in DNA replication,10/198,21/12185,3.09E-13,4.19E-12,3.19E-12,RAD51/BLM/GINS2/MCM6/GINS1/CDC45/MCM5/MCM2/MCM3/MCM4,10,BP
GO:0051383,kinetochore organization,10/198,21/12185,3.09E-13,4.19E-12,3.19E-12,NUF2/CENPF/DLGAP5/NDC80/CENPA/SMC4/CENPE/CENPK/CENPH/CENPW,10,BP
GO:0051988,regulation of attachment of spindle microtubules to kinetochore,10/198,21/12185,3.09E-13,4.19E-12,3.19E-12,CDCA8/NEK2/INCENP/RACGAP1/ZWILCH/AURKB/SPAG5/BIRC5/ECT2/CCNB1,10,BP
GO:0065004,protein-DNA complex assembly,21/198,172/12185,5.28E-13,7.09E-12,5.40E-12,NASP/CENPF/H2AX/DLGAP5/RAD51/OIP5/CDT1/CHAF1A/CENPO/CENPA/HJURP/CHAF1B/CDC45/MCM2/CENPE/HMGB2/CENPK/CENPH/GMNN/CENPW/CENPI,21,BP
GO:0000727,double-strand break repair via break-induced replication,8/198,11/12185,6.68E-13,8.88E-12,6.76E-12,CDC7/GINS2/MCM6/CDC45/MCM5/MCM2/MCM3/MCM4,8,BP
GO:1902969,mitotic DNA replication,9/198,16/12185,6.83E-13,8.99E-12,6.84E-12,BRCA2/RAD51/TK1/MCM6/GINS1/CDC45/MCM2/MCM3/MCM4,9,BP
GO:0007127,meiosis I,15/198,75/12185,8.28E-13,1.08E-11,8.21E-12,RAD54L/RAD51AP1/ESPL1/BRCA2/RAD51/CCNB2/PLK1/TOP2A/BRIP1/NDC80/AURKA/FANCD2/MND1/TRIP13/PTTG1,15,BP
GO:0051302,regulation of cell division,19/198,141/12185,1.19E-12,1.54E-11,1.17E-11,CDCA8/ASPM/KIF14/KIF20B/INCENP/RACGAP1/CIT/BRCA2/KIF23/BLM/PRC1/PLK1/AURKB/CDC6/KIF18B/BIRC5/AURKA/ECT2/KIF20A,19,BP
GO:1902749,regulation of cell cycle G2/M phase transition,17/198,107/12185,1.24E-12,1.59E-11,1.21E-11,CLSPN/ORC1/CDC7/KIF14/DTL/CENPF/CDK1/RRM1/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6/AURKA/CCNB1/CDC25C,17,BP
GO:0051052,regulation of DNA metabolic process,32/198,452/12185,1.60E-12,2.02E-11,1.54E-11,CDC7/NEK2/CDK1/H2AX/FOXM1/RAD51AP1/TIMELESS/PARPBP/RFC5/RFC3/RAD51/PIF1/TICRR/BLM/RMI2/CDT1/AURKB/CDC6/KPNA2/MCM6/MCM5/POLQ/MCM2/RFC4/CCNA2/DEK/GMNN/MCM3/RFC2/ESCO2/MCM4/DSCC1,32,BP
GO:0051255,spindle midzone assembly,8/198,12/12185,1.98E-12,2.48E-11,1.88E-11,CDCA8/INCENP/RACGAP1/KIF23/PRC1/AURKB/BIRC5/KIF4A,8,BP
GO:0010389,regulation of G2/M transition of mitotic cell cycle,16/198,96/12185,2.72E-12,3.38E-11,2.57E-11,CLSPN/ORC1/CDC7/KIF14/DTL/CENPF/CDK1/RRM1/TICRR/BLM/PLK1/AURKB/CDC6/AURKA/CCNB1/CDC25C,16,BP
GO:0032467,positive regulation of cytokinesis,11/198,34/12185,3.26E-12,4.01E-11,3.05E-11,CDCA8/KIF14/KIF20B/INCENP/RACGAP1/CIT/KIF23/AURKB/CDC6/BIRC5/ECT2,11,BP
GO:0030174,regulation of DNA-templated DNA replication initiation,8/198,14/12185,1.17E-11,1.42E-10,1.08E-10,TICRR/CDT1/MCM6/MCM5/MCM2/GMNN/MCM3/MCM4,8,BP
GO:0051315,attachment of mitotic spindle microtubules to kinetochore,9/198,21/12185,1.64E-11,1.97E-10,1.50E-10,CDCA8/KIF2C/NUF2/INCENP/CDT1/AURKB/BIRC5/NDC80/CENPE,9,BP
GO:0010639,negative regulation of organelle organization,25/198,314/12185,4.55E-11,5.44E-10,4.14E-10,CDCA8/CDC20/NUF2/CENPF/ZWINT/INCENP/ESPL1/BUB1B/KNL1/PIF1/ZWILCH/PLK1/AURKB/TOP2A/BIRC5/NDC80/SPC24/BUB1/SPC25/TPX2/MAD2L1/TRIP13/CCNB1/TTK/KIF24,25,BP
GO:1901976,regulation of cell cycle checkpoint,11/198,43/12185,5.77E-11,6.83E-10,5.20E-10,CDCA8/INCENP/BRCA2/KNL1/RAD51/WDR76/AURKB/BIRC5/NDC80/MAD2L1/CCNB1,11,BP
GO:1901970,positive regulation of mitotic sister chromatid separation,8/198,17/12185,9.05E-11,1.06E-09,8.08E-10,CDCA8/CDC20/INCENP/ESPL1/DLGAP5/AURKB/BIRC5/UBE2C,8,BP
GO:0045931,positive regulation of mitotic cell cycle,15/198,109/12185,2.27E-10,2.64E-09,2.01E-09,CDC20/STIL/CDC7/DTL/CDK1/RRM1/ESPL1/BRCA2/DLGAP5/CDC6/RRM2/UBE2C/AURKA/CCNB1/CDC25C,15,BP
GO:0090231,regulation of spindle checkpoint,8/198,19/12185,2.74E-10,3.10E-09,2.36E-09,CDCA8/INCENP/KNL1/AURKB/BIRC5/NDC80/MAD2L1/CCNB1,8,BP
GO:0090266,regulation of mitotic cell cycle spindle assembly checkpoint,8/198,19/12185,2.74E-10,3.10E-09,2.36E-09,CDCA8/INCENP/KNL1/AURKB/BIRC5/NDC80/MAD2L1/CCNB1,8,BP
GO:1903504,regulation of mitotic spindle checkpoint,8/198,19/12185,2.74E-10,3.10E-09,2.36E-09,CDCA8/INCENP/KNL1/AURKB/BIRC5/NDC80/MAD2L1/CCNB1,8,BP
GO:0051653,spindle localization,11/198,51/12185,4.27E-10,4.79E-09,3.64E-09,GPSM2/ASPM/ESPL1/NUSAP1/NDE1/PLK1/SPAG5/NDC80/CENPA/MAD2L1/SAPCD2,11,BP
GO:1901992,positive regulation of mitotic cell cycle phase transition,13/198,82/12185,6.20E-10,6.89E-09,5.25E-09,CDC20/STIL/CDC7/DTL/CDK1/RRM1/ESPL1/DLGAP5/CDC6/RRM2/UBE2C/CCNB1/CDC25C,13,BP
GO:1901989,positive regulation of cell cycle phase transition,14/198,99/12185,6.39E-10,7.05E-09,5.37E-09,CDC20/STIL/CDC7/DTL/CDK1/RRM1/ESPL1/DLGAP5/CDC6/RRM2/FAM83D/UBE2C/CCNB1/CDC25C,14,BP
GO:0051293,establishment of spindle localization,10/198,47/12185,3.14E-09,3.43E-08,2.61E-08,GPSM2/ESPL1/NUSAP1/NDE1/PLK1/SPAG5/NDC80/CENPA/MAD2L1/SAPCD2,10,BP
GO:0071897,DNA biosynthetic process,17/198,174/12185,3.18E-09,3.44E-08,2.62E-08,NEK2/DTL/CENPF/RRM1/POLD3/RFC5/RFC3/POLE2/PCLAF/PIF1/AURKB/TK1/POLQ/RFC4/CCNA2/RFC2/DSCC1,17,BP
GO:0030261,chromosome condensation,9/198,35/12185,3.23E-09,3.44E-08,2.62E-08,CDK1/NCAPD2/NUSAP1/PLK1/TOP2A/NCAPH/SMC4/NCAPG/NCAPG2,9,BP
GO:0040001,establishment of mitotic spindle localization,9/198,35/12185,3.23E-09,3.44E-08,2.62E-08,GPSM2/ESPL1/NUSAP1/NDE1/PLK1/NDC80/CENPA/MAD2L1/SAPCD2,9,BP
GO:0031055,chromatin remodeling at centromere,6/198,10/12185,3.40E-09,3.53E-08,2.69E-08,NASP/OIP5/CENPA/HJURP/CENPW/CENPI,6,BP
GO:0034080,CENP-A containing chromatin assembly,6/198,10/12185,3.40E-09,3.53E-08,2.69E-08,NASP/OIP5/CENPA/HJURP/CENPW/CENPI,6,BP
GO:0044771,meiotic cell cycle phase transition,6/198,10/12185,3.40E-09,3.53E-08,2.69E-08,CDC20/CCNB2/PKMYT1/NDC80/CDC25C/TTK,6,BP
GO:0000076,DNA replication checkpoint signaling,7/198,17/12185,4.56E-09,4.67E-08,3.55E-08,CLSPN/ORC1/TIMELESS/TICRR/CDT1/CDC6/CDC45,7,BP
GO:0051382,kinetochore assembly,7/198,17/12185,4.56E-09,4.67E-08,3.55E-08,CENPF/DLGAP5/CENPA/CENPE/CENPK/CENPH/CENPW,7,BP
GO:0051781,positive regulation of cell division,11/198,64/12185,5.54E-09,5.63E-08,4.28E-08,CDCA8/KIF14/KIF20B/INCENP/RACGAP1/CIT/KIF23/AURKB/CDC6/BIRC5/ECT2,11,BP
GO:0000077,DNA damage checkpoint signaling,14/198,121/12185,9.31E-09,9.39E-08,7.15E-08,CLSPN/DTL/CDK1/H2AX/BRCA2/RAD51/WDR76/TICRR/BLM/PLK1/BRIP1/CHEK2/GTSE1/FANCD2,14,BP
GO:0007143,female meiotic nuclear division,8/198,28/12185,9.93E-09,9.93E-08,7.56E-08,CCNB2/PLK1/TOP2A/NDC80/NCAPH/AURKA/TRIP13/TTK,8,BP
GO:0090232,positive regulation of spindle checkpoint,6/198,12/12185,1.45E-08,1.43E-07,1.09E-07,CDCA8/INCENP/AURKB/BIRC5/NDC80/MAD2L1,6,BP
GO:0090267,positive regulation of mitotic cell cycle spindle assembly checkpoint,6/198,12/12185,1.45E-08,1.43E-07,1.09E-07,CDCA8/INCENP/AURKB/BIRC5/NDC80/MAD2L1,6,BP
GO:0035825,homologous recombination,9/198,45/12185,3.52E-08,3.44E-07,2.62E-07,RAD54L/RAD51AP1/RAD51/TOP2A/BRIP1/UHRF1/FANCD2/MND1/TRIP13,9,BP
GO:0051294,establishment of spindle orientation,8/198,35/12185,6.82E-08,6.61E-07,5.04E-07,GPSM2/NDE1/PLK1/SPAG5/NDC80/CENPA/MAD2L1/SAPCD2,8,BP
GO:0006271,DNA strand elongation involved in DNA replication,6/198,15/12185,7.56E-08,7.28E-07,5.54E-07,POLD3/RFC3/GINS1/RFC4/MCM3/MCM4,6,BP
GO:1902750,negative regulation of cell cycle G2/M phase transition,10/198,65/12185,8.42E-08,8.05E-07,6.13E-07,CLSPN/ORC1/DTL/CDK1/TICRR/BLM/PKMYT1/PLK1/AURKB/CDC6,10,BP
GO:0044774,mitotic DNA integrity checkpoint signaling,11/198,84/12185,1.04E-07,9.89E-07,7.53E-07,CLSPN/ORC1/DTL/CDK1/TICRR/BLM/PLK1/CDC6/CHEK2/GTSE1/FANCD2,11,BP
GO:0007131,reciprocal meiotic recombination,8/198,37/12185,1.09E-07,1.01E-06,7.69E-07,RAD54L/RAD51AP1/RAD51/TOP2A/BRIP1/FANCD2/MND1/TRIP13,8,BP
GO:0070192,chromosome organization involved in meiotic cell cycle,8/198,37/12185,1.09E-07,1.01E-06,7.69E-07,NCAPD2/RAD51/BRIP1/NCAPH/FANCD2/SMC4/MND1/TRIP13,8,BP
GO:0140527,reciprocal homologous recombination,8/198,37/12185,1.09E-07,1.01E-06,7.69E-07,RAD54L/RAD51AP1/RAD51/TOP2A/BRIP1/FANCD2/MND1/TRIP13,8,BP
GO:0007098,centrosome cycle,13/198,128/12185,1.53E-07,1.41E-06,1.07E-06,STIL/NEK2/CDK1/KIF11/BRCA2/PCLAF/NDE1/PLK1/NDC80/AURKA/SGO1/PLK4/XRCC2,13,BP
GO:0007062,sister chromatid cohesion,9/198,53/12185,1.57E-07,1.44E-06,1.10E-06,CDC20/ESPL1/BUB1B/PLK1/BUB1/SGO2/SGO1/ESCO2/DSCC1,9,BP
GO:0042770,signal transduction in response to DNA damage,15/198,179/12185,2.15E-07,1.95E-06,1.49E-06,CLSPN/DTL/CDK1/H2AX/FOXM1/BRCA2/RAD51/WDR76/TICRR/BLM/PLK1/BRIP1/CHEK2/GTSE1/FANCD2,15,BP
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,10/198,72/12185,2.29E-07,2.06E-06,1.57E-06,PSRC1/CDKN3/CCNB2/BLM/PKMYT1/PLK1/CDC6/CCNA2/CCNB1/CDC25C,10,BP
GO:1901978,positive regulation of cell cycle checkpoint,6/198,18/12185,2.69E-07,2.41E-06,1.84E-06,CDCA8/INCENP/AURKB/BIRC5/NDC80/MAD2L1,6,BP
GO:1904029,regulation of cyclin-dependent protein kinase activity,10/198,74/12185,2.98E-07,2.65E-06,2.02E-06,PSRC1/CDKN3/CCNB2/BLM/PKMYT1/PLK1/CDC6/CCNA2/CCNB1/CDC25C,10,BP
GO:0071459,"protein localization to chromosome, centromeric region",7/198,29/12185,3.10E-07,2.72E-06,2.07E-06,CDK1/BUB1B/KNL1/ZWILCH/AURKB/CENPA/TTK,7,BP
GO:0032506,cytokinetic process,8/198,42/12185,3.10E-07,2.72E-06,2.07E-06,IQGAP3/KIF20B/CEP55/RACGAP1/AURKB/ECT2/KIF20A/ANLN,8,BP
GO:0007076,mitotic chromosome condensation,6/198,19/12185,3.88E-07,3.38E-06,2.58E-06,NCAPD2/NUSAP1/PLK1/NCAPH/SMC4/NCAPG,6,BP
GO:0000132,establishment of mitotic spindle orientation,7/198,30/12185,3.99E-07,3.45E-06,2.63E-06,GPSM2/NDE1/PLK1/NDC80/CENPA/MAD2L1/SAPCD2,7,BP
GO:0031023,microtubule organizing center organization,13/198,140/12185,4.37E-07,3.76E-06,2.86E-06,STIL/NEK2/CDK1/KIF11/BRCA2/PCLAF/NDE1/PLK1/NDC80/AURKA/SGO1/PLK4/XRCC2,13,BP
GO:0090224,regulation of spindle organization,8/198,44/12185,4.53E-07,3.87E-06,2.95E-06,STIL/GPSM2/PSRC1/BORA/PLK1/SPAG5/TPX2/TACC3,8,BP
GO:0051987,positive regulation of attachment of spindle microtubules to kinetochore,5/198,11/12185,4.60E-07,3.90E-06,2.97E-06,CDCA8/INCENP/AURKB/BIRC5/CCNB1,5,BP
GO:0034502,protein localization to chromosome,11/198,99/12185,5.72E-07,4.83E-06,3.67E-06,CDK1/BRCA2/BUB1B/KNL1/ZWILCH/PLK1/AURKB/CENPA/TTK/MMS22L/ESCO2,11,BP
GO:0010972,negative regulation of G2/M transition of mitotic cell cycle,9/198,62/12185,6.35E-07,5.32E-06,4.05E-06,CLSPN/ORC1/DTL/CDK1/TICRR/BLM/PLK1/AURKB/CDC6,9,BP
GO:0045143,homologous chromosome segregation,7/198,34/12185,9.98E-07,8.31E-06,6.32E-06,ESPL1/PLK1/BRIP1/FANCD2/MND1/TRIP13/PTTG1,7,BP
GO:0010212,response to ionizing radiation,12/198,128/12185,1.11E-06,9.17E-06,6.98E-06,RAD54L/RRM1/H2AX/RAD51AP1/BRCA2/RAD51/TICRR/BLM/CHEK2/FANCD2/ECT2/XRCC2,12,BP
GO:0060623,regulation of chromosome condensation,5/198,13/12185,1.25E-06,1.02E-05,7.75E-06,NCAPD2/NCAPH/SMC4/NCAPG/NCAPG2,5,BP
GO:0090235,regulation of metaphase plate congression,5/198,13/12185,1.25E-06,1.02E-05,7.75E-06,CDCA8/INCENP/AURKB/SPAG5/BIRC5,5,BP
GO:0044818,mitotic G2/M transition checkpoint,8/198,52/12185,1.72E-06,1.40E-05,1.06E-05,CLSPN/ORC1/DTL/CDK1/TICRR/BLM/PLK1/CDC6,8,BP
GO:0051785,positive regulation of nuclear division,7/198,39/12185,2.66E-06,2.15E-05,1.63E-05,CDC20/RAD51AP1/ESPL1/DLGAP5/NUSAP1/UBE2C/AURKA,7,BP
GO:0034501,protein localization to kinetochore,5/198,15/12185,2.83E-06,2.26E-05,1.72E-05,CDK1/KNL1/ZWILCH/AURKB/TTK,5,BP
GO:1903083,protein localization to condensed chromosome,5/198,15/12185,2.83E-06,2.26E-05,1.72E-05,CDK1/KNL1/ZWILCH/AURKB/TTK,5,BP
GO:0060236,regulation of mitotic spindle organization,7/198,40/12185,3.18E-06,2.52E-05,1.92E-05,STIL/GPSM2/PSRC1/BORA/PLK1/TPX2/TACC3,7,BP
GO:0051347,positive regulation of transferase activity,18/198,314/12185,3.58E-06,2.82E-05,2.15E-05,CLSPN/CDC20/PSRC1/KIF14/NEK2/RFC5/RFC3/BORA/PLK1/AURKB/UBE2S/TPX2/UBE2C/ECT2/RFC4/CENPE/RFC2/DSCC1,18,BP
GO:0010971,positive regulation of G2/M transition of mitotic cell cycle,6/198,28/12185,4.77E-06,3.73E-05,2.84E-05,CDC7/DTL/CDK1/RRM1/CCNB1/CDC25C,6,BP
GO:0044773,mitotic DNA damage checkpoint signaling,9/198,80/12185,5.64E-06,4.37E-05,3.32E-05,CLSPN/DTL/CDK1/TICRR/BLM/PLK1/CHEK2/GTSE1/FANCD2,9,BP
GO:0000212,meiotic spindle organization,5/198,17/12185,5.69E-06,4.37E-05,3.32E-05,ASPM/ESPL1/CCNB2/NDC80/AURKA,5,BP
GO:1904666,regulation of ubiquitin protein ligase activity,5/198,17/12185,5.69E-06,4.37E-05,3.32E-05,CDC20/PLK1/UBE2S/UBE2C/MAD2L1,5,BP
GO:0051054,positive regulation of DNA metabolic process,16/198,263/12185,6.02E-06,4.59E-05,3.50E-05,CDC7/NEK2/CDK1/H2AX/FOXM1/RAD51AP1/TIMELESS/RFC5/RFC3/RAD51/CDT1/AURKB/RFC4/CCNA2/RFC2/DSCC1,16,BP
GO:0007292,female gamete generation,10/198,104/12185,7.09E-06,5.38E-05,4.10E-05,ASPM/BRCA2/CCNB2/PLK1/TOP2A/NDC80/NCAPH/AURKA/TRIP13/TTK,10,BP
GO:0045840,positive regulation of mitotic nuclear division,6/198,30/12185,7.32E-06,5.46E-05,4.16E-05,CDC20/ESPL1/DLGAP5/NUSAP1/UBE2C/AURKA,6,BP
GO:0051642,centrosome localization,6/198,30/12185,7.32E-06,5.46E-05,4.16E-05,GPSM2/ASPM/DLGAP5/NDE1/AURKA/MAD2L1,6,BP
GO:0061842,microtubule organizing center localization,6/198,30/12185,7.32E-06,5.46E-05,4.16E-05,GPSM2/ASPM/DLGAP5/NDE1/AURKA/MAD2L1,6,BP
GO:1902751,positive regulation of cell cycle G2/M phase transition,6/198,31/12185,8.96E-06,6.64E-05,5.05E-05,CDC7/DTL/CDK1/RRM1/CCNB1/CDC25C,6,BP
GO:2000573,positive regulation of DNA biosynthetic process,8/198,65/12185,9.64E-06,7.10E-05,5.41E-05,NEK2/RFC5/RFC3/AURKB/RFC4/CCNA2/RFC2/DSCC1,8,BP
GO:0051445,regulation of meiotic cell cycle,7/198,47/12185,9.76E-06,7.15E-05,5.44E-05,CDC20/ASPM/RAD51AP1/PKMYT1/TRIP13/CDC25C/TTK,7,BP
GO:0010638,positive regulation of organelle organization,21/198,443/12185,1.07E-05,7.77E-05,5.92E-05,CDC20/STIL/GPSM2/PSRC1/NEK2/CDK1/RAD51AP1/NCAPD2/ESPL1/DLGAP5/NUSAP1/AURKB/SPAG5/NCAPH/BUB1/UBE2C/AURKA/SMC4/NCAPG/PLK4/NCAPG2,21,BP
GO:0009314,response to radiation,18/198,343/12185,1.21E-05,8.80E-05,6.70E-05,RAD54L/DTL/RRM1/POLD3/H2AX/RAD51AP1/BRCA2/RAD51/PCLAF/TICRR/BLM/AURKB/CHEK2/FANCD2/ECT2/XRCC2/PBK/FANCG,18,BP
GO:0044837,actomyosin contractile ring organization,4/198,10/12185,1.32E-05,9.48E-05,7.22E-05,IQGAP3/RACGAP1/ECT2/ANLN,4,BP
GO:0044843,cell cycle G1/S phase transition,14/198,223/12185,1.64E-05,0.000117648,8.96E-05,E2F2/STIL/CDC7/IQGAP3/KIF14/CDK1/RRM1/CDKN3/CDC6/RRM2/FAM83D/CHEK2/GTSE1/CCNA2,14,BP
GO:0022616,DNA strand elongation,6/198,35/12185,1.87E-05,0.000133298,0.000101482,POLD3/RFC3/GINS1/RFC4/MCM3/MCM4,6,BP
GO:0090306,meiotic spindle assembly,4/198,11/12185,2.04E-05,0.00014469,0.000110156,ASPM/CCNB2/NDC80/AURKA,4,BP
GO:0022412,cellular process involved in reproduction in multicellular organism,15/198,263/12185,2.54E-05,0.000179097,0.00013635,ASPM/KIF18A/BRCA2/KNL1/CCNB2/PLK1/TOP2A/BRIP1/NDC80/NCAPH/AURKA/HMGB2/TRIP13/TTK/FANCG,15,BP
GO:0000731,DNA synthesis involved in DNA repair,6/198,37/12185,2.61E-05,0.000181808,0.000138414,DTL/RRM1/POLD3/RFC3/POLE2/PCLAF,6,BP
GO:0007095,mitotic G2 DNA damage checkpoint signaling,6/198,37/12185,2.61E-05,0.000181808,0.000138414,CLSPN/DTL/CDK1/TICRR/BLM/PLK1,6,BP
GO:0007276,gamete generation,21/198,472/12185,2.75E-05,0.000191001,0.000145414,IFT25/ASPM/KIF18A/H2AX/RACGAP1/BRCA2/KNL1/CCNB2/PLK1/TOP2A/BRIP1/NDC80/NCAPH/AURKA/FANCD2/HMGB2/TRIP13/CDC25C/PTTG1/TTK/FANCG,21,BP
GO:0000082,G1/S transition of mitotic cell cycle,13/198,205/12185,2.98E-05,0.000205609,0.000156534,E2F2/STIL/CDC7/IQGAP3/KIF14/CDK1/RRM1/CDKN3/CDC6/RRM2/CHEK2/GTSE1/CCNA2,13,BP
GO:0036297,interstrand cross-link repair,6/198,38/12185,3.05E-05,0.000209601,0.000159574,RAD51AP1/RAD51/FANCI/FANCD2/NEIL3/FANCG,6,BP
GO:0007018,microtubule-based movement,16/198,302/12185,3.35E-05,0.000228975,0.000174324,KIF2C/IFT25/KIF14/KIF20B/KIF11/KIF18A/DLGAP5/KIF23/NDE1/KIF18B/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,16,BP
GO:0070507,regulation of microtubule cytoskeleton organization,11/198,152/12185,3.72E-05,0.000252481,0.000192219,STIL/GPSM2/PSRC1/KIF18A/SKA3/BORA/PLK1/SPAG5/SKA1/TPX2/TACC3,11,BP
GO:0007100,mitotic centrosome separation,4/198,13/12185,4.31E-05,0.00028967,0.000220532,NEK2/KIF11/NDE1/AURKA,4,BP
GO:0045842,positive regulation of mitotic metaphase/anaphase transition,4/198,13/12185,4.31E-05,0.00028967,0.000220532,CDC20/ESPL1/DLGAP5/UBE2C,4,BP
GO:2001252,positive regulation of chromosome organization,9/198,104/12185,4.78E-05,0.000319482,0.000243229,NEK2/CDK1/NCAPD2/AURKB/NCAPH/BUB1/SMC4/NCAPG/NCAPG2,9,BP
GO:0051299,centrosome separation,4/198,14/12185,5.96E-05,0.000394233,0.000300138,NEK2/KIF11/NDE1/AURKA,4,BP
GO:1902101,positive regulation of metaphase/anaphase transition of cell cycle,4/198,14/12185,5.96E-05,0.000394233,0.000300138,CDC20/ESPL1/DLGAP5/UBE2C,4,BP
GO:2000278,regulation of DNA biosynthetic process,9/198,108/12185,6.44E-05,0.000423558,0.000322464,NEK2/RFC5/RFC3/PIF1/AURKB/RFC4/CCNA2/RFC2/DSCC1,9,BP
GO:0032886,regulation of microtubule-based process,13/198,223/12185,7.12E-05,0.00046629,0.000354997,STIL/GPSM2/PSRC1/KIF18A/SKA3/BORA/PLK1/SPAG5/SKA1/TPX2/AURKA/TACC3/PLK4,13,BP
GO:0071479,cellular response to ionizing radiation,7/198,65/12185,8.44E-05,0.000549824,0.000418593,H2AX/RAD51AP1/BRCA2/RAD51/BLM/CHEK2/ECT2,7,BP
GO:0051053,negative regulation of DNA metabolic process,9/198,114/12185,9.81E-05,0.000635839,0.000484078,TIMELESS/PARPBP/PIF1/BLM/RMI2/CDT1/CDC6/POLQ/GMNN,9,BP
GO:0007064,mitotic sister chromatid cohesion,5/198,31/12185,0.000129773,0.000837037,0.000637255,CDC20/BUB1/SGO1/ESCO2/DSCC1,5,BP
GO:0071478,cellular response to radiation,10/198,151/12185,0.000175898,0.001128899,0.000859456,POLD3/H2AX/RAD51AP1/BRCA2/RAD51/BLM/AURKB/CHEK2/ECT2/PBK,10,BP
GO:0045005,DNA-templated DNA replication maintenance of fidelity,6/198,52/12185,0.000186513,0.001187072,0.000903744,TIMELESS/BRCA2/RAD51/BLM/TRAIP/MMS22L,6,BP
GO:0031109,microtubule polymerization or depolymerization,9/198,124/12185,0.000186803,0.001187072,0.000903744,KIF2C/PSRC1/KIF18A/SKA3/NDE1/KIF18B/SKA1/TPX2/KIF24,9,BP
GO:0072698,protein localization to microtubule cytoskeleton,6/198,53/12185,0.000207512,0.001312207,0.000999012,STIL/KIF20B/SPAG5/FAM83D/AURKA/TTK,6,BP
GO:0051443,positive regulation of ubiquitin-protein transferase activity,4/198,19/12185,0.000216503,0.001362384,0.001037213,CDC20/PLK1/UBE2S/UBE2C,4,BP
GO:0051438,regulation of ubiquitin-protein transferase activity,5/198,35/12185,0.000235219,0.001472974,0.001121408,CDC20/PLK1/UBE2S/UBE2C/MAD2L1,5,BP
GO:0008156,negative regulation of DNA replication,4/198,20/12185,0.000267205,0.001665193,0.001267748,TIMELESS/CDT1/CDC6/GMNN,4,BP
GO:0044380,protein localization to cytoskeleton,6/198,56/12185,0.000281874,0.001748159,0.001330912,STIL/KIF20B/SPAG5/FAM83D/AURKA/TTK,6,BP
GO:0000018,regulation of DNA recombination,8/198,106/12185,0.000326508,0.002015292,0.001534286,RAD51AP1/TIMELESS/PARPBP/RAD51/BLM/RMI2/KPNA2/POLQ,8,BP
GO:0030010,establishment of cell polarity,9/198,134/12185,0.000334157,0.00205268,0.00156275,GPSM2/KIF20B/NDE1/PLK1/SPAG5/NDC80/CENPA/MAD2L1/SAPCD2,9,BP
GO:0031145,anaphase-promoting complex-dependent catabolic process,4/198,22/12185,0.000393294,0.002394822,0.00182323,CDC20/PLK1/UBE2S/UBE2C,4,BP
GO:0034728,nucleosome organization,7/198,83/12185,0.000393568,0.002394822,0.00182323,NASP/H2AX/CHD2/CHAF1A/CHAF1B/MCM2/HMGB2,7,BP
GO:0051447,negative regulation of meiotic cell cycle,3/198,10/12185,0.000466191,0.002784197,0.00211967,PKMYT1/TRIP13/TTK,3,BP
GO:0070601,centromeric sister chromatid cohesion,3/198,10/12185,0.000466191,0.002784197,0.00211967,BUB1B/BUB1/SGO1,3,BP
GO:0072697,protein localization to cell cortex,3/198,10/12185,0.000466191,0.002784197,0.00211967,GPSM2/PLK1/SAPCD2,3,BP
GO:0072711,cellular response to hydroxyurea,3/198,10/12185,0.000466191,0.002784197,0.00211967,TIMELESS/RAD51/BLM,3,BP
GO:0007019,microtubule depolymerization,5/198,41/12185,0.000501801,0.002983054,0.002271065,KIF2C/KIF18A/KIF18B/TPX2/KIF24,5,BP
GO:0045859,regulation of protein kinase activity,16/198,389/12185,0.000612461,0.003624195,0.002759179,CLSPN/PSRC1/KIF14/BORA/CDKN3/CCNB2/BLM/PKMYT1/PLK1/CDC6/TPX2/ECT2/CENPE/CCNA2/CCNB1/CDC25C,16,BP
GO:0051177,meiotic sister chromatid cohesion,3/198,11/12185,0.000633358,0.003692423,0.002811123,BUB1B/BUB1/SGO2,3,BP
GO:0072710,response to hydroxyurea,3/198,11/12185,0.000633358,0.003692423,0.002811123,TIMELESS/RAD51/BLM,3,BP
GO:0006334,nucleosome assembly,6/198,65/12185,0.00063544,0.003692423,0.002811123,NASP/H2AX/CHAF1A/CHAF1B/MCM2/HMGB2,6,BP
GO:0010569,regulation of double-strand break repair via homologous recombination,6/198,65/12185,0.00063544,0.003692423,0.002811123,RAD51AP1/TIMELESS/PARPBP/RAD51/RMI2/POLQ,6,BP
GO:0019985,translesion synthesis,4/198,25/12185,0.000654698,0.003787268,0.00288333,DTL/POLD3/POLE2/PCLAF,4,BP
GO:0007129,homologous chromosome pairing at meiosis,4/198,26/12185,0.000763977,0.004380133,0.003334691,BRIP1/FANCD2/MND1/TRIP13,4,BP
GO:1902410,mitotic cytokinetic process,4/198,26/12185,0.000763977,0.004380133,0.003334691,IQGAP3/KIF20B/CEP55/KIF20A,4,BP
GO:2000779,regulation of double-strand break repair,8/198,122/12185,0.00083626,0.004773344,0.003634051,FOXM1/RAD51AP1/TIMELESS/PARPBP/RAD51/RMI2/POLQ/DEK,8,BP
GO:0010332,response to gamma radiation,5/198,46/12185,0.000859572,0.00486337,0.00370259,H2AX/BRCA2/CHEK2/FANCD2/XRCC2,5,BP
GO:0031297,replication fork processing,5/198,46/12185,0.000859572,0.00486337,0.00370259,BRCA2/RAD51/BLM/TRAIP/MMS22L,5,BP
GO:2000241,regulation of reproductive process,8/198,124/12185,0.000930174,0.005239842,0.003989207,CDC20/ASPM/RAD51AP1/PKMYT1/AURKA/TRIP13/CDC25C/TTK,8,BP
GO:0090435,protein localization to nuclear envelope,3/198,13/12185,0.001071785,0.006011318,0.004576548,PLK1/LMNB2/LMNB1,3,BP
GO:1902808,positive regulation of cell cycle G1/S phase transition,5/198,49/12185,0.001149674,0.006420259,0.004887884,STIL/RRM1/CDC6/RRM2/FAM83D,5,BP
GO:0007163,establishment or maintenance of cell polarity,10/198,195/12185,0.0013155,0.007314635,0.005568792,KIF2C/GPSM2/KIF20B/NDE1/PLK1/SPAG5/NDC80/CENPA/MAD2L1/SAPCD2,10,BP
GO:0001833,inner cell mass cell proliferation,3/198,14/12185,0.001347838,0.007430388,0.005656917,BRCA2/GINS1/NCAPG2,3,BP
GO:0051782,negative regulation of cell division,3/198,14/12185,0.001347838,0.007430388,0.005656917,ASPM/BLM/AURKB,3,BP
GO:0090169,regulation of spindle assembly,4/198,31/12185,0.001509214,0.008284619,0.006307262,STIL/GPSM2/PLK1/SPAG5,4,BP
GO:0006301,postreplication repair,4/198,34/12185,0.002141614,0.011706278,0.008912246,DTL/POLD3/POLE2/PCLAF,4,BP
GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",3/198,17/12185,0.002429142,0.013221912,0.010066131,FOXM1/BRCA2/CHEK2,3,BP
GO:0045910,negative regulation of DNA recombination,4/198,36/12185,0.002652352,0.014376192,0.01094491,PARPBP/BLM/RMI2/POLQ,4,BP
GO:0043549,regulation of kinase activity,16/198,450/12185,0.002764331,0.014920447,0.011359263,CLSPN/PSRC1/KIF14/BORA/CDKN3/CCNB2/BLM/PKMYT1/PLK1/CDC6/TPX2/ECT2/CENPE/CCNA2/CCNB1/CDC25C,16,BP
GO:0042772,"DNA damage response, signal transduction resulting in transcription",3/198,18/12185,0.002880347,0.015481868,0.011786685,FOXM1/BRCA2/CHEK2,3,BP
GO:0030866,cortical actin cytoskeleton organization,4/198,37/12185,0.00293656,0.015718515,0.01196685,IQGAP3/RACGAP1/ECT2/ANLN,4,BP
GO:0032147,activation of protein kinase activity,5/198,61/12185,0.003066255,0.016344915,0.012443742,CLSPN/KIF14/BORA/TPX2/ECT2,5,BP
GO:0061351,neural precursor cell proliferation,7/198,119/12185,0.003256,0.017284938,0.013159402,ASPM/KIF14/RRM1/RACGAP1/NDE1/SHCBP1/MELK,7,BP
GO:0001832,blastocyst growth,3/198,19/12185,0.003379818,0.017795778,0.013548316,BRCA2/GINS1/NCAPG2,3,BP
GO:0040020,regulation of meiotic nuclear division,3/198,19/12185,0.003379818,0.017795778,0.013548316,CDC20/RAD51AP1/TRIP13,3,BP
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,4/198,39/12185,0.003566061,0.018700078,0.014236779,STIL/RRM1/CDC6/RRM2,4,BP
GO:0007548,sex differentiation,9/198,189/12185,0.003736461,0.019514311,0.014856673,NASP/ASPM/RRM1/KIF18A/BRCA2/BRIP1/HMGB2/FANCG/CENPI,9,BP
GO:2000042,negative regulation of double-strand break repair via homologous recombination,3/198,20/12185,0.003929103,0.020437673,0.015559648,PARPBP/RMI2/POLQ,3,BP
GO:0008406,gonad development,8/198,156/12185,0.003948672,0.020456977,0.015574345,NASP/ASPM/RRM1/KIF18A/BRCA2/BRIP1/HMGB2/FANCG,8,BP
GO:0001824,blastocyst development,6/198,94/12185,0.004251951,0.021940065,0.016703452,NASP/NEK2/BRCA2/RRM2/GINS1/NCAPG2,6,BP
GO:0071900,regulation of protein serine/threonine kinase activity,10/198,230/12185,0.004367266,0.02244531,0.017088106,PSRC1/CDKN3/CCNB2/BLM/PKMYT1/PLK1/CDC6/CCNA2/CCNB1/CDC25C,10,BP
GO:0045137,development of primary sexual characteristics,8/198,159/12185,0.004429326,0.022673931,0.017262161,NASP/ASPM/RRM1/KIF18A/BRCA2/BRIP1/HMGB2/FANCG,8,BP
GO:0048232,male gamete generation,13/198,348/12185,0.004512573,0.02300877,0.017517081,IFT25/ASPM/KIF18A/H2AX/RACGAP1/BRCA2/KNL1/BRIP1/HMGB2/TRIP13/CDC25C/PTTG1/FANCG,13,BP
GO:1902806,regulation of cell cycle G1/S phase transition,8/198,160/12185,0.004599162,0.023357949,0.017782918,STIL/KIF14/RRM1/CDC6/RRM2/FAM83D/CHEK2/GTSE1,8,BP
GO:0071168,protein localization to chromatin,4/198,42/12185,0.004672931,0.023639536,0.017997296,PLK1/CENPA/MMS22L/ESCO2,4,BP
GO:0008584,male gonad development,6/198,98/12185,0.005212235,0.026264779,0.019995952,NASP/ASPM/RRM1/KIF18A/BRIP1/HMGB2,6,BP
GO:0006282,regulation of DNA repair,9/198,200/12185,0.005399936,0.027104735,0.020635429,H2AX/FOXM1/RAD51AP1/TIMELESS/PARPBP/RAD51/RMI2/POLQ/DEK,9,BP
GO:0046546,development of primary male sexual characteristics,6/198,99/12185,0.005475287,0.027376435,0.02084228,NASP/ASPM/RRM1/KIF18A/BRIP1/HMGB2,6,BP
GO:0051298,centrosome duplication,5/198,70/12185,0.005548586,0.027635815,0.021039752,STIL/BRCA2/NDE1/NDC80/PLK4,5,BP
GO:0001556,oocyte maturation,3/198,23/12185,0.005889642,0.029109727,0.022161873,BRCA2/AURKA/TRIP13,3,BP
GO:2000001,regulation of DNA damage checkpoint,3/198,23/12185,0.005889642,0.029109727,0.022161873,BRCA2/RAD51/WDR76,3,BP
GO:0030865,cortical cytoskeleton organization,4/198,45/12185,0.005990137,0.029493424,0.02245399,IQGAP3/RACGAP1/ECT2/ANLN,4,BP
GO:0021987,cerebral cortex development,6/198,101/12185,0.006030363,0.029578584,0.022518824,ASPM/KIF14/H2AX/ARHGAP11B/NDE1/TACC3,6,BP
GO:0071392,cellular response to estradiol stimulus,3/198,26/12185,0.008343784,0.040770765,0.031039677,KIF18A/H2AZ1/CCNA2,3,BP
GO:2000045,regulation of G1/S transition of mitotic cell cycle,7/198,143/12185,0.008787806,0.042778374,0.032568113,STIL/KIF14/RRM1/CDC6/RRM2/CHEK2/GTSE1,7,BP
GO:0007283,spermatogenesis,12/198,337/12185,0.009028543,0.043785041,0.033334511,IFT25/ASPM/H2AX/RACGAP1/BRCA2/KNL1/BRIP1/HMGB2/TRIP13/CDC25C/PTTG1/FANCG,12,BP
GO:0007140,male meiotic nuclear division,3/198,27/12185,0.009276065,0.044649717,0.033992808,KIF18A/BRCA2/TRIP13,3,BP
GO:0010165,response to X-ray,3/198,27/12185,0.009276065,0.044649717,0.033992808,BRCA2/BLM/XRCC2,3,BP
GO:0000723,telomere maintenance,7/198,145/12185,0.00944777,0.04530715,0.034493326,NEK2/EXO1/BRCA2/RAD51/PIF1/BLM/AURKB,7,BP
GO:0046661,male sex differentiation,6/198,113/12185,0.010254917,0.048995715,0.037301511,NASP/ASPM/RRM1/KIF18A/BRIP1/HMGB2,6,BP
GO:0071214,cellular response to abiotic stimulus,10/198,262/12185,0.010568561,0.050122954,0.038159703,POLD3/H2AX/RAD51AP1/BRCA2/RAD51/BLM/AURKB/CHEK2/ECT2/PBK,10,BP
GO:0104004,cellular response to environmental stimulus,10/198,262/12185,0.010568561,0.050122954,0.038159703,POLD3/H2AX/RAD51AP1/BRCA2/RAD51/BLM/AURKB/CHEK2/ECT2/PBK,10,BP
GO:0035561,regulation of chromatin binding,2/198,10/12185,0.010850133,0.051269861,0.039032869,CDT1/GMNN,2,BP
GO:0070979,protein K11-linked ubiquitination,3/198,29/12185,0.011316589,0.053278833,0.040562343,UBE2T/UBE2S/UBE2C,3,BP
GO:0006298,mismatch repair,3/198,30/12185,0.012426075,0.058078392,0.044216353,EXO1/POLD3/RNASEH2A,3,BP
GO:0010458,exit from mitosis,3/198,30/12185,0.012426075,0.058078392,0.044216353,UBE2S/UBE2C/ANLN,3,BP
GO:0016446,somatic hypermutation of immunoglobulin genes,2/198,11/12185,0.013120528,0.060448147,0.046020499,EXO1/POLQ,2,BP
GO:0033262,regulation of nuclear cell cycle DNA replication,2/198,11/12185,0.013120528,0.060448147,0.046020499,CDC7/CDT1,2,BP
GO:0042276,error-prone translesion synthesis,2/198,11/12185,0.013120528,0.060448147,0.046020499,POLD3/POLE2,2,BP
GO:0085020,protein K6-linked ubiquitination,2/198,11/12185,0.013120528,0.060448147,0.046020499,UBE2T/UBE2S,2,BP
GO:0032200,telomere organization,7/198,157/12185,0.014191771,0.065150835,0.049600758,NEK2/EXO1/BRCA2/RAD51/PIF1/BLM/AURKB,7,BP
GO:0072331,signal transduction by p53 class mediator,7/198,158/12185,0.014651982,0.067025025,0.05102762,E2F2/FOXM1/BRCA2/AURKB/AURKA/CHEK2/GTSE1,7,BP
GO:0071312,cellular response to alkaloid,3/198,32/12185,0.014826008,0.067343487,0.051270072,RAD51/BLM/CCNA2,3,BP
GO:2000780,negative regulation of double-strand break repair,3/198,32/12185,0.014826008,0.067343487,0.051270072,PARPBP/RMI2/POLQ,3,BP
GO:0002566,somatic diversification of immune receptors via somatic mutation,2/198,12/12185,0.015577754,0.068819529,0.052393815,EXO1/POLQ,2,BP
GO:0009263,deoxyribonucleotide biosynthetic process,2/198,12/12185,0.015577754,0.068819529,0.052393815,RRM1/RRM2,2,BP
GO:0009265,2'-deoxyribonucleotide biosynthetic process,2/198,12/12185,0.015577754,0.068819529,0.052393815,RRM1/RRM2,2,BP
GO:0010992,ubiquitin recycling,2/198,12/12185,0.015577754,0.068819529,0.052393815,UBE2S/UBE2C,2,BP
GO:0046385,deoxyribose phosphate biosynthetic process,2/198,12/12185,0.015577754,0.068819529,0.052393815,RRM1/RRM2,2,BP
GO:0051290,protein heterotetramerization,2/198,12/12185,0.015577754,0.068819529,0.052393815,RRM1/RRM2,2,BP
GO:0051657,maintenance of organelle location,2/198,12/12185,0.015577754,0.068819529,0.052393815,GPSM2/ASPM,2,BP
GO:1903429,regulation of cell maturation,2/198,12/12185,0.015577754,0.068819529,0.052393815,KIF14/AURKA,2,BP
GO:0071539,protein localization to centrosome,3/198,33/12185,0.01611724,0.07095986,0.054023296,STIL/SPAG5/AURKA,3,BP
GO:0045738,negative regulation of DNA repair,3/198,34/12185,0.017469719,0.076134926,0.057963187,PARPBP/RMI2/POLQ,3,BP
GO:0045740,positive regulation of DNA replication,3/198,34/12185,0.017469719,0.076134926,0.057963187,CDC7/CDK1/CDT1,3,BP
GO:1905508,protein localization to microtubule organizing center,3/198,34/12185,0.017469719,0.076134926,0.057963187,STIL/SPAG5/AURKA,3,BP
GO:0007281,germ cell development,8/198,203/12185,0.017871715,0.077624621,0.059097325,ASPM/BRCA2/KNL1/BRIP1/AURKA/HMGB2/TRIP13/FANCG,8,BP
GO:0014841,skeletal muscle satellite cell proliferation,2/198,13/12185,0.018215203,0.07780666,0.059235915,NDC80/DSN1,2,BP
GO:0033599,regulation of mammary gland epithelial cell proliferation,2/198,13/12185,0.018215203,0.07780666,0.059235915,IQGAP3/BRCA2,2,BP
GO:0034086,maintenance of sister chromatid cohesion,2/198,13/12185,0.018215203,0.07780666,0.059235915,BUB1/DSCC1,2,BP
GO:0034088,maintenance of mitotic sister chromatid cohesion,2/198,13/12185,0.018215203,0.07780666,0.059235915,BUB1/DSCC1,2,BP
GO:2000105,positive regulation of DNA-templated DNA replication,2/198,13/12185,0.018215203,0.07780666,0.059235915,CDC7/CDT1,2,BP
GO:0001701,in utero embryonic development,11/198,330/12185,0.019041948,0.081069678,0.061720122,NASP/STIL/NEK2/BRCA2/CCNB2/RRM2/GINS1/PLK4/CCNB1/XRCC2/NCAPG2,11,BP
GO:0001934,positive regulation of protein phosphorylation,13/198,420/12185,0.019694544,0.083572243,0.06362538,CLSPN/CDCA8/PSRC1/IQGAP3/KIF14/INCENP/BORA/PLK1/AURKB/BIRC5/TPX2/ECT2/CENPE,13,BP
GO:0048608,reproductive structure development,8/198,207/12185,0.019844079,0.083930696,0.063898278,NASP/ASPM/RRM1/KIF18A/BRCA2/BRIP1/HMGB2/FANCG,8,BP
GO:0031398,positive regulation of protein ubiquitination,5/198,96/12185,0.020026916,0.084427196,0.064276274,CDC20/FANCI/PLK1/UBE2S/UBE2C,5,BP
GO:0000722,telomere maintenance via recombination,2/198,14/12185,0.02102643,0.086658449,0.065974976,BRCA2/RAD51,2,BP
GO:0001325,formation of extrachromosomal circular DNA,2/198,14/12185,0.02102643,0.086658449,0.065974976,EXO1/BLM,2,BP
GO:0010457,centriole-centriole cohesion,2/198,14/12185,0.02102643,0.086658449,0.065974976,NEK2/SGO1,2,BP
GO:0070193,synaptonemal complex organization,2/198,14/12185,0.02102643,0.086658449,0.065974976,PLK1/TRIP13,2,BP
GO:0072520,seminiferous tubule development,2/198,14/12185,0.02102643,0.086658449,0.065974976,KIF18A/BRIP1,2,BP
GO:0090656,t-circle formation,2/198,14/12185,0.02102643,0.086658449,0.065974976,EXO1/BLM,2,BP
GO:0090737,telomere maintenance via telomere trimming,2/198,14/12185,0.02102643,0.086658449,0.065974976,EXO1/BLM,2,BP
GO:0061458,reproductive system development,8/198,210/12185,0.021421967,0.088007445,0.067001996,NASP/ASPM/RRM1/KIF18A/BRCA2/BRIP1/HMGB2/FANCG,8,BP
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",4/198,67/12185,0.0234158,0.095589818,0.072774623,FOXM1/BRCA2/CHEK2/GTSE1,4,BP
GO:0048477,oogenesis,4/198,67/12185,0.0234158,0.095589818,0.072774623,ASPM/BRCA2/AURKA/TRIP13,4,BP
GO:0007141,male meiosis I,2/198,15/12185,0.024005152,0.097074124,0.073904658,BRCA2/TRIP13,2,BP
GO:0048308,organelle inheritance,2/198,15/12185,0.024005152,0.097074124,0.073904658,CDK1/PLK1,2,BP
GO:0048313,Golgi inheritance,2/198,15/12185,0.024005152,0.097074124,0.073904658,CDK1/PLK1,2,BP
GO:0051261,protein depolymerization,5/198,101/12185,0.024339287,0.098117752,0.074699194,KIF2C/KIF18A/KIF18B/TPX2/KIF24,5,BP
GO:0051493,regulation of cytoskeleton organization,13/198,436/12185,0.025782294,0.103611087,0.078881391,STIL/GPSM2/PSRC1/KIF18A/SKA3/BORA/PLK1/SPAG5/SKA1/TPX2/ECT2/TACC3/PLK4,13,BP
GO:0045814,"negative regulation of gene expression, epigenetic",5/198,103/12185,0.026219125,0.105039352,0.07996876,HELLS/LMNB2/UHRF1/LMNB1/PHF19,5,BP
GO:0006266,DNA ligation,2/198,16/12185,0.02714524,0.107086725,0.08152747,RAD51/TOP2A,2,BP
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",2/198,16/12185,0.02714524,0.107086725,0.08152747,CHEK2/GTSE1,2,BP
GO:0007096,regulation of exit from mitosis,2/198,16/12185,0.02714524,0.107086725,0.08152747,UBE2C/ANLN,2,BP
GO:0021846,cell proliferation in forebrain,2/198,16/12185,0.02714524,0.107086725,0.08152747,KIF14/RRM1,2,BP
GO:0031573,mitotic intra-S DNA damage checkpoint signaling,2/198,16/12185,0.02714524,0.107086725,0.08152747,CHEK2/FANCD2,2,BP
GO:0048146,positive regulation of fibroblast proliferation,3/198,41/12185,0.028662855,0.112728911,0.08582299,CDC6/CCNA2/CCNB1,3,BP
GO:0009411,response to UV,6/198,143/12185,0.029208947,0.114180427,0.086928061,DTL/POLD3/BRCA2/PCLAF/AURKB/PBK,6,BP
GO:1901875,positive regulation of post-translational protein modification,6/198,143/12185,0.029208947,0.114180427,0.086928061,CDC20/FANCI/PLK1/UBE2S/UBE2C/DEK,6,BP
GO:0007063,regulation of sister chromatid cohesion,2/198,17/12185,0.030440719,0.11678226,0.088908893,ESPL1/BUB1,2,BP
GO:0014856,skeletal muscle cell proliferation,2/198,17/12185,0.030440719,0.11678226,0.088908893,NDC80/DSN1,2,BP
GO:0051446,positive regulation of meiotic cell cycle,2/198,17/12185,0.030440719,0.11678226,0.088908893,RAD51AP1/CDC25C,2,BP
GO:0061952,midbody abscission,2/198,17/12185,0.030440719,0.11678226,0.088908893,CEP55/KIF20A,2,BP
GO:1904355,positive regulation of telomere capping,2/198,17/12185,0.030440719,0.11678226,0.088908893,NEK2/AURKB,2,BP
GO:0048599,oocyte development,3/198,42/12185,0.030508234,0.11678226,0.088908893,BRCA2/AURKA/TRIP13,3,BP
GO:2000242,negative regulation of reproductive process,3/198,42/12185,0.030508234,0.11678226,0.088908893,PKMYT1/TRIP13/TTK,3,BP
GO:0021543,pallium development,6/198,145/12185,0.030973381,0.118212015,0.089997397,ASPM/KIF14/H2AX/ARHGAP11B/NDE1/TACC3,6,BP
GO:0006513,protein monoubiquitination,3/198,43/12185,0.032414765,0.122985434,0.093631505,UBE2T/DTL/UHRF1,3,BP
GO:0009994,oocyte differentiation,3/198,43/12185,0.032414765,0.122985434,0.093631505,BRCA2/AURKA/TRIP13,3,BP
GO:0007286,spermatid development,5/198,110/12185,0.033518524,0.12680028,0.096535831,KNL1/BRIP1/HMGB2/TRIP13/FANCG,5,BP
GO:0000729,DNA double-strand break processing,2/198,18/12185,0.033885766,0.127814731,0.097308155,BLM/BRIP1,2,BP
GO:0010833,telomere maintenance via telomere lengthening,4/198,76/12185,0.03506592,0.1314972,0.1001117,NEK2/RAD51/PIF1/AURKB,4,BP
GO:1902117,positive regulation of organelle assembly,4/198,76/12185,0.03506592,0.1314972,0.1001117,STIL/GPSM2/SPAG5/PLK4,4,BP
GO:0031100,animal organ regeneration,3/198,45/12185,0.03641019,0.135748973,0.103348668,CDK1/AURKA/CCNA2,3,BP
GO:0051972,regulation of telomerase activity,3/198,45/12185,0.03641019,0.135748973,0.103348668,NEK2/PIF1/AURKB,3,BP
GO:0031507,heterochromatin formation,4/198,77/12185,0.036534098,0.135818405,0.103401527,HELLS/LMNB2/UHRF1/LMNB1,4,BP
GO:0042327,positive regulation of phosphorylation,13/198,461/12185,0.037929477,0.140600649,0.107042355,CLSPN/CDCA8/PSRC1/IQGAP3/KIF14/INCENP/BORA/PLK1/AURKB/BIRC5/TPX2/ECT2/CENPE,13,BP
GO:0048515,spermatid differentiation,5/198,116/12185,0.04069039,0.150402874,0.114505003,KNL1/BRIP1/HMGB2/TRIP13/FANCG,5,BP
GO:1903322,positive regulation of protein modification by small protein conjugation or removal,5/198,118/12185,0.043272483,0.159490009,0.121423239,CDC20/FANCI/PLK1/UBE2S/UBE2C,5,BP
GO:0046599,regulation of centriole replication,2/198,21/12185,0.045062237,0.165142858,0.125726876,STIL/PLK4,2,BP
GO:0097150,neuronal stem cell population maintenance,2/198,21/12185,0.045062237,0.165142858,0.125726876,ASPM/FANCD2,2,BP
GO:0018209,peptidyl-serine modification,8/198,244/12185,0.045881173,0.167667741,0.127649125,CLSPN/CDC7/CDK1/POGLUT3/PLK1/AURKA/TTK/PBK,8,BP
GO:0070828,heterochromatin organization,4/198,84/12185,0.047793464,0.174162622,0.13259382,HELLS/LMNB2/UHRF1/LMNB1,4,BP
GO:0033598,mammary gland epithelial cell proliferation,2/198,22/12185,0.049050187,0.177738036,0.135315861,IQGAP3/BRCA2,2,BP
GO:0051291,protein heterooligomerization,2/198,22/12185,0.049050187,0.177738036,0.135315861,RRM1/RRM2,2,BP
GO:0046605,regulation of centrosome cycle,3/198,51/12185,0.049828406,0.180052224,0.137077703,STIL/AURKA/PLK4,3,BP
GO:0045860,positive regulation of protein kinase activity,7/198,206/12185,0.051135086,0.184257711,0.140279432,CLSPN/PSRC1/KIF14/BORA/TPX2/ECT2/CENPE,7,BP
GO:0032210,regulation of telomere maintenance via telomerase,3/198,52/12185,0.052268732,0.187296288,0.142592768,NEK2/PIF1/AURKB,3,BP
GO:2000243,positive regulation of reproductive process,3/198,52/12185,0.052268732,0.187296288,0.142592768,RAD51AP1/AURKA/CDC25C,3,BP
GO:0006997,nucleus organization,5/198,125/12185,0.053072509,0.188918243,0.143827597,CDK1/PLK1/LMNB2/HMGB2/LMNB1,5,BP
GO:0006312,mitotic recombination,2/198,23/12185,0.053160715,0.188918243,0.143827597,BRCA2/RAD51,2,BP
GO:0007097,nuclear migration,2/198,23/12185,0.053160715,0.188918243,0.143827597,LMNB2/LMNB1,2,BP
GO:0006998,nuclear envelope organization,3/198,53/12185,0.054765881,0.194087874,0.147763351,PLK1/LMNB2/LMNB1,3,BP
GO:0048144,fibroblast proliferation,4/198,88/12185,0.054997306,0.194374039,0.147981214,CDK1/CDC6/CCNA2/CCNB1,4,BP
GO:0031110,regulation of microtubule polymerization or depolymerization,4/198,89/12185,0.056885106,0.200496685,0.152642519,PSRC1/SKA3/SKA1/TPX2,4,BP
GO:0071353,cellular response to interleukin-4,2/198,24/12185,0.05738883,0.201720954,0.153574582,TUBA1B/MCM2,2,BP
GO:0007405,neuroblast proliferation,3/198,55/12185,0.059928195,0.210074379,0.159934227,ASPM/RACGAP1/NDE1,3,BP
GO:0070670,response to interleukin-4,2/198,25/12185,0.061729668,0.215802903,0.164295478,TUBA1B/MCM2,2,BP
GO:0071480,cellular response to gamma radiation,2/198,26/12185,0.066178491,0.230108501,0.175186643,H2AX/CHEK2,2,BP
GO:1904353,regulation of telomere capping,2/198,26/12185,0.066178491,0.230108501,0.175186643,NEK2/AURKB,2,BP
GO:0014855,striated muscle cell proliferation,3/198,58/12185,0.068081868,0.236090349,0.179740755,CDK1/NDC80/DSN1,3,BP
GO:0031396,regulation of protein ubiquitination,6/198,178/12185,0.07039839,0.241982054,0.184226239,CDC20/FANCI/PLK1/UBE2S/UBE2C/MAD2L1,6,BP
GO:0009185,ribonucleoside diphosphate metabolic process,2/198,27/12185,0.070730685,0.241982054,0.184226239,RRM1/RRM2,2,BP
GO:0031571,mitotic G1 DNA damage checkpoint signaling,2/198,27/12185,0.070730685,0.241982054,0.184226239,CHEK2/GTSE1,2,BP
GO:0044819,mitotic G1/S transition checkpoint signaling,2/198,27/12185,0.070730685,0.241982054,0.184226239,CHEK2/GTSE1,2,BP
GO:1904385,cellular response to angiotensin,2/198,27/12185,0.070730685,0.241982054,0.184226239,CDC6/BRIP1,2,BP
GO:1904356,regulation of telomere maintenance via telomere lengthening,3/198,59/12185,0.070906369,0.241982054,0.184226239,NEK2/PIF1/AURKB,3,BP
GO:0051098,regulation of binding,7/198,223/12185,0.071771528,0.244288314,0.185982046,PLK1/CDT1/AURKB/HJURP/AURKA/HMGB2/GMNN,7,BP
GO:1990776,response to angiotensin,2/198,28/12185,0.075381755,0.255901221,0.194823206,CDC6/BRIP1,2,BP
GO:0006303,double-strand break repair via nonhomologous end joining,3/198,62/12185,0.079689377,0.269108106,0.204877897,POLQ/HMGB2/DEK,3,BP
GO:0051262,protein tetramerization,3/198,62/12185,0.079689377,0.269108106,0.204877897,RRM1/TK1/RRM2,3,BP
GO:0051259,protein complex oligomerization,6/198,185/12185,0.081337478,0.273956519,0.2085691,RRM1/BLM/TK1/RRM2/POLQ/ECT2,6,BP
GO:0002200,somatic diversification of immune receptors,3/198,63/12185,0.082717643,0.277879583,0.211555815,EXO1/POLQ/HMGB2,3,BP
GO:0000002,mitochondrial genome maintenance,2/198,30/12185,0.084963126,0.283944127,0.216172885,RRM1/PIF1,2,BP
GO:0051647,nucleus localization,2/198,30/12185,0.084963126,0.283944127,0.216172885,LMNB2/LMNB1,2,BP
GO:0018105,peptidyl-serine phosphorylation,7/198,235/12185,0.088939138,0.296463792,0.22570438,CLSPN/CDC7/CDK1/PLK1/AURKA/TTK/PBK,7,BP
GO:0009132,nucleoside diphosphate metabolic process,2/198,31/12185,0.089885015,0.298844509,0.227516872,RRM1/RRM2,2,BP
GO:0007004,telomere maintenance via telomerase,3/198,66/12185,0.092093035,0.304615422,0.231910395,NEK2/PIF1/AURKB,3,BP
GO:0009798,axis specification,3/198,66/12185,0.092093035,0.304615422,0.231910395,STIL/IFT25/AURKA,3,BP
GO:1902115,regulation of organelle assembly,6/198,192/12185,0.093174449,0.307404194,0.234033548,STIL/GPSM2/PLK1/SPAG5/PLK4/KIF24,6,BP
GO:0002244,hematopoietic progenitor cell differentiation,4/198,106/12185,0.094118768,0.309727578,0.235802391,CHD2/TOP2A/ANLN/ESCO2,4,BP
GO:0006278,RNA-templated DNA biosynthetic process,3/198,67/12185,0.09531228,0.312857102,0.238184966,NEK2/PIF1/AURKB,3,BP
GO:0048469,cell maturation,4/198,107/12185,0.096599053,0.316276087,0.240787915,KIF14/BRCA2/AURKA/TRIP13,4,BP
GO:0009394,2'-deoxyribonucleotide metabolic process,2/198,33/12185,0.099970995,0.323214494,0.246070276,RRM1/RRM2,2,BP
GO:0042307,positive regulation of protein import into nucleus,2/198,33/12185,0.099970995,0.323214494,0.246070276,CDK1/ECT2,2,BP
GO:0051973,positive regulation of telomerase activity,2/198,33/12185,0.099970995,0.323214494,0.246070276,NEK2/AURKB,2,BP
GO:0090102,cochlea development,2/198,33/12185,0.099970995,0.323214494,0.246070276,MCM2/CCNA2,2,BP
GO:1905168,positive regulation of double-strand break repair via homologous recombination,2/198,33/12185,0.099970995,0.323214494,0.246070276,RAD51AP1/TIMELESS,2,BP
GO:0030900,forebrain development,8/198,291/12185,0.102316182,0.329969687,0.251213152,STIL/ASPM/KIF14/RRM1/H2AX/ARHGAP11B/NDE1/TACC3,8,BP
GO:0009262,deoxyribonucleotide metabolic process,2/198,34/12185,0.105127324,0.336511783,0.256193793,RRM1/RRM2,2,BP
GO:0019692,deoxyribose phosphate metabolic process,2/198,34/12185,0.105127324,0.336511783,0.256193793,RRM1/RRM2,2,BP
GO:0032212,positive regulation of telomere maintenance via telomerase,2/198,34/12185,0.105127324,0.336511783,0.256193793,NEK2/AURKB,2,BP
GO:0033674,positive regulation of kinase activity,7/198,246/12185,0.106549262,0.340219177,0.259016314,CLSPN/PSRC1/KIF14/BORA/TPX2/ECT2/CENPE,7,BP
GO:0043279,response to alkaloid,3/198,71/12185,0.108637241,0.34602973,0.263440015,RAD51/BLM/CCNA2,3,BP
GO:0048145,regulation of fibroblast proliferation,3/198,72/12185,0.112076147,0.356104013,0.271109787,CDC6/CCNA2/CCNB1,3,BP
GO:0071241,cellular response to inorganic substance,5/198,157/12185,0.112813902,0.357567404,0.272223898,TIMELESS/RAD51/BLM/ECT2/CCNA2,5,BP
GO:0051101,regulation of DNA binding,3/198,74/12185,0.119077007,0.376493479,0.286632734,CDT1/HJURP/HMGB2,3,BP
GO:0016233,telomere capping,2/198,37/12185,0.121005263,0.380723876,0.289853428,NEK2/AURKB,2,BP
GO:1904358,positive regulation of telomere maintenance via telomere lengthening,2/198,37/12185,0.121005263,0.380723876,0.289853428,NEK2/AURKB,2,BP
GO:0051495,positive regulation of cytoskeleton organization,5/198,161/12185,0.121917982,0.382662279,0.291329177,STIL/GPSM2/PSRC1/SPAG5/PLK4,5,BP
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,3/198,75/12185,0.122637185,0.383985362,0.292336469,E2F2/BRCA2/CHEK2,3,BP
GO:0021537,telencephalon development,6/198,210/12185,0.127592166,0.398036511,0.303033916,ASPM/KIF14/H2AX/ARHGAP11B/NDE1/TACC3,6,BP
GO:1901873,regulation of post-translational protein modification,7/198,258/12185,0.12774195,0.398036511,0.303033916,CDC20/FANCI/PLK1/UBE2S/UBE2C/MAD2L1/DEK,7,BP
GO:0045739,positive regulation of DNA repair,4/198,119/12185,0.128653771,0.399911722,0.304461556,H2AX/FOXM1/RAD51AP1/TIMELESS,4,BP
GO:0007099,centriole replication,2/198,39/12185,0.131896309,0.407048417,0.309894878,STIL/PLK4,2,BP
GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,2/198,39/12185,0.131896309,0.407048417,0.309894878,BRCA2/CHEK2,2,BP
GO:0099024,plasma membrane invagination,2/198,39/12185,0.131896309,0.407048417,0.309894878,AURKB/XKR5,2,BP
GO:0001578,microtubule bundle formation,3/198,78/12185,0.133545978,0.411155876,0.313021976,PSRC1/PLK1/KIF20A,3,BP
GO:0046777,protein autophosphorylation,5/198,167/12185,0.136194483,0.418104649,0.31831223,NEK2/AURKB/AURKA/CHEK2/MELK,5,BP
GO:0006289,nucleotide-excision repair,3/198,79/12185,0.137255335,0.418104649,0.31831223,POLD3/BRCA2/BRIP1,3,BP
GO:0032355,response to estradiol,3/198,79/12185,0.137255335,0.418104649,0.31831223,KIF18A/H2AZ1/CCNA2,3,BP
GO:2000781,positive regulation of double-strand break repair,3/198,79/12185,0.137255335,0.418104649,0.31831223,FOXM1/RAD51AP1/TIMELESS,3,BP
GO:0009116,nucleoside metabolic process,2/198,40/12185,0.137423544,0.418104649,0.31831223,TK1/MACROD2,2,BP
GO:1900182,positive regulation of protein localization to nucleus,3/198,81/12185,0.144778284,0.439444672,0.334558857,CDK1/PLK1/ECT2,3,BP
GO:0098534,centriole assembly,2/198,42/12185,0.148625654,0.448282802,0.341287519,STIL/PLK4,2,BP
GO:1903320,regulation of protein modification by small protein conjugation or removal,6/198,220/12185,0.14904172,0.448282802,0.341287519,CDC20/FANCI/PLK1/UBE2S/UBE2C/MAD2L1,6,BP
GO:0021681,cerebellar granular layer development,1/198,10/12185,0.151165131,0.448282802,0.341287519,KIF14,1,BP
GO:0035066,positive regulation of histone acetylation,1/198,10/12185,0.151165131,0.448282802,0.341287519,DEK,1,BP
GO:0043652,engulfment of apoptotic cell,1/198,10/12185,0.151165131,0.448282802,0.341287519,XKR5,1,BP
GO:0051081,nuclear membrane disassembly,1/198,10/12185,0.151165131,0.448282802,0.341287519,PLK1,1,BP
GO:0051764,actin crosslink formation,1/198,10/12185,0.151165131,0.448282802,0.341287519,GAS2L3,1,BP
GO:0055015,ventricular cardiac muscle cell development,1/198,10/12185,0.151165131,0.448282802,0.341287519,CDK1,1,BP
GO:0090657,telomeric loop disassembly,1/198,10/12185,0.151165131,0.448282802,0.341287519,BLM,1,BP
GO:1903671,negative regulation of sprouting angiogenesis,1/198,10/12185,0.151165131,0.448282802,0.341287519,E2F2,1,BP
GO:0032873,negative regulation of stress-activated MAPK cascade,2/198,43/12185,0.154294478,0.455468824,0.346758395,FOXM1/PBK,2,BP
GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,2/198,43/12185,0.154294478,0.455468824,0.346758395,FOXM1/PBK,2,BP
GO:0006284,base-excision repair,2/198,44/12185,0.160004587,0.470172932,0.357952954,POLQ/NEIL3,2,BP
GO:0010824,regulation of centrosome duplication,2/198,44/12185,0.160004587,0.470172932,0.357952954,STIL/PLK4,2,BP
GO:0042176,regulation of protein catabolic process,8/198,326/12185,0.161853843,0.474105501,0.360946905,CDC20/DTL/PLK1/FAM83D/AURKA/CHEK2/MAD2L1/PBK,8,BP
GO:0007130,synaptonemal complex assembly,1/198,11/12185,0.164969591,0.474105501,0.360946905,TRIP13,1,BP
GO:0008272,sulfate transport,1/198,11/12185,0.164969591,0.474105501,0.360946905,RACGAP1,1,BP
GO:0023035,CD40 signaling pathway,1/198,11/12185,0.164969591,0.474105501,0.360946905,FANCD2,1,BP
GO:0030397,membrane disassembly,1/198,11/12185,0.164969591,0.474105501,0.360946905,PLK1,1,BP
GO:0032688,negative regulation of interferon-beta production,1/198,11/12185,0.164969591,0.474105501,0.360946905,TRAIP,1,BP
GO:0033623,regulation of integrin activation,1/198,11/12185,0.164969591,0.474105501,0.360946905,KIF14,1,BP
GO:0071371,cellular response to gonadotropin stimulus,1/198,11/12185,0.164969591,0.474105501,0.360946905,CCNA2,1,BP
GO:0034504,protein localization to nucleus,7/198,277/12185,0.165259551,0.474105501,0.360946905,CDK1/POLA2/PLK1/KPNA2/LMNB2/ECT2/LMNB1,7,BP
GO:0007020,microtubule nucleation,2/198,45/12185,0.165753163,0.474105501,0.360946905,NDE1/TPX2,2,BP
GO:0032608,interferon-beta production,2/198,45/12185,0.165753163,0.474105501,0.360946905,TRAIP/HMGB2,2,BP
GO:0032648,regulation of interferon-beta production,2/198,45/12185,0.165753163,0.474105501,0.360946905,TRAIP/HMGB2,2,BP
GO:0034644,cellular response to UV,3/198,87/12185,0.168116275,0.479800875,0.365282918,POLD3/AURKB/PBK,3,BP
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,4/198,133/12185,0.170811317,0.486416334,0.370319412,CDC20/PLK1/AURKA/PBK,4,BP
GO:0010324,membrane invagination,2/198,46/12185,0.17153747,0.487408229,0.371074563,AURKB/XKR5,2,BP
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,3/198,88/12185,0.17210871,0.487956561,0.371492021,CDC20/PLK1/AURKA,3,BP
GO:0046785,microtubule polymerization,3/198,89/12185,0.176128138,0.49533411,0.37710871,PSRC1/NDE1/TPX2,3,BP
GO:0002903,negative regulation of B cell apoptotic process,1/198,12/12185,0.178550667,0.49533411,0.37710871,AURKB,1,BP
GO:0006285,"base-excision repair, AP site formation",1/198,12/12185,0.178550667,0.49533411,0.37710871,NEIL3,1,BP
GO:0030214,hyaluronan catabolic process,1/198,12/12185,0.178550667,0.49533411,0.37710871,HMMR,1,BP
GO:0035331,negative regulation of hippo signaling,1/198,12/12185,0.178550667,0.49533411,0.37710871,CIT,1,BP
GO:0044320,cellular response to leptin stimulus,1/198,12/12185,0.178550667,0.49533411,0.37710871,CCNA2,1,BP
GO:0048532,anatomical structure arrangement,1/198,12/12185,0.178550667,0.49533411,0.37710871,KIF14,1,BP
GO:0055057,neuroblast division,1/198,12/12185,0.178550667,0.49533411,0.37710871,ASPM,1,BP
GO:0071732,cellular response to nitric oxide,1/198,12/12185,0.178550667,0.49533411,0.37710871,CCNA2,1,BP
GO:0140719,constitutive heterochromatin formation,1/198,12/12185,0.178550667,0.49533411,0.37710871,HELLS,1,BP
GO:0051260,protein homooligomerization,4/198,136/12185,0.180415864,0.499434474,0.380230408,BLM/TK1/POLQ/ECT2,4,BP
GO:0042752,regulation of circadian rhythm,3/198,92/12185,0.188339606,0.520252874,0.396079911,CDK1/TIMELESS/TOP2A,3,BP
GO:0042306,regulation of protein import into nucleus,2/198,49/12185,0.189078544,0.521178039,0.39678426,CDK1/ECT2,2,BP
GO:0000712,resolution of meiotic recombination intermediates,1/198,13/12185,0.191911956,0.52119247,0.396795247,TOP2A,1,BP
GO:0006264,mitochondrial DNA replication,1/198,13/12185,0.191911956,0.52119247,0.396795247,RRM1,1,BP
GO:0016202,regulation of striated muscle tissue development,1/198,13/12185,0.191911956,0.52119247,0.396795247,CENPF,1,BP
GO:0017121,plasma membrane phospholipid scrambling,1/198,13/12185,0.191911956,0.52119247,0.396795247,XKR5,1,BP
GO:0032486,Rap protein signal transduction,1/198,13/12185,0.191911956,0.52119247,0.396795247,KIF14,1,BP
GO:0070914,UV-damage excision repair,1/198,13/12185,0.191911956,0.52119247,0.396795247,POLD3,1,BP
GO:0070986,left/right axis specification,1/198,13/12185,0.191911956,0.52119247,0.396795247,IFT25,1,BP
GO:0040029,epigenetic regulation of gene expression,5/198,190/12185,0.197056799,0.534040484,0.406576721,HELLS/LMNB2/UHRF1/LMNB1/PHF19,5,BP
GO:0006606,protein import into nucleus,4/198,142/12185,0.200143474,0.540947905,0.411835492,CDK1/POLA2/KPNA2/ECT2,4,BP
GO:0002520,immune system development,4/198,143/12185,0.203493686,0.540947905,0.411835492,EXO1/CCNB2/POLQ/HMGB2,4,BP
GO:0006473,protein acetylation,3/198,96/12185,0.204946635,0.540947905,0.411835492,DEK/ESCO2/DSCC1,3,BP
GO:0006206,pyrimidine nucleobase metabolic process,1/198,14/12185,0.205056997,0.540947905,0.411835492,RRM1,1,BP
GO:0008356,asymmetric cell division,1/198,14/12185,0.205056997,0.540947905,0.411835492,ASPM,1,BP
GO:0010225,response to UV-C,1/198,14/12185,0.205056997,0.540947905,0.411835492,BRCA2,1,BP
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,1/198,14/12185,0.205056997,0.540947905,0.411835492,PSRC1,1,BP
GO:0048634,regulation of muscle organ development,1/198,14/12185,0.205056997,0.540947905,0.411835492,CENPF,1,BP
GO:0051444,negative regulation of ubiquitin-protein transferase activity,1/198,14/12185,0.205056997,0.540947905,0.411835492,MAD2L1,1,BP
GO:0055012,ventricular cardiac muscle cell differentiation,1/198,14/12185,0.205056997,0.540947905,0.411835492,CDK1,1,BP
GO:0071731,response to nitric oxide,1/198,14/12185,0.205056997,0.540947905,0.411835492,CCNA2,1,BP
GO:0090399,replicative senescence,1/198,14/12185,0.205056997,0.540947905,0.411835492,CHEK2,1,BP
GO:1902170,cellular response to reactive nitrogen species,1/198,14/12185,0.205056997,0.540947905,0.411835492,CCNA2,1,BP
GO:0009416,response to light stimulus,6/198,244/12185,0.206415505,0.541250254,0.412065677,DTL/POLD3/BRCA2/PCLAF/AURKB/PBK,6,BP
GO:0048524,positive regulation of viral process,2/198,52/12185,0.206849903,0.541250254,0.412065677,TOP2A/KPNA2,2,BP
GO:0061180,mammary gland epithelium development,2/198,52/12185,0.206849903,0.541250254,0.412065677,IQGAP3/BRCA2,2,BP
GO:0070534,protein K63-linked ubiquitination,2/198,52/12185,0.206849903,0.541250254,0.412065677,UBE2T/UBE2S,2,BP
GO:0046824,positive regulation of nucleocytoplasmic transport,2/198,53/12185,0.212813982,0.555728821,0.423088527,CDK1/ECT2,2,BP
GO:0071482,cellular response to light stimulus,3/198,98/12185,0.213374116,0.556065879,0.423345137,POLD3/AURKB/PBK,3,BP
GO:0051056,regulation of small GTPase mediated signal transduction,6/198,248/12185,0.216678878,0.559057972,0.425623083,KIF14/FOXM1/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2,6,BP
GO:0051170,import into nucleus,4/198,147/12185,0.217056893,0.559057972,0.425623083,CDK1/POLA2/KPNA2/ECT2,4,BP
GO:1903900,regulation of viral life cycle,3/198,99/12185,0.217615919,0.559057972,0.425623083,TOP2A/KPNA2/TRIM59,3,BP
GO:0001675,acrosome assembly,1/198,15/12185,0.217989271,0.559057972,0.425623083,KNL1,1,BP
GO:0033762,response to glucagon,1/198,15/12185,0.217989271,0.559057972,0.425623083,CCNA2,1,BP
GO:0045091,regulation of single stranded viral RNA replication via double stranded DNA intermediate,1/198,15/12185,0.217989271,0.559057972,0.425623083,TOP2A,1,BP
GO:0046597,negative regulation of viral entry into host cell,1/198,15/12185,0.217989271,0.559057972,0.425623083,TRIM59,1,BP
GO:2000269,regulation of fibroblast apoptotic process,1/198,15/12185,0.217989271,0.559057972,0.425623083,XRCC2,1,BP
GO:0016445,somatic diversification of immunoglobulins,2/198,54/12185,0.218794549,0.560009858,0.426347774,EXO1/POLQ,2,BP
GO:0032204,regulation of telomere maintenance,3/198,100/12185,0.221875331,0.565650547,0.430642154,NEK2/PIF1/AURKB,3,BP
GO:1901796,regulation of signal transduction by p53 class mediator,3/198,100/12185,0.221875331,0.565650547,0.430642154,AURKB/AURKA/CHEK2,3,BP
GO:0002902,regulation of B cell apoptotic process,1/198,16/12185,0.230712207,0.571245195,0.434901483,AURKB,1,BP
GO:0006213,pyrimidine nucleoside metabolic process,1/198,16/12185,0.230712207,0.571245195,0.434901483,TK1,1,BP
GO:0007289,spermatid nucleus differentiation,1/198,16/12185,0.230712207,0.571245195,0.434901483,HMGB2,1,BP
GO:0009163,nucleoside biosynthetic process,1/198,16/12185,0.230712207,0.571245195,0.434901483,TK1,1,BP
GO:0021692,cerebellar Purkinje cell layer morphogenesis,1/198,16/12185,0.230712207,0.571245195,0.434901483,KIF14,1,BP
GO:0030903,notochord development,1/198,16/12185,0.230712207,0.571245195,0.434901483,STIL,1,BP
GO:0033151,V(D)J recombination,1/198,16/12185,0.230712207,0.571245195,0.434901483,HMGB2,1,BP
GO:0034404,nucleobase-containing small molecule biosynthetic process,1/198,16/12185,0.230712207,0.571245195,0.434901483,TK1,1,BP
GO:0035795,negative regulation of mitochondrial membrane permeability,1/198,16/12185,0.230712207,0.571245195,0.434901483,ARHGAP11B,1,BP
GO:0039692,single stranded viral RNA replication via double stranded DNA intermediate,1/198,16/12185,0.230712207,0.571245195,0.434901483,TOP2A,1,BP
GO:0044321,response to leptin,1/198,16/12185,0.230712207,0.571245195,0.434901483,CCNA2,1,BP
GO:0070200,establishment of protein localization to telomere,1/198,16/12185,0.230712207,0.571245195,0.434901483,BRCA2,1,BP
GO:0090128,regulation of synapse maturation,1/198,16/12185,0.230712207,0.571245195,0.434901483,CDC20,1,BP
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,1/198,16/12185,0.230712207,0.571245195,0.434901483,PSRC1,1,BP
GO:2000758,positive regulation of peptidyl-lysine acetylation,1/198,16/12185,0.230712207,0.571245195,0.434901483,DEK,1,BP
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,3/198,103/12185,0.234751121,0.58013208,0.441667263,CDC20/PLK1/AURKA,3,BP
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,2/198,57/12185,0.236814514,0.580780842,0.442161179,EXO1/HMGB2,2,BP
GO:0016444,somatic cell DNA recombination,2/198,57/12185,0.236814514,0.580780842,0.442161179,EXO1/HMGB2,2,BP
GO:0045911,positive regulation of DNA recombination,2/198,57/12185,0.236814514,0.580780842,0.442161179,RAD51AP1/TIMELESS,2,BP
GO:0070301,cellular response to hydrogen peroxide,2/198,57/12185,0.236814514,0.580780842,0.442161179,CDK1/ECT2,2,BP
GO:0071695,anatomical structure maturation,4/198,153/12185,0.237842102,0.58219414,0.443237154,KIF14/BRCA2/AURKA/TRIP13,4,BP
GO:0009162,deoxyribonucleoside monophosphate metabolic process,1/198,17/12185,0.243229175,0.587576096,0.447334555,TK1,1,BP
GO:0010804,negative regulation of tumor necrosis factor-mediated signaling pathway,1/198,17/12185,0.243229175,0.587576096,0.447334555,TRAIP,1,BP
GO:0032069,regulation of nuclease activity,1/198,17/12185,0.243229175,0.587576096,0.447334555,HMGB2,1,BP
GO:0034698,response to gonadotropin,1/198,17/12185,0.243229175,0.587576096,0.447334555,CCNA2,1,BP
GO:0060706,cell differentiation involved in embryonic placenta development,1/198,17/12185,0.243229175,0.587576096,0.447334555,PLK4,1,BP
GO:1902018,negative regulation of cilium assembly,1/198,17/12185,0.243229175,0.587576096,0.447334555,KIF24,1,BP
GO:1903902,positive regulation of viral life cycle,1/198,17/12185,0.243229175,0.587576096,0.447334555,KPNA2,1,BP
GO:0007264,small GTPase mediated signal transduction,9/198,421/12185,0.246539862,0.594460601,0.45257588,GPSM2/IQGAP3/KIF14/FOXM1/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2/CCNA2,9,BP
GO:0030218,erythrocyte differentiation,3/198,106/12185,0.247756543,0.596279739,0.45396083,RACGAP1/HMGB2/NCAPG2,3,BP
GO:0021700,developmental maturation,5/198,209/12185,0.253163468,0.601553113,0.457975564,CDC20/KIF14/BRCA2/AURKA/TRIP13,5,BP
GO:0070227,lymphocyte apoptotic process,2/198,60/12185,0.254911066,0.601553113,0.457975564,AURKB/CHEK2,2,BP
GO:1901657,glycosyl compound metabolic process,2/198,60/12185,0.254911066,0.601553113,0.457975564,TK1/MACROD2,2,BP
GO:0006027,glycosaminoglycan catabolic process,1/198,18/12185,0.255543493,0.601553113,0.457975564,HMMR,1,BP
GO:0035065,regulation of histone acetylation,1/198,18/12185,0.255543493,0.601553113,0.457975564,DEK,1,BP
GO:0035372,protein localization to microtubule,1/198,18/12185,0.255543493,0.601553113,0.457975564,KIF20B,1,BP
GO:0035720,intraciliary anterograde transport,1/198,18/12185,0.255543493,0.601553113,0.457975564,IFT25,1,BP
GO:0045945,positive regulation of transcription by RNA polymerase III,1/198,18/12185,0.255543493,0.601553113,0.457975564,DEK,1,BP
GO:0046794,transport of virus,1/198,18/12185,0.255543493,0.601553113,0.457975564,KPNA2,1,BP
GO:1903901,negative regulation of viral life cycle,1/198,18/12185,0.255543493,0.601553113,0.457975564,TRIM59,1,BP
GO:1905709,negative regulation of membrane permeability,1/198,18/12185,0.255543493,0.601553113,0.457975564,ARHGAP11B,1,BP
GO:2001224,positive regulation of neuron migration,1/198,18/12185,0.255543493,0.601553113,0.457975564,KIF20B,1,BP
GO:1901800,positive regulation of proteasomal protein catabolic process,3/198,108/12185,0.256488482,0.602677855,0.458831855,CDC20/PLK1/AURKA,3,BP
GO:0051099,positive regulation of binding,3/198,109/12185,0.260870676,0.608730122,0.463439579,CDT1/HMGB2/GMNN,3,BP
GO:0032091,negative regulation of protein binding,2/198,61/12185,0.26095175,0.608730122,0.463439579,AURKB/AURKA,2,BP
GO:0097194,execution phase of apoptosis,2/198,61/12185,0.26095175,0.608730122,0.463439579,TOP2A/XKR5,2,BP
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,2/198,61/12185,0.26095175,0.608730122,0.463439579,CHEK2/GTSE1,2,BP
GO:0022411,cellular component disassembly,9/198,430/12185,0.265710413,0.615471246,0.468571744,KIF2C/CDK1/KIF18A/PLK1/TOP2A/KIF18B/TPX2/AURKA/KIF24,9,BP
GO:0070936,protein K48-linked ubiquitination,2/198,62/12185,0.266993829,0.615471246,0.468571744,UBE2T/UBE2C,2,BP
GO:0006607,NLS-bearing protein import into nucleus,1/198,19/12185,0.267658426,0.615471246,0.468571744,KPNA2,1,BP
GO:0032211,negative regulation of telomere maintenance via telomerase,1/198,19/12185,0.267658426,0.615471246,0.468571744,PIF1,1,BP
GO:0033622,integrin activation,1/198,19/12185,0.267658426,0.615471246,0.468571744,KIF14,1,BP
GO:0045589,regulation of regulatory T cell differentiation,1/198,19/12185,0.267658426,0.615471246,0.468571744,FANCD2,1,BP
GO:0070242,thymocyte apoptotic process,1/198,19/12185,0.267658426,0.615471246,0.468571744,CHEK2,1,BP
GO:0071295,cellular response to vitamin,1/198,19/12185,0.267658426,0.615471246,0.468571744,BRIP1,1,BP
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,4/198,162/12185,0.269831195,0.619363418,0.47153494,CDC20/PLK1/AURKA/PBK,4,BP
GO:0051865,protein autoubiquitination,2/198,63/12185,0.273035671,0.624686499,0.475587518,UBE2T/UHRF1,2,BP
GO:0097193,intrinsic apoptotic signaling pathway,6/198,269/12185,0.273118749,0.624686499,0.475587518,E2F2/RTKN2/HELLS/BRCA2/CHEK2/MELK,6,BP
GO:0034101,erythrocyte homeostasis,3/198,113/12185,0.278490425,0.629414606,0.47918713,RACGAP1/HMGB2/NCAPG2,3,BP
GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle,1/198,20/12185,0.279577186,0.629414606,0.47918713,E2F2,1,BP
GO:0006026,aminoglycan catabolic process,1/198,20/12185,0.279577186,0.629414606,0.47918713,HMMR,1,BP
GO:0009065,glutamine family amino acid catabolic process,1/198,20/12185,0.279577186,0.629414606,0.47918713,ARHGAP11B,1,BP
GO:0021772,olfactory bulb development,1/198,20/12185,0.279577186,0.629414606,0.47918713,KIF14,1,BP
GO:0036120,cellular response to platelet-derived growth factor stimulus,1/198,20/12185,0.279577186,0.629414606,0.47918713,CCNA2,1,BP
GO:0042278,purine nucleoside metabolic process,1/198,20/12185,0.279577186,0.629414606,0.47918713,MACROD2,1,BP
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,1/198,20/12185,0.279577186,0.629414606,0.47918713,PLK1,1,BP
GO:1904030,negative regulation of cyclin-dependent protein kinase activity,1/198,20/12185,0.279577186,0.629414606,0.47918713,PLK1,1,BP
GO:0016570,histone modification,3/198,114/12185,0.282914515,0.635818336,0.48406243,AURKB/UHRF1/DEK,3,BP
GO:0031503,protein-containing complex localization,4/198,166/12185,0.284293195,0.637805603,0.48557538,IFT25/BIRC5/LMNB2/LMNB1,4,BP
GO:1902807,negative regulation of cell cycle G1/S phase transition,2/198,65/12185,0.285112376,0.638532926,0.486129106,CHEK2/GTSE1,2,BP
GO:0044346,fibroblast apoptotic process,1/198,21/12185,0.291302933,0.644563951,0.490720658,XRCC2,1,BP
GO:0045066,regulatory T cell differentiation,1/198,21/12185,0.291302933,0.644563951,0.490720658,FANCD2,1,BP
GO:0046688,response to copper ion,1/198,21/12185,0.291302933,0.644563951,0.490720658,CDK1,1,BP
GO:0060045,positive regulation of cardiac muscle cell proliferation,1/198,21/12185,0.291302933,0.644563951,0.490720658,CDK1,1,BP
GO:0090141,positive regulation of mitochondrial fission,1/198,21/12185,0.291302933,0.644563951,0.490720658,AURKA,1,BP
GO:1901673,regulation of mitotic spindle assembly,1/198,21/12185,0.291302933,0.644563951,0.490720658,PLK1,1,BP
GO:2000114,regulation of establishment of cell polarity,1/198,21/12185,0.291302933,0.644563951,0.490720658,KIF20B,1,BP
GO:0032984,protein-containing complex disassembly,5/198,223/12185,0.296779765,0.655129391,0.498764359,KIF2C/KIF18A/KIF18B/TPX2/KIF24,5,BP
GO:0072527,pyrimidine-containing compound metabolic process,2/198,67/12185,0.297169829,0.655129391,0.498764359,RRM1/TK1,2,BP
GO:0001783,B cell apoptotic process,1/198,22/12185,0.302838778,0.655129391,0.498764359,AURKB,1,BP
GO:0002455,humoral immune response mediated by circulating immunoglobulin,1/198,22/12185,0.302838778,0.655129391,0.498764359,EXO1,1,BP
GO:0021988,olfactory lobe development,1/198,22/12185,0.302838778,0.655129391,0.498764359,KIF14,1,BP
GO:0030262,apoptotic nuclear changes,1/198,22/12185,0.302838778,0.655129391,0.498764359,TOP2A,1,BP
GO:0032042,mitochondrial DNA metabolic process,1/198,22/12185,0.302838778,0.655129391,0.498764359,RRM1,1,BP
GO:0035330,regulation of hippo signaling,1/198,22/12185,0.302838778,0.655129391,0.498764359,CIT,1,BP
GO:0036119,response to platelet-derived growth factor,1/198,22/12185,0.302838778,0.655129391,0.498764359,CCNA2,1,BP
GO:0050829,defense response to Gram-negative bacterium,1/198,22/12185,0.302838778,0.655129391,0.498764359,HMGB2,1,BP
GO:0097421,liver regeneration,1/198,22/12185,0.302838778,0.655129391,0.498764359,AURKA,1,BP
GO:1901659,glycosyl compound biosynthetic process,1/198,22/12185,0.302838778,0.655129391,0.498764359,TK1,1,BP
GO:0032206,positive regulation of telomere maintenance,2/198,68/12185,0.303187788,0.655129391,0.498764359,NEK2/AURKB,2,BP
GO:2000177,regulation of neural precursor cell proliferation,2/198,68/12185,0.303187788,0.655129391,0.498764359,ASPM/SHCBP1,2,BP
GO:0043393,regulation of protein binding,3/198,119/12185,0.30511524,0.657092922,0.500259238,PLK1/AURKB/AURKA,3,BP
GO:1904375,regulation of protein localization to cell periphery,3/198,119/12185,0.30511524,0.657092922,0.500259238,GPSM2/PLK1/SAPCD2,3,BP
GO:0097306,cellular response to alcohol,2/198,69/12185,0.30919677,0.663988914,0.505509308,RAD51/BLM,2,BP
GO:0050792,regulation of viral process,3/198,120/12185,0.30956677,0.663988914,0.505509308,TOP2A/KPNA2/TRIM59,3,BP
GO:0032388,positive regulation of intracellular transport,4/198,173/12185,0.309861493,0.663988914,0.505509308,CDK1/KIF20B/SPAG5/ECT2,4,BP
GO:0010800,positive regulation of peptidyl-threonine phosphorylation,1/198,23/12185,0.314187781,0.668815573,0.509183949,PLK1,1,BP
GO:0045652,regulation of megakaryocyte differentiation,1/198,23/12185,0.314187781,0.668815573,0.509183949,HMGB2,1,BP
GO:1901985,positive regulation of protein acetylation,1/198,23/12185,0.314187781,0.668815573,0.509183949,DEK,1,BP
GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,1/198,23/12185,0.314187781,0.668815573,0.509183949,HMGB2,1,BP
GO:0002377,immunoglobulin production,2/198,70/12185,0.315195483,0.66985531,0.509975524,EXO1/POLQ,2,BP
GO:0006346,DNA methylation-dependent heterochromatin formation,1/198,24/12185,0.325352953,0.682447657,0.519562353,HELLS,1,BP
GO:0006541,glutamine metabolic process,1/198,24/12185,0.325352953,0.682447657,0.519562353,ARHGAP11B,1,BP
GO:0006921,cellular component disassembly involved in execution phase of apoptosis,1/198,24/12185,0.325352953,0.682447657,0.519562353,TOP2A,1,BP
GO:0021680,cerebellar Purkinje cell layer development,1/198,24/12185,0.325352953,0.682447657,0.519562353,KIF14,1,BP
GO:0030212,hyaluronan metabolic process,1/198,24/12185,0.325352953,0.682447657,0.519562353,HMMR,1,BP
GO:0032878,regulation of establishment or maintenance of cell polarity,1/198,24/12185,0.325352953,0.682447657,0.519562353,KIF20B,1,BP
GO:0055023,positive regulation of cardiac muscle tissue growth,1/198,24/12185,0.325352953,0.682447657,0.519562353,CDK1,1,BP
GO:0070199,establishment of protein localization to chromosome,1/198,24/12185,0.325352953,0.682447657,0.519562353,BRCA2,1,BP
GO:1900180,regulation of protein localization to nucleus,3/198,124/12185,0.327389472,0.685604577,0.521965785,CDK1/PLK1/ECT2,3,BP
GO:1903052,positive regulation of proteolysis involved in protein catabolic process,3/198,125/12185,0.331846221,0.693811386,0.528213809,CDC20/PLK1/AURKA,3,BP
GO:0061136,regulation of proteasomal protein catabolic process,4/198,180/12185,0.335648187,0.697548329,0.531058826,CDC20/PLK1/AURKA/PBK,4,BP
GO:0002052,positive regulation of neuroblast proliferation,1/198,25/12185,0.336337256,0.697548329,0.531058826,ASPM,1,BP
GO:0007026,negative regulation of microtubule depolymerization,1/198,25/12185,0.336337256,0.697548329,0.531058826,TPX2,1,BP
GO:1904357,negative regulation of telomere maintenance via telomere lengthening,1/198,25/12185,0.336337256,0.697548329,0.531058826,PIF1,1,BP
GO:2001032,regulation of double-strand break repair via nonhomologous end joining,1/198,25/12185,0.336337256,0.697548329,0.531058826,DEK,1,BP
GO:0008585,female gonad development,2/198,74/12185,0.339063312,0.702073311,0.534503794,BRCA2/FANCG,2,BP
GO:0007265,Ras protein signal transduction,6/198,294/12185,0.344188281,0.709691367,0.540303587,GPSM2/IQGAP3/KIF14/FOXM1/RACGAP1/CCNA2,6,BP
GO:0000578,embryonic axis specification,1/198,26/12185,0.347143607,0.709691367,0.540303587,STIL,1,BP
GO:0008340,determination of adult lifespan,1/198,26/12185,0.347143607,0.709691367,0.540303587,RAD54L,1,BP
GO:0039694,viral RNA genome replication,1/198,26/12185,0.347143607,0.709691367,0.540303587,TOP2A,1,BP
GO:0045070,positive regulation of viral genome replication,1/198,26/12185,0.347143607,0.709691367,0.540303587,TOP2A,1,BP
GO:0045648,positive regulation of erythrocyte differentiation,1/198,26/12185,0.347143607,0.709691367,0.540303587,HMGB2,1,BP
GO:0048854,brain morphogenesis,1/198,26/12185,0.347143607,0.709691367,0.540303587,FANCD2,1,BP
GO:0060074,synapse maturation,1/198,26/12185,0.347143607,0.709691367,0.540303587,CDC20,1,BP
GO:0046545,development of primary female sexual characteristics,2/198,76/12185,0.350905141,0.715736457,0.544905846,BRCA2/FANCG,2,BP
GO:0051258,protein polymerization,5/198,240/12185,0.351210215,0.715736457,0.544905846,PSRC1/NDE1/UBE2S/TPX2/UBE2C,5,BP
GO:0060421,positive regulation of heart growth,1/198,27/12185,0.357774873,0.724648497,0.551690778,CDK1,1,BP
GO:1903670,regulation of sprouting angiogenesis,1/198,27/12185,0.357774873,0.724648497,0.551690778,E2F2,1,BP
GO:1904376,negative regulation of protein localization to cell periphery,1/198,27/12185,0.357774873,0.724648497,0.551690778,SAPCD2,1,BP
GO:0031032,actomyosin structure organization,4/198,186/12185,0.357830304,0.724648497,0.551690778,IQGAP3/RACGAP1/ECT2/ANLN,4,BP
GO:0019058,viral life cycle,5/198,244/12185,0.364130892,0.736252116,0.560524867,CDK1/TOP2A/KPNA2/TRIM59/DEK,5,BP
GO:0001764,neuron migration,3/198,133/12185,0.367425056,0.736467755,0.560689037,ASPM/KIF20B/NDE1,3,BP
GO:0043543,protein acylation,3/198,133/12185,0.367425056,0.736467755,0.560689037,DEK/ESCO2/DSCC1,3,BP
GO:0009112,nucleobase metabolic process,1/198,28/12185,0.368233877,0.736467755,0.560689037,RRM1,1,BP
GO:0043029,T cell homeostasis,1/198,28/12185,0.368233877,0.736467755,0.560689037,CCNB2,1,BP
GO:0070229,negative regulation of lymphocyte apoptotic process,1/198,28/12185,0.368233877,0.736467755,0.560689037,AURKB,1,BP
GO:0090140,regulation of mitochondrial fission,1/198,28/12185,0.368233877,0.736467755,0.560689037,AURKA,1,BP
GO:2000756,regulation of peptidyl-lysine acetylation,1/198,28/12185,0.368233877,0.736467755,0.560689037,DEK,1,BP
GO:0045732,positive regulation of protein catabolic process,4/198,189/12185,0.368923957,0.736705735,0.560870217,CDC20/DTL/PLK1/AURKA,4,BP
GO:0090316,positive regulation of intracellular protein transport,3/198,134/12185,0.371854809,0.74141067,0.564452187,CDK1/KIF20B/ECT2,3,BP
GO:0021591,ventricular system development,1/198,29/12185,0.378523397,0.747772102,0.569295284,CENPF,1,BP
GO:0021696,cerebellar cortex morphogenesis,1/198,29/12185,0.378523397,0.747772102,0.569295284,KIF14,1,BP
GO:0031114,regulation of microtubule depolymerization,1/198,29/12185,0.378523397,0.747772102,0.569295284,TPX2,1,BP
GO:0070198,"protein localization to chromosome, telomeric region",1/198,29/12185,0.378523397,0.747772102,0.569295284,BRCA2,1,BP
GO:0120033,negative regulation of plasma membrane bounded cell projection assembly,1/198,29/12185,0.378523397,0.747772102,0.569295284,KIF24,1,BP
GO:1902742,apoptotic process involved in development,1/198,29/12185,0.378523397,0.747772102,0.569295284,XKR5,1,BP
GO:0042773,ATP synthesis coupled electron transport,2/198,82/12185,0.385965499,0.754461046,0.574387724,CDK1/CCNB1,2,BP
GO:0042775,mitochondrial ATP synthesis coupled electron transport,2/198,82/12185,0.385965499,0.754461046,0.574387724,CDK1/CCNB1,2,BP
GO:0045995,regulation of embryonic development,2/198,82/12185,0.385965499,0.754461046,0.574387724,CDK1/RACGAP1,2,BP
GO:0006359,regulation of transcription by RNA polymerase III,1/198,30/12185,0.388646165,0.754461046,0.574387724,DEK,1,BP
GO:0006911,"phagocytosis, engulfment",1/198,30/12185,0.388646165,0.754461046,0.574387724,XKR5,1,BP
GO:0021872,forebrain generation of neurons,1/198,30/12185,0.388646165,0.754461046,0.574387724,ASPM,1,BP
GO:0032480,negative regulation of type I interferon production,1/198,30/12185,0.388646165,0.754461046,0.574387724,TRAIP,1,BP
GO:0032728,positive regulation of interferon-beta production,1/198,30/12185,0.388646165,0.754461046,0.574387724,HMGB2,1,BP
GO:0046596,regulation of viral entry into host cell,1/198,30/12185,0.388646165,0.754461046,0.574387724,TRIM59,1,BP
GO:0060043,regulation of cardiac muscle cell proliferation,1/198,30/12185,0.388646165,0.754461046,0.574387724,CDK1,1,BP
GO:0060218,hematopoietic stem cell differentiation,1/198,30/12185,0.388646165,0.754461046,0.574387724,CHD2,1,BP
GO:0002262,myeloid cell homeostasis,3/198,138/12185,0.389512447,0.754461046,0.574387724,RACGAP1/HMGB2/NCAPG2,3,BP
GO:0031099,regeneration,3/198,138/12185,0.389512447,0.754461046,0.574387724,CDK1/AURKA/CCNA2,3,BP
GO:0006304,DNA modification,2/198,83/12185,0.391731704,0.757622035,0.576794255,HELLS/NEIL3,2,BP
GO:0030705,cytoskeleton-dependent intracellular transport,4/198,197/12185,0.398434769,0.765178992,0.582547531,IFT25/TUBA1B/NDE1/KIF4A,4,BP
GO:0031116,positive regulation of microtubule polymerization,1/198,31/12185,0.39860487,0.765178992,0.582547531,PSRC1,1,BP
GO:0033574,response to testosterone,1/198,31/12185,0.39860487,0.765178992,0.582547531,NASP,1,BP
GO:0050830,defense response to Gram-positive bacterium,1/198,31/12185,0.39860487,0.765178992,0.582547531,HMGB2,1,BP
GO:0071425,hematopoietic stem cell proliferation,1/198,31/12185,0.39860487,0.765178992,0.582547531,BRCA2,1,BP
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,8/198,430/12185,0.399277301,0.765330934,0.582663208,CDC20/KIF14/DTL/PLK1/UBE2S/UBE2C/AURKA/PBK,8,BP
GO:0042542,response to hydrogen peroxide,2/198,85/12185,0.403190756,0.769402478,0.585762964,CDK1/ECT2,2,BP
GO:0071887,leukocyte apoptotic process,2/198,85/12185,0.403190756,0.769402478,0.585762964,AURKB/CHEK2,2,BP
GO:0090398,cellular senescence,2/198,85/12185,0.403190756,0.769402478,0.585762964,H2AX/BRCA2,2,BP
GO:0043388,positive regulation of DNA binding,1/198,32/12185,0.408402158,0.776815889,0.591406956,HMGB2,1,BP
GO:2000279,negative regulation of DNA biosynthetic process,1/198,32/12185,0.408402158,0.776815889,0.591406956,PIF1,1,BP
GO:1990830,cellular response to leukemia inhibitory factor,2/198,86/12185,0.408882162,0.776815889,0.591406956,HELLS/MYBL2,2,BP
GO:0018107,peptidyl-threonine phosphorylation,2/198,87/12185,0.414547241,0.781036163,0.594619943,CDK1/PLK1,2,BP
GO:0072089,stem cell proliferation,2/198,87/12185,0.414547241,0.781036163,0.594619943,BRCA2/HMGB2,2,BP
GO:0009948,anterior/posterior axis specification,1/198,33/12185,0.418040632,0.781036163,0.594619943,AURKA,1,BP
GO:0032205,negative regulation of telomere maintenance,1/198,33/12185,0.418040632,0.781036163,0.594619943,PIF1,1,BP
GO:0035307,positive regulation of protein dephosphorylation,1/198,33/12185,0.418040632,0.781036163,0.594619943,CDCA2,1,BP
GO:0043277,apoptotic cell clearance,1/198,33/12185,0.418040632,0.781036163,0.594619943,XKR5,1,BP
GO:0045943,positive regulation of transcription by RNA polymerase I,1/198,33/12185,0.418040632,0.781036163,0.594619943,DEK,1,BP
GO:0070316,regulation of G0 to G1 transition,1/198,33/12185,0.418040632,0.781036163,0.594619943,RRM1,1,BP
GO:1901861,regulation of muscle tissue development,1/198,33/12185,0.418040632,0.781036163,0.594619943,CENPF,1,BP
GO:1902692,regulation of neuroblast proliferation,1/198,33/12185,0.418040632,0.781036163,0.594619943,ASPM,1,BP
GO:0001843,neural tube closure,2/198,88/12185,0.420185347,0.781036163,0.594619943,STIL/KIF20B,2,BP
GO:0032479,regulation of type I interferon production,2/198,88/12185,0.420185347,0.781036163,0.594619943,TRAIP/HMGB2,2,BP
GO:0032606,type I interferon production,2/198,88/12185,0.420185347,0.781036163,0.594619943,TRAIP/HMGB2,2,BP
GO:0046660,female sex differentiation,2/198,88/12185,0.420185347,0.781036163,0.594619943,BRCA2/FANCG,2,BP
GO:1990823,response to leukemia inhibitory factor,2/198,88/12185,0.420185347,0.781036163,0.594619943,HELLS/MYBL2,2,BP
GO:0000209,protein polyubiquitination,4/198,204/12185,0.424075518,0.78673963,0.598962117,UBE2T/DTL/UBE2S/UBE2C,4,BP
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,2/198,89/12185,0.425795857,0.78673963,0.598962117,BRCA2/CHEK2,2,BP
GO:0060606,tube closure,2/198,89/12185,0.425795857,0.78673963,0.598962117,STIL/KIF20B,2,BP
GO:0031670,cellular response to nutrient,1/198,34/12185,0.427522853,0.78673963,0.598962117,BRIP1,1,BP
GO:0045023,G0 to G1 transition,1/198,34/12185,0.427522853,0.78673963,0.598962117,RRM1,1,BP
GO:0045332,phospholipid translocation,1/198,34/12185,0.427522853,0.78673963,0.598962117,XKR5,1,BP
GO:0046622,positive regulation of organ growth,1/198,34/12185,0.427522853,0.78673963,0.598962117,CDK1,1,BP
GO:0010799,regulation of peptidyl-threonine phosphorylation,1/198,35/12185,0.436851343,0.795957955,0.60598023,PLK1,1,BP
GO:0014037,Schwann cell differentiation,1/198,35/12185,0.436851343,0.795957955,0.60598023,CDK1,1,BP
GO:0014075,response to amine,1/198,35/12185,0.436851343,0.795957955,0.60598023,CDK1,1,BP
GO:0031112,positive regulation of microtubule polymerization or depolymerization,1/198,35/12185,0.436851343,0.795957955,0.60598023,PSRC1,1,BP
GO:0032435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,1/198,35/12185,0.436851343,0.795957955,0.60598023,PBK,1,BP
GO:0042220,response to cocaine,1/198,35/12185,0.436851343,0.795957955,0.60598023,CCNA2,1,BP
GO:0072528,pyrimidine-containing compound biosynthetic process,1/198,35/12185,0.436851343,0.795957955,0.60598023,TK1,1,BP
GO:0014020,primary neural tube formation,2/198,92/12185,0.442456016,0.803598978,0.611797508,STIL/KIF20B,2,BP
GO:0019827,stem cell population maintenance,3/198,151/12185,0.445921279,0.803598978,0.611797508,ASPM/FANCD2/PHF19,3,BP
GO:0021587,cerebellum morphogenesis,1/198,36/12185,0.44602858,0.803598978,0.611797508,KIF14,1,BP
GO:0031111,negative regulation of microtubule polymerization or depolymerization,1/198,36/12185,0.44602858,0.803598978,0.611797508,TPX2,1,BP
GO:0031641,regulation of myelination,1/198,36/12185,0.44602858,0.803598978,0.611797508,KIF14,1,BP
GO:0043124,negative regulation of canonical NF-kappaB signal transduction,1/198,36/12185,0.44602858,0.803598978,0.611797508,TRIM59,1,BP
GO:0048538,thymus development,1/198,36/12185,0.44602858,0.803598978,0.611797508,CCNB2,1,BP
GO:0052372,modulation by symbiont of entry into host,1/198,36/12185,0.44602858,0.803598978,0.611797508,TRIM59,1,BP
GO:0033002,muscle cell proliferation,3/198,152/12185,0.450181217,0.808572365,0.615583857,CDK1/NDC80/DSN1,3,BP
GO:0051402,neuron apoptotic process,4/198,212/12185,0.453044781,0.808572365,0.615583857,KIF14/CIT/MYBL2/XRCC2,4,BP
GO:0018210,peptidyl-threonine modification,2/198,94/12185,0.453414623,0.808572365,0.615583857,CDK1/PLK1,2,BP
GO:0098727,maintenance of cell number,3/198,153/12185,0.454427999,0.808572365,0.615583857,ASPM/FANCD2/PHF19,3,BP
GO:0002437,inflammatory response to antigenic stimulus,1/198,37/12185,0.455057006,0.808572365,0.615583857,HMGB2,1,BP
GO:0009124,nucleoside monophosphate biosynthetic process,1/198,37/12185,0.455057006,0.808572365,0.615583857,TK1,1,BP
GO:0031056,regulation of histone modification,1/198,37/12185,0.455057006,0.808572365,0.615583857,DEK,1,BP
GO:0045646,regulation of erythrocyte differentiation,1/198,37/12185,0.455057006,0.808572365,0.615583857,HMGB2,1,BP
GO:0046686,response to cadmium ion,1/198,37/12185,0.455057006,0.808572365,0.615583857,CDK1,1,BP
GO:0140718,facultative heterochromatin formation,1/198,37/12185,0.455057006,0.808572365,0.615583857,HELLS,1,BP
GO:1903050,regulation of proteolysis involved in protein catabolic process,4/198,213/12185,0.456634764,0.81025976,0.616868508,CDC20/PLK1/AURKA/PBK,4,BP
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,2/198,95/12185,0.458847999,0.812595253,0.61864657,RTKN2/HELLS,2,BP
GO:0000266,mitochondrial fission,1/198,38/12185,0.46393902,0.812595253,0.61864657,AURKA,1,BP
GO:0021575,hindbrain morphogenesis,1/198,38/12185,0.46393902,0.812595253,0.61864657,KIF14,1,BP
GO:0032781,positive regulation of ATP-dependent activity,1/198,38/12185,0.46393902,0.812595253,0.61864657,UHRF1,1,BP
GO:0043903,regulation of biological process involved in symbiotic interaction,1/198,38/12185,0.46393902,0.812595253,0.61864657,TRIM59,1,BP
GO:0072348,sulfur compound transport,1/198,38/12185,0.46393902,0.812595253,0.61864657,RACGAP1,1,BP
GO:1901983,regulation of protein acetylation,1/198,38/12185,0.46393902,0.812595253,0.61864657,DEK,1,BP
GO:2000107,negative regulation of leukocyte apoptotic process,1/198,38/12185,0.46393902,0.812595253,0.61864657,AURKB,1,BP
GO:2001222,regulation of neuron migration,1/198,38/12185,0.46393902,0.812595253,0.61864657,KIF20B,1,BP
GO:0046822,regulation of nucleocytoplasmic transport,2/198,96/12185,0.464250156,0.812595253,0.61864657,CDK1/ECT2,2,BP
GO:0001841,neural tube formation,2/198,97/12185,0.46962067,0.817363689,0.622276885,STIL/KIF20B,2,BP
GO:0097305,response to alcohol,3/198,157/12185,0.471277015,0.817363689,0.622276885,CDK1/RAD51/BLM,3,BP
GO:0006305,DNA alkylation,1/198,39/12185,0.472676986,0.817363689,0.622276885,HELLS,1,BP
GO:0006306,DNA methylation,1/198,39/12185,0.472676986,0.817363689,0.622276885,HELLS,1,BP
GO:0034204,lipid translocation,1/198,39/12185,0.472676986,0.817363689,0.622276885,XKR5,1,BP
GO:0035306,positive regulation of dephosphorylation,1/198,39/12185,0.472676986,0.817363689,0.622276885,CDCA2,1,BP
GO:0050918,positive chemotaxis,1/198,39/12185,0.472676986,0.817363689,0.622276885,HMGB2,1,BP
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,1/198,39/12185,0.472676986,0.817363689,0.622276885,HMGB2,1,BP
GO:2000179,positive regulation of neural precursor cell proliferation,1/198,39/12185,0.472676986,0.817363689,0.622276885,ASPM,1,BP
GO:0042177,negative regulation of protein catabolic process,2/198,98/12185,0.47495914,0.819966034,0.624258106,MAD2L1/PBK,2,BP
GO:0007623,circadian rhythm,3/198,158/12185,0.475453173,0.819966034,0.624258106,CDK1/TIMELESS/TOP2A,3,BP
GO:0001541,ovarian follicle development,1/198,40/12185,0.481273228,0.825588384,0.628538525,FANCG,1,BP
GO:0035329,hippo signaling,1/198,40/12185,0.481273228,0.825588384,0.628538525,CIT,1,BP
GO:0043525,positive regulation of neuron apoptotic process,1/198,40/12185,0.481273228,0.825588384,0.628538525,MYBL2,1,BP
GO:1902116,negative regulation of organelle assembly,1/198,40/12185,0.481273228,0.825588384,0.628538525,KIF24,1,BP
GO:0051100,negative regulation of binding,2/198,100/12185,0.485538448,0.831798935,0.633266753,AURKB/AURKA,2,BP
GO:0002204,somatic recombination of immunoglobulin genes involved in immune response,1/198,41/12185,0.489730034,0.834546557,0.635358578,EXO1,1,BP
GO:0002208,somatic diversification of immunoglobulins involved in immune response,1/198,41/12185,0.489730034,0.834546557,0.635358578,EXO1,1,BP
GO:0045190,isotype switching,1/198,41/12185,0.489730034,0.834546557,0.635358578,EXO1,1,BP
GO:0070228,regulation of lymphocyte apoptotic process,1/198,41/12185,0.489730034,0.834546557,0.635358578,AURKB,1,BP
GO:0060972,left/right pattern formation,2/198,101/12185,0.490778588,0.83523005,0.635878937,STIL/IFT25,2,BP
GO:0019079,viral genome replication,2/198,102/12185,0.495985285,0.836567776,0.636897377,TOP2A/DEK,2,BP
GO:0030879,mammary gland development,2/198,102/12185,0.495985285,0.836567776,0.636897377,IQGAP3/BRCA2,2,BP
GO:0021695,cerebellar cortex development,1/198,42/12185,0.498049653,0.836567776,0.636897377,KIF14,1,BP
GO:0045665,negative regulation of neuron differentiation,1/198,42/12185,0.498049653,0.836567776,0.636897377,ASPM,1,BP
GO:0047496,vesicle transport along microtubule,1/198,42/12185,0.498049653,0.836567776,0.636897377,NDE1,1,BP
GO:0051289,protein homotetramerization,1/198,42/12185,0.498049653,0.836567776,0.636897377,TK1,1,BP
GO:0060038,cardiac muscle cell proliferation,1/198,42/12185,0.498049653,0.836567776,0.636897377,CDK1,1,BP
GO:0060976,coronary vasculature development,1/198,42/12185,0.498049653,0.836567776,0.636897377,CNTRL,1,BP
GO:0070231,T cell apoptotic process,1/198,42/12185,0.498049653,0.836567776,0.636897377,CHEK2,1,BP
GO:1901224,positive regulation of non-canonical NF-kappaB signal transduction,1/198,42/12185,0.498049653,0.836567776,0.636897377,RTKN2,1,BP
GO:0010970,transport along microtubule,3/198,165/12185,0.50424975,0.844920239,0.64325629,IFT25/NDE1/KIF4A,3,BP
GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,1/198,43/12185,0.5062343,0.844920239,0.64325629,EXO1,1,BP
GO:0070830,bicellular tight junction assembly,1/198,43/12185,0.5062343,0.844920239,0.64325629,ECT2,1,BP
GO:0071763,nuclear membrane organization,1/198,43/12185,0.5062343,0.844920239,0.64325629,PLK1,1,BP
GO:0022904,respiratory electron transport chain,2/198,104/12185,0.506297167,0.844920239,0.64325629,CDK1/CCNB1,2,BP
GO:0048511,rhythmic process,4/198,229/12185,0.512879348,0.853834154,0.650042649,DTL/CDK1/TIMELESS/TOP2A,4,BP
GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,1/198,44/12185,0.514286153,0.853834154,0.650042649,TRAIP,1,BP
GO:0055021,regulation of cardiac muscle tissue growth,1/198,44/12185,0.514286153,0.853834154,0.650042649,CDK1,1,BP
GO:0097035,regulation of membrane lipid distribution,1/198,44/12185,0.514286153,0.853834154,0.650042649,XKR5,1,BP
GO:0030219,megakaryocyte differentiation,1/198,45/12185,0.522207358,0.86365063,0.657516147,HMGB2,1,BP
GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,1/198,45/12185,0.522207358,0.86365063,0.657516147,KIF14,1,BP
GO:1902275,regulation of chromatin organization,1/198,45/12185,0.522207358,0.86365063,0.657516147,MKI67,1,BP
GO:0048872,homeostasis of number of cells,4/198,234/12185,0.529919337,0.872066363,0.663923228,RACGAP1/CCNB2/HMGB2/NCAPG2,4,BP
GO:0001756,somitogenesis,1/198,46/12185,0.530000022,0.872066363,0.663923228,XRCC2,1,BP
GO:0006356,regulation of transcription by RNA polymerase I,1/198,46/12185,0.530000022,0.872066363,0.663923228,DEK,1,BP
GO:0008089,anterograde axonal transport,1/198,46/12185,0.530000022,0.872066363,0.663923228,KIF4A,1,BP
GO:0001838,embryonic epithelial tube formation,2/198,109/12185,0.53147277,0.87226447,0.664074052,STIL/KIF20B,2,BP
GO:0046718,viral entry into host cell,2/198,109/12185,0.53147277,0.87226447,0.664074052,CDK1/TRIM59,2,BP
GO:0043523,regulation of neuron apoptotic process,3/198,172/12185,0.532220678,0.872382051,0.664163569,KIF14/MYBL2/XRCC2,3,BP
GO:0001655,urogenital system development,1/198,47/12185,0.537666221,0.87685136,0.667566152,HELLS,1,BP
GO:0031648,protein destabilization,1/198,47/12185,0.537666221,0.87685136,0.667566152,PLK1,1,BP
GO:0045685,regulation of glial cell differentiation,1/198,47/12185,0.537666221,0.87685136,0.667566152,CDK1,1,BP
GO:1901799,negative regulation of proteasomal protein catabolic process,1/198,47/12185,0.537666221,0.87685136,0.667566152,PBK,1,BP
GO:0009880,embryonic pattern specification,1/198,48/12185,0.545207998,0.884677129,0.673524081,STIL,1,BP
GO:0042073,intraciliary transport,1/198,48/12185,0.545207998,0.884677129,0.673524081,IFT25,1,BP
GO:0120192,tight junction assembly,1/198,48/12185,0.545207998,0.884677129,0.673524081,ECT2,1,BP
GO:2000059,negative regulation of ubiquitin-dependent protein catabolic process,1/198,48/12185,0.545207998,0.884677129,0.673524081,PBK,1,BP
GO:0010498,proteasomal protein catabolic process,8/198,492/12185,0.550292524,0.88993924,0.677530242,CDC20/KIF14/DTL/PLK1/UBE2S/UBE2C/AURKA/PBK,8,BP
GO:0001947,heart looping,1/198,49/12185,0.552627362,0.88993924,0.677530242,STIL,1,BP
GO:0014823,response to activity,1/198,49/12185,0.552627362,0.88993924,0.677530242,CDK1,1,BP
GO:0016447,somatic recombination of immunoglobulin gene segments,1/198,49/12185,0.552627362,0.88993924,0.677530242,EXO1,1,BP
GO:0016573,histone acetylation,1/198,49/12185,0.552627362,0.88993924,0.677530242,DEK,1,BP
GO:0060420,regulation of heart growth,1/198,49/12185,0.552627362,0.88993924,0.677530242,CDK1,1,BP
GO:0001822,kidney development,4/198,241/12185,0.553280055,0.88993924,0.677530242,IFT25/CENPF/HELLS/CNTRL,4,BP
GO:0043467,regulation of generation of precursor metabolites and energy,2/198,114/12185,0.555765133,0.892823191,0.679725856,CDK1/CCNB1,2,BP
GO:0002260,lymphocyte homeostasis,1/198,50/12185,0.559926289,0.893776954,0.680451977,CCNB2,1,BP
GO:0033363,secretory granule organization,1/198,50/12185,0.559926289,0.893776954,0.680451977,KNL1,1,BP
GO:0035904,aorta development,1/198,50/12185,0.559926289,0.893776954,0.680451977,CNTRL,1,BP
GO:0090175,regulation of establishment of planar polarity,1/198,50/12185,0.559926289,0.893776954,0.680451977,SAPCD2,1,BP
GO:1904888,cranial skeletal system development,1/198,50/12185,0.559926289,0.893776954,0.680451977,CEP55,1,BP
GO:0044409,entry into host,2/198,115/12185,0.560515935,0.893776954,0.680451977,CDK1/TRIM59,2,BP
GO:0035264,multicellular organism growth,2/198,116/12185,0.565230587,0.89983724,0.685065806,STIL/XRCC2,2,BP
GO:0001960,negative regulation of cytokine-mediated signaling pathway,1/198,51/12185,0.567106726,0.89983724,0.685065806,TRAIP,1,BP
GO:0043297,apical junction assembly,1/198,51/12185,0.567106726,0.89983724,0.685065806,ECT2,1,BP
GO:0061371,determination of heart left/right asymmetry,1/198,51/12185,0.567106726,0.89983724,0.685065806,STIL,1,BP
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,1/198,52/12185,0.574170585,0.90607694,0.689816226,MELK,1,BP
GO:0018393,internal peptidyl-lysine acetylation,1/198,52/12185,0.574170585,0.90607694,0.689816226,DEK,1,BP
GO:0032481,positive regulation of type I interferon production,1/198,52/12185,0.574170585,0.90607694,0.689816226,HMGB2,1,BP
GO:0046902,regulation of mitochondrial membrane permeability,1/198,52/12185,0.574170585,0.90607694,0.689816226,ARHGAP11B,1,BP
GO:0071456,cellular response to hypoxia,2/198,118/12185,0.574551114,0.90607694,0.689816226,BRIP1/CCNA2,2,BP
GO:0072001,renal system development,4/198,248/12185,0.576020088,0.907284388,0.690735483,IFT25/CENPF/HELLS/CNTRL,4,BP
GO:0072175,epithelial tube formation,2/198,119/12185,0.579156855,0.911112614,0.693649995,STIL/KIF20B,2,BP
GO:0120193,tight junction organization,1/198,53/12185,0.58111975,0.913087062,0.695153186,ECT2,1,BP
GO:0007224,smoothened signaling pathway,2/198,120/12185,0.583726179,0.916066631,0.697421596,STIL/IFT25,2,BP
GO:0051348,negative regulation of transferase activity,3/198,186/12185,0.585409405,0.917591899,0.698582816,PIF1/PLK1/MAD2L1,3,BP
GO:0044782,cilium organization,5/198,316/12185,0.58695623,0.918899924,0.699578645,IFT25/AURKA/POC1A/PLK4/KIF24,5,BP
GO:0030177,positive regulation of Wnt signaling pathway,2/198,121/12185,0.588259046,0.919823235,0.700281582,ASPM/DEPDC1B,2,BP
GO:0006119,oxidative phosphorylation,2/198,122/12185,0.592755429,0.924263834,0.703662307,CDK1/CCNB1,2,BP
GO:0010035,response to inorganic substance,6/198,383/12185,0.594078284,0.924263834,0.703662307,CDK1/TIMELESS/RAD51/BLM/ECT2/CCNA2,6,BP
GO:0003143,embryonic heart tube morphogenesis,1/198,55/12185,0.594681382,0.924263834,0.703662307,STIL,1,BP
GO:0006475,internal protein amino acid acetylation,1/198,55/12185,0.594681382,0.924263834,0.703662307,DEK,1,BP
GO:0060761,negative regulation of response to cytokine stimulus,1/198,55/12185,0.594681382,0.924263834,0.703662307,TRAIP,1,BP
GO:0034614,cellular response to reactive oxygen species,2/198,123/12185,0.597215311,0.92708514,0.705810229,CDK1/ECT2,2,BP
GO:0033273,response to vitamin,1/198,56/12185,0.601297465,0.931709369,0.709330756,BRIP1,1,BP
GO:0043524,negative regulation of neuron apoptotic process,2/198,124/12185,0.601638686,0.931709369,0.709330756,KIF14/XRCC2,2,BP
GO:0008543,fibroblast growth factor receptor signaling pathway,1/198,57/12185,0.607806089,0.93871279,0.714662614,SHCBP1,1,BP
GO:0043462,regulation of ATP-dependent activity,1/198,57/12185,0.607806089,0.93871279,0.714662614,UHRF1,1,BP
GO:0009952,anterior/posterior pattern specification,2/198,126/12185,0.610375932,0.93871279,0.714662614,AURKA/XRCC2,2,BP
GO:0016331,morphogenesis of embryonic epithelium,2/198,126/12185,0.610375932,0.93871279,0.714662614,STIL/KIF20B,2,BP
GO:0048839,inner ear development,2/198,126/12185,0.610375932,0.93871279,0.714662614,MCM2/CCNA2,2,BP
GO:0033157,regulation of intracellular protein transport,3/198,193/12185,0.610527156,0.93871279,0.714662614,CDK1/KIF20B/ECT2,3,BP
GO:0099111,microtubule-based transport,3/198,194/12185,0.614031979,0.941009024,0.716410787,IFT25/NDE1/KIF4A,3,BP
GO:2001234,negative regulation of apoptotic signaling pathway,3/198,194/12185,0.614031979,0.941009024,0.716410787,RTKN2/HELLS/HMGB2,3,BP
GO:0031113,regulation of microtubule polymerization,1/198,58/12185,0.614208991,0.941009024,0.716410787,PSRC1,1,BP
GO:0050678,regulation of epithelial cell proliferation,4/198,261/12185,0.616473613,0.943358198,0.718199264,IQGAP3/BRCA2/UHRF1/HMGB2,4,BP
GO:0036294,cellular response to decreased oxygen levels,2/198,128/12185,0.618967302,0.946051919,0.720250053,BRIP1/CCNA2,2,BP
GO:0002312,B cell activation involved in immune response,1/198,59/12185,0.620507879,0.947284218,0.72118823,EXO1,1,BP
GO:0035148,tube formation,2/198,129/12185,0.623208365,0.948883476,0.72240578,STIL/KIF20B,2,BP
GO:0009064,glutamine family amino acid metabolic process,1/198,60/12185,0.626704435,0.948883476,0.72240578,ARHGAP11B,1,BP
GO:0045666,positive regulation of neuron differentiation,1/198,60/12185,0.626704435,0.948883476,0.72240578,ECT2,1,BP
GO:0072091,regulation of stem cell proliferation,1/198,60/12185,0.626704435,0.948883476,0.72240578,HMGB2,1,BP
GO:0098930,axonal transport,1/198,60/12185,0.626704435,0.948883476,0.72240578,KIF4A,1,BP
GO:0099518,vesicle cytoskeletal trafficking,1/198,60/12185,0.626704435,0.948883476,0.72240578,NDE1,1,BP
GO:1902017,regulation of cilium assembly,1/198,60/12185,0.626704435,0.948883476,0.72240578,KIF24,1,BP
GO:0006383,transcription by RNA polymerase III,1/198,61/12185,0.632800313,0.950305476,0.72348838,DEK,1,BP
GO:0009123,nucleoside monophosphate metabolic process,1/198,61/12185,0.632800313,0.950305476,0.72348838,TK1,1,BP
GO:0061053,somite development,1/198,61/12185,0.632800313,0.950305476,0.72348838,XRCC2,1,BP
GO:0090559,regulation of membrane permeability,1/198,61/12185,0.632800313,0.950305476,0.72348838,ARHGAP11B,1,BP
GO:1901880,negative regulation of protein depolymerization,1/198,61/12185,0.632800313,0.950305476,0.72348838,TPX2,1,BP
GO:1904377,positive regulation of protein localization to cell periphery,1/198,61/12185,0.632800313,0.950305476,0.72348838,GPSM2,1,BP
GO:2000106,regulation of leukocyte apoptotic process,1/198,61/12185,0.632800313,0.950305476,0.72348838,AURKB,1,BP
GO:0070371,ERK1 and ERK2 cascade,3/198,200/12185,0.634616167,0.95192425,0.724720788,IQGAP3/CDK1/FAM83D,3,BP
GO:0045664,regulation of neuron differentiation,2/198,132/12185,0.635713658,0.952462972,0.725130929,ASPM/ECT2,2,BP
GO:0048678,response to axon injury,1/198,62/12185,0.638797141,0.954864788,0.726959484,CDK1,1,BP
GO:1903051,negative regulation of proteolysis involved in protein catabolic process,1/198,62/12185,0.638797141,0.954864788,0.726959484,PBK,1,BP
GO:0002440,production of molecular mediator of immune response,2/198,133/12185,0.639809667,0.955271378,0.72726903,EXO1/POLQ,2,BP
GO:0071407,cellular response to organic cyclic compound,6/198,403/12185,0.643538519,0.955929322,0.727769937,CDK1/KIF18A/RAD51/BLM/H2AZ1/CCNA2,6,BP
GO:0043409,negative regulation of MAPK cascade,2/198,134/12185,0.643869589,0.955929322,0.727769937,FOXM1/PBK,2,BP
GO:0035304,regulation of protein dephosphorylation,1/198,63/12185,0.64469652,0.955929322,0.727769937,CDCA2,1,BP
GO:0045069,regulation of viral genome replication,1/198,63/12185,0.64469652,0.955929322,0.727769937,TOP2A,1,BP
GO:0048525,negative regulation of viral process,1/198,63/12185,0.64469652,0.955929322,0.727769937,TRIM59,1,BP
GO:0071277,cellular response to calcium ion,1/198,63/12185,0.64469652,0.955929322,0.727769937,ECT2,1,BP
GO:0003002,regionalization,4/198,271/12185,0.645921873,0.956646632,0.728316041,STIL/IFT25/AURKA/XRCC2,4,BP
GO:0045824,negative regulation of innate immune response,1/198,64/12185,0.650500025,0.960120174,0.730960524,AURKB,1,BP
GO:0055017,cardiac muscle tissue growth,1/198,64/12185,0.650500025,0.960120174,0.730960524,CDK1,1,BP
GO:1901606,alpha-amino acid catabolic process,1/198,64/12185,0.650500025,0.960120174,0.730960524,ARHGAP11B,1,BP
GO:0007030,Golgi organization,2/198,136/12185,0.651881519,0.961059611,0.731675738,CDK1/PLK1,2,BP
GO:0001736,establishment of planar polarity,1/198,65/12185,0.656209207,0.961560435,0.732057026,SAPCD2,1,BP
GO:0007164,establishment of tissue polarity,1/198,65/12185,0.656209207,0.961560435,0.732057026,SAPCD2,1,BP
GO:0007422,peripheral nervous system development,1/198,65/12185,0.656209207,0.961560435,0.732057026,CDK1,1,BP
GO:0018394,peptidyl-lysine acetylation,1/198,65/12185,0.656209207,0.961560435,0.732057026,DEK,1,BP
GO:1901222,regulation of non-canonical NF-kappaB signal transduction,1/198,65/12185,0.656209207,0.961560435,0.732057026,RTKN2,1,BP
GO:0016032,viral process,5/198,342/12185,0.656693599,0.961560435,0.732057026,CDK1/TOP2A/KPNA2/TRIM59/DEK,5,BP
GO:0010822,positive regulation of mitochondrion organization,1/198,66/12185,0.661825591,0.967976204,0.736941492,AURKA,1,BP
GO:0044000,movement in host,2/198,139/12185,0.663631097,0.969517684,0.738115055,CDK1/TRIM59,2,BP
GO:0003281,ventricular septum development,1/198,67/12185,0.667350678,0.970738101,0.739044184,CNTRL,1,BP
GO:0045639,positive regulation of myeloid cell differentiation,1/198,67/12185,0.667350678,0.970738101,0.739044184,HMGB2,1,BP
GO:0022900,electron transport chain,2/198,140/12185,0.667476508,0.970738101,0.739044184,CDK1/CCNB1,2,BP
GO:1903008,organelle disassembly,2/198,140/12185,0.667476508,0.970738101,0.739044184,CDK1/AURKA,2,BP
GO:0071453,cellular response to oxygen levels,2/198,141/12185,0.67128656,0.974740289,0.742091138,BRIP1/CCNA2,2,BP
GO:0009582,detection of abiotic stimulus,1/198,68/12185,0.672785945,0.974740289,0.742091138,TIMELESS,1,BP
GO:0035050,embryonic heart tube development,1/198,68/12185,0.672785945,0.974740289,0.742091138,STIL,1,BP
GO:0021915,neural tube development,2/198,142/12185,0.67506138,0.974740289,0.742091138,STIL/KIF20B,2,BP
GO:1902075,cellular response to salt,2/198,142/12185,0.67506138,0.974740289,0.742091138,ECT2/CCNA2,2,BP
GO:1901653,cellular response to peptide,4/198,282/12185,0.676563909,0.974740289,0.742091138,TIMELESS/CDC6/BRIP1/CCNA2,4,BP
GO:0034599,cellular response to oxidative stress,3/198,213/12185,0.67656736,0.974740289,0.742091138,CDK1/FANCD2/ECT2,3,BP
GO:0001892,embryonic placenta development,1/198,69/12185,0.678132845,0.974740289,0.742091138,PLK4,1,BP
GO:0043242,negative regulation of protein-containing complex disassembly,1/198,69/12185,0.678132845,0.974740289,0.742091138,TPX2,1,BP
GO:0006360,transcription by RNA polymerase I,1/198,70/12185,0.683392807,0.974740289,0.742091138,DEK,1,BP
GO:0007338,single fertilization,1/198,70/12185,0.683392807,0.974740289,0.742091138,CDK1,1,BP
GO:0016525,negative regulation of angiogenesis,1/198,70/12185,0.683392807,0.974740289,0.742091138,E2F2,1,BP
GO:0021766,hippocampus development,1/198,70/12185,0.683392807,0.974740289,0.742091138,KIF14,1,BP
GO:0031397,negative regulation of protein ubiquitination,1/198,70/12185,0.683392807,0.974740289,0.742091138,MAD2L1,1,BP
GO:0045471,response to ethanol,1/198,70/12185,0.683392807,0.974740289,0.742091138,CDK1,1,BP
GO:0048534,hematopoietic or lymphoid organ development,1/198,70/12185,0.683392807,0.974740289,0.742091138,CCNB2,1,BP
GO:0060419,heart growth,1/198,70/12185,0.683392807,0.974740289,0.742091138,CDK1,1,BP
GO:0044089,positive regulation of cellular component biogenesis,6/198,421/12185,0.684859341,0.974740289,0.742091138,STIL/GPSM2/PSRC1/SPAG5/PLK4/ANLN,6,BP
GO:0032872,regulation of stress-activated MAPK cascade,2/198,145/12185,0.6861758,0.974740289,0.742091138,FOXM1/PBK,2,BP
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,1/198,71/12185,0.688567237,0.974740289,0.742091138,HMGB2,1,BP
GO:0035282,segmentation,1/198,71/12185,0.688567237,0.974740289,0.742091138,XRCC2,1,BP
GO:0046620,regulation of organ growth,1/198,71/12185,0.688567237,0.974740289,0.742091138,CDK1,1,BP
GO:1901343,negative regulation of vasculature development,1/198,71/12185,0.688567237,0.974740289,0.742091138,E2F2,1,BP
GO:2000181,negative regulation of blood vessel morphogenesis,1/198,71/12185,0.688567237,0.974740289,0.742091138,E2F2,1,BP
GO:0043583,ear development,2/198,146/12185,0.689811067,0.974740289,0.742091138,MCM2/CCNA2,2,BP
GO:0031647,regulation of protein stability,4/198,287/12185,0.689874328,0.974740289,0.742091138,PLK1/NDC80/AURKA/CHEK2,4,BP
GO:0008088,axo-dendritic transport,1/198,72/12185,0.69365752,0.979013349,0.745344312,KIF4A,1,BP
GO:0030324,lung development,2/198,148/12185,0.696978195,0.979649861,0.745828903,IFT25/TIMELESS,2,BP
GO:0070302,regulation of stress-activated protein kinase signaling cascade,2/198,148/12185,0.696978195,0.979649861,0.745828903,FOXM1/PBK,2,BP
GO:0032386,regulation of intracellular transport,4/198,290/12185,0.697673957,0.979649861,0.745828903,CDK1/KIF20B/SPAG5/ECT2,4,BP
GO:0001776,leukocyte homeostasis,1/198,73/12185,0.698665017,0.979649861,0.745828903,CCNB2,1,BP
GO:0001938,positive regulation of endothelial cell proliferation,1/198,73/12185,0.698665017,0.979649861,0.745828903,HMGB2,1,BP
GO:0006493,protein O-linked glycosylation,1/198,73/12185,0.698665017,0.979649861,0.745828903,POGLUT3,1,BP
GO:0050679,positive regulation of epithelial cell proliferation,2/198,149/12185,0.70051037,0.981170877,0.746986885,IQGAP3/HMGB2,2,BP
GO:0015914,phospholipid transport,1/198,74/12185,0.703591068,0.984417004,0.749458233,XKR5,1,BP
GO:0006913,nucleocytoplasmic transport,4/198,294/12185,0.707855423,0.985850828,0.750549835,CDK1/POLA2/KPNA2/ECT2,4,BP
GO:0051169,nuclear transport,4/198,294/12185,0.707855423,0.985850828,0.750549835,CDK1/POLA2/KPNA2/ECT2,4,BP
GO:0006959,humoral immune response,1/198,75/12185,0.70843699,0.985850828,0.750549835,EXO1,1,BP
GO:0055013,cardiac muscle cell development,1/198,75/12185,0.70843699,0.985850828,0.750549835,CDK1,1,BP
GO:1901879,regulation of protein depolymerization,1/198,75/12185,0.70843699,0.985850828,0.750549835,TPX2,1,BP
GO:0060271,cilium assembly,4/198,295/12185,0.710361856,0.986091695,0.750733212,IFT25/POC1A/PLK4/KIF24,4,BP
GO:0030323,respiratory tube development,2/198,152/12185,0.710903315,0.986091695,0.750733212,IFT25/TIMELESS,2,BP
GO:0051701,biological process involved in interaction with host,2/198,152/12185,0.710903315,0.986091695,0.750733212,CDK1/TRIM59,2,BP
GO:0021549,cerebellum development,1/198,76/12185,0.713204082,0.986102106,0.750741139,KIF14,1,BP
GO:1903510,mucopolysaccharide metabolic process,1/198,76/12185,0.713204082,0.986102106,0.750741139,HMMR,1,BP
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,1/198,76/12185,0.713204082,0.986102106,0.750741139,HMGB2,1,BP
GO:0046578,regulation of Ras protein signal transduction,2/198,154/12185,0.717664011,0.989404665,0.753255449,KIF14/FOXM1,2,BP
GO:2001242,regulation of intrinsic apoptotic signaling pathway,2/198,154/12185,0.717664011,0.989404665,0.753255449,RTKN2/HELLS,2,BP
GO:0032273,positive regulation of protein polymerization,1/198,77/12185,0.717893618,0.989404665,0.753255449,PSRC1,1,BP
GO:0016064,immunoglobulin mediated immune response,1/198,78/12185,0.722506854,0.99363949,0.756479514,EXO1,1,BP
GO:0033209,tumor necrosis factor-mediated signaling pathway,1/198,78/12185,0.722506854,0.99363949,0.756479514,TRAIP,1,BP
GO:0019724,B cell mediated immunity,1/198,79/12185,0.727045025,0.996692968,0.758804193,EXO1,1,BP
GO:0044344,cellular response to fibroblast growth factor stimulus,1/198,79/12185,0.727045025,0.996692968,0.758804193,SHCBP1,1,BP
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,1/198,79/12185,0.727045025,0.996692968,0.758804193,MAD2L1,1,BP
GO:0009063,amino acid catabolic process,1/198,80/12185,0.731509348,0.999618129,0.761031183,ARHGAP11B,1,BP
GO:0055006,cardiac cell development,1/198,81/12185,0.735901016,0.999618129,0.761031183,CDK1,1,BP
GO:0071901,negative regulation of protein serine/threonine kinase activity,1/198,81/12185,0.735901016,0.999618129,0.761031183,PLK1,1,BP
GO:0007389,pattern specification process,4/198,306/12185,0.736907748,0.999618129,0.761031183,STIL/IFT25/AURKA/XRCC2,4,BP
GO:1902532,negative regulation of intracellular signal transduction,6/198,447/12185,0.738844867,0.999618129,0.761031183,RTKN2/HELLS/FOXM1/CIT/TRIM59/PBK,6,BP
GO:0022037,metencephalon development,1/198,82/12185,0.740221208,0.999618129,0.761031183,KIF14,1,BP
GO:0060840,artery development,1/198,82/12185,0.740221208,0.999618129,0.761031183,CNTRL,1,BP
GO:0000302,response to reactive oxygen species,2/198,161/12185,0.74029137,0.999618129,0.761031183,CDK1/ECT2,2,BP
GO:0009636,response to toxic substance,2/198,161/12185,0.74029137,0.999618129,0.761031183,CDK1/BRIP1,2,BP
GO:0001738,morphogenesis of a polarized epithelium,1/198,83/12185,0.74447108,0.999618129,0.761031183,SAPCD2,1,BP
GO:0071774,response to fibroblast growth factor,1/198,83/12185,0.74447108,0.999618129,0.761031183,SHCBP1,1,BP
GO:0071375,cellular response to peptide hormone stimulus,3/198,237/12185,0.744500318,0.999618129,0.761031183,CDC6/BRIP1/CCNA2,3,BP
GO:0051222,positive regulation of protein transport,3/198,238/12185,0.7470683,0.999618129,0.761031183,CDK1/KIF20B/ECT2,3,BP
GO:0050673,epithelial cell proliferation,4/198,311/12185,0.748356701,0.999618129,0.761031183,IQGAP3/BRCA2/UHRF1/HMGB2,4,BP
GO:0035303,regulation of dephosphorylation,1/198,84/12185,0.748651771,0.999618129,0.761031183,CDCA2,1,BP
GO:0072384,organelle transport along microtubule,1/198,84/12185,0.748651771,0.999618129,0.761031183,NDE1,1,BP
GO:1901293,nucleoside phosphate biosynthetic process,3/198,240/12185,0.752142813,0.999618129,0.761031183,RRM1/TK1/RRM2,3,BP
GO:1901874,negative regulation of post-translational protein modification,1/198,85/12185,0.752764402,0.999618129,0.761031183,MAD2L1,1,BP
GO:0048732,gland development,4/198,314/12185,0.755042674,0.999618129,0.761031183,IQGAP3/BRCA2/CCNB2/AURKA,4,BP
GO:0060541,respiratory system development,2/198,166/12185,0.755495003,0.999618129,0.761031183,IFT25/TIMELESS,2,BP
GO:1903829,positive regulation of protein localization,5/198,387/12185,0.758433549,0.999618129,0.761031183,GPSM2/CDK1/KIF20B/PLK1/ECT2,5,BP
GO:0009060,aerobic respiration,2/198,168/12185,0.761359328,0.999618129,0.761031183,CDK1/CCNB1,2,BP
GO:0120032,regulation of plasma membrane bounded cell projection assembly,2/198,169/12185,0.764245795,0.999618129,0.761031183,ANLN/KIF24,2,BP
GO:0021761,limbic system development,1/198,88/12185,0.764704871,0.999618129,0.761031183,KIF14,1,BP
GO:0030203,glycosaminoglycan metabolic process,1/198,88/12185,0.764704871,0.999618129,0.761031183,HMMR,1,BP
GO:0110020,regulation of actomyosin structure organization,1/198,88/12185,0.764704871,0.999618129,0.761031183,ECT2,1,BP
GO:0060491,regulation of cell projection assembly,2/198,171/12185,0.769928398,0.999618129,0.761031183,ANLN/KIF24,2,BP
GO:0034446,substrate adhesion-dependent cell spreading,1/198,90/12185,0.772344626,0.999618129,0.761031183,KIF14,1,BP
GO:0046683,response to organophosphorus,1/198,90/12185,0.772344626,0.999618129,0.761031183,RFC3,1,BP
GO:0090630,activation of GTPase activity,1/198,90/12185,0.772344626,0.999618129,0.761031183,ECT2,1,BP
GO:0038061,non-canonical NF-kappaB signal transduction,1/198,91/12185,0.776071435,0.999618129,0.761031183,RTKN2,1,BP
GO:0050728,negative regulation of inflammatory response,1/198,91/12185,0.776071435,0.999618129,0.761031183,PBK,1,BP
GO:0015698,inorganic anion transport,1/198,92/12185,0.779737539,0.999618129,0.761031183,RACGAP1,1,BP
GO:0090263,positive regulation of canonical Wnt signaling pathway,1/198,92/12185,0.779737539,0.999618129,0.761031183,ASPM,1,BP
GO:0051651,maintenance of location in cell,2/198,175/12185,0.780938264,0.999618129,0.761031183,GPSM2/ASPM,2,BP
GO:0006022,aminoglycan metabolic process,1/198,93/12185,0.78334392,0.999618129,0.761031183,HMMR,1,BP
GO:1904951,positive regulation of establishment of protein localization,3/198,254/12185,0.785418741,0.999618129,0.761031183,CDK1/KIF20B/ECT2,3,BP
GO:0009566,fertilization,1/198,94/12185,0.786891547,0.999618129,0.761031183,CDK1,1,BP
GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,1/198,94/12185,0.786891547,0.999618129,0.761031183,ANLN,1,BP
GO:0006367,transcription initiation at RNA polymerase II promoter,1/198,96/12185,0.793814332,0.999618129,0.761031183,E2F2,1,BP
GO:0007368,determination of left/right symmetry,1/198,96/12185,0.793814332,0.999618129,0.761031183,STIL,1,BP
GO:2000027,regulation of animal organ morphogenesis,1/198,96/12185,0.793814332,0.999618129,0.761031183,SAPCD2,1,BP
GO:0031348,negative regulation of defense response,2/198,180/12185,0.794052209,0.999618129,0.761031183,AURKB/PBK,2,BP
GO:0051403,stress-activated MAPK cascade,2/198,180/12185,0.794052209,0.999618129,0.761031183,FOXM1/PBK,2,BP
GO:0071417,cellular response to organonitrogen compound,6/198,479/12185,0.795879844,0.999618129,0.761031183,TIMELESS/RAD51/BLM/CDC6/BRIP1/CCNA2,6,BP
GO:0043547,positive regulation of GTPase activity,2/198,182/12185,0.799101677,0.999618129,0.761031183,ARHGAP11A/ECT2,2,BP
GO:0002040,sprouting angiogenesis,1/198,98/12185,0.800513331,0.999618129,0.761031183,E2F2,1,BP
GO:0007605,sensory perception of sound,1/198,98/12185,0.800513331,0.999618129,0.761031183,BIRC5,1,BP
GO:0003279,cardiac septum development,1/198,99/12185,0.803781169,0.999618129,0.761031183,CNTRL,1,BP
GO:0072594,establishment of protein localization to organelle,5/198,412/12185,0.804352382,0.999618129,0.761031183,CDK1/POLA2/BRCA2/KPNA2/ECT2,5,BP
GO:0001936,regulation of endothelial cell proliferation,1/198,100/12185,0.806995742,0.999618129,0.761031183,HMGB2,1,BP
GO:0009799,specification of symmetry,1/198,100/12185,0.806995742,0.999618129,0.761031183,STIL,1,BP
GO:0009855,determination of bilateral symmetry,1/198,100/12185,0.806995742,0.999618129,0.761031183,STIL,1,BP
GO:1904019,epithelial cell apoptotic process,1/198,100/12185,0.806995742,0.999618129,0.761031183,E2F2,1,BP
GO:0050680,negative regulation of epithelial cell proliferation,1/198,101/12185,0.810157913,0.999618129,0.761031183,BRCA2,1,BP
GO:0062197,cellular response to chemical stress,3/198,266/12185,0.810938313,0.999618129,0.761031183,CDK1/FANCD2/ECT2,3,BP
GO:0031098,stress-activated protein kinase signaling cascade,2/198,187/12185,0.811250483,0.999618129,0.761031183,FOXM1/PBK,2,BP
GO:0050769,positive regulation of neurogenesis,2/198,187/12185,0.811250483,0.999618129,0.761031183,ASPM/XRCC2,2,BP
GO:0007584,response to nutrient,1/198,102/12185,0.813268534,0.999618129,0.761031183,BRIP1,1,BP
GO:0042742,defense response to bacterium,1/198,102/12185,0.813268534,0.999618129,0.761031183,HMGB2,1,BP
GO:2000377,regulation of reactive oxygen species metabolic process,1/198,102/12185,0.813268534,0.999618129,0.761031183,FOXM1,1,BP
GO:0060562,epithelial tube morphogenesis,3/198,269/12185,0.816905615,0.999618129,0.761031183,STIL/KIF20B/TIMELESS,3,BP
GO:0002832,negative regulation of response to biotic stimulus,1/198,104/12185,0.819338451,0.999618129,0.761031183,AURKB,1,BP
GO:0051592,response to calcium ion,1/198,105/12185,0.82229938,0.999618129,0.761031183,ECT2,1,BP
GO:0060041,retina development in camera-type eye,1/198,105/12185,0.82229938,0.999618129,0.761031183,RRM1,1,BP
GO:0001889,liver development,1/198,107/12185,0.828077162,0.999618129,0.761031183,AURKA,1,BP
GO:0007043,cell-cell junction assembly,1/198,107/12185,0.828077162,0.999618129,0.761031183,ECT2,1,BP
GO:0010927,cellular component assembly involved in morphogenesis,1/198,107/12185,0.828077162,0.999618129,0.761031183,KNL1,1,BP
GO:0015748,organophosphate ester transport,1/198,107/12185,0.828077162,0.999618129,0.761031183,XKR5,1,BP
GO:0071902,positive regulation of protein serine/threonine kinase activity,1/198,107/12185,0.828077162,0.999618129,0.761031183,PSRC1,1,BP
GO:0009410,response to xenobiotic stimulus,3/198,275/12185,0.828364202,0.999618129,0.761031183,RAD54L/CENPF/CDK1,3,BP
GO:0048863,stem cell differentiation,2/198,195/12185,0.829334833,0.999618129,0.761031183,CHD2/PHF19,2,BP
GO:0045580,regulation of T cell differentiation,1/198,108/12185,0.830895569,0.999618129,0.761031183,FANCD2,1,BP
GO:0051092,positive regulation of NF-kappaB transcription factor activity,1/198,108/12185,0.830895569,0.999618129,0.761031183,RTKN2,1,BP
GO:0051606,detection of stimulus,1/198,108/12185,0.830895569,0.999618129,0.761031183,TIMELESS,1,BP
GO:0043244,regulation of protein-containing complex disassembly,1/198,110/12185,0.836395208,0.999618129,0.761031183,TPX2,1,BP
GO:0055007,cardiac muscle cell differentiation,1/198,110/12185,0.836395208,0.999618129,0.761031183,CDK1,1,BP
GO:0061008,hepaticobiliary system development,1/198,110/12185,0.836395208,0.999618129,0.761031183,AURKA,1,BP
GO:0051960,regulation of nervous system development,4/198,357/12185,0.83645283,0.999618129,0.761031183,ASPM/KIF14/HMGB2/XRCC2,4,BP
GO:0045862,positive regulation of proteolysis,3/198,280/12185,0.837441596,0.999618129,0.761031183,CDC20/PLK1/AURKA,3,BP
GO:0001890,placenta development,1/198,111/12185,0.83907792,0.999618129,0.761031183,PLK4,1,BP
GO:0007006,mitochondrial membrane organization,1/198,111/12185,0.83907792,0.999618129,0.761031183,ARHGAP11B,1,BP
GO:0003231,cardiac ventricle development,1/198,112/12185,0.841716861,0.999618129,0.761031183,CNTRL,1,BP
GO:0030902,hindbrain development,1/198,112/12185,0.841716861,0.999618129,0.761031183,KIF14,1,BP
GO:0050954,sensory perception of mechanical stimulus,1/198,112/12185,0.841716861,0.999618129,0.761031183,BIRC5,1,BP
GO:0043122,regulation of canonical NF-kappaB signal transduction,2/198,203/12185,0.845851111,0.999618129,0.761031183,TRIM59/ECT2,2,BP
GO:0042552,myelination,1/198,114/12185,0.84686626,0.999618129,0.761031183,KIF14,1,BP
GO:0071222,cellular response to lipopolysaccharide,1/198,114/12185,0.84686626,0.999618129,0.761031183,HMGB2,1,BP
GO:0002285,lymphocyte activation involved in immune response,1/198,115/12185,0.849378105,0.999618129,0.761031183,EXO1,1,BP
GO:0007266,Rho protein signal transduction,1/198,115/12185,0.849378105,0.999618129,0.761031183,RACGAP1,1,BP
GO:0001959,regulation of cytokine-mediated signaling pathway,1/198,116/12185,0.851848953,0.999618129,0.761031183,TRAIP,1,BP
GO:0007272,ensheathment of neurons,1/198,116/12185,0.851848953,0.999618129,0.761031183,KIF14,1,BP
GO:0008366,axon ensheathment,1/198,116/12185,0.851848953,0.999618129,0.761031183,KIF14,1,BP
GO:0001935,endothelial cell proliferation,1/198,117/12185,0.85427947,0.999618129,0.761031183,HMGB2,1,BP
GO:0007009,plasma membrane organization,1/198,117/12185,0.85427947,0.999618129,0.761031183,XKR5,1,BP
GO:0048754,branching morphogenesis of an epithelial tube,1/198,118/12185,0.85667031,0.999618129,0.761031183,TIMELESS,1,BP
GO:0071219,cellular response to molecule of bacterial origin,1/198,118/12185,0.85667031,0.999618129,0.761031183,HMGB2,1,BP
GO:0045333,cellular respiration,2/198,210/12185,0.859103179,0.999618129,0.761031183,CDK1/CCNB1,2,BP
GO:0050727,regulation of inflammatory response,2/198,210/12185,0.859103179,0.999618129,0.761031183,FANCD2/PBK,2,BP
GO:1901652,response to peptide,4/198,373/12185,0.860392452,0.999618129,0.761031183,TIMELESS/CDC6/BRIP1/CCNA2,4,BP
GO:0050777,negative regulation of immune response,1/198,120/12185,0.861335531,0.999618129,0.761031183,AURKB,1,BP
GO:0048639,positive regulation of developmental growth,1/198,121/12185,0.863611168,0.999618129,0.761031183,CDK1,1,BP
GO:2001236,regulation of extrinsic apoptotic signaling pathway,1/198,122/12185,0.865849645,0.999618129,0.761031183,HMGB2,1,BP
GO:0031333,negative regulation of protein-containing complex assembly,1/198,123/12185,0.868051566,0.999618129,0.761031183,KIF14,1,BP
GO:0030099,myeloid cell differentiation,3/198,300/12185,0.869741365,0.999618129,0.761031183,RACGAP1/HMGB2/NCAPG2,3,BP
GO:0050767,regulation of neurogenesis,3/198,301/12185,0.871197749,0.999618129,0.761031183,ASPM/HMGB2/XRCC2,3,BP
GO:1990778,protein localization to cell periphery,3/198,301/12185,0.871197749,0.999618129,0.761031183,GPSM2/PLK1/SAPCD2,3,BP
GO:0060759,regulation of response to cytokine stimulus,1/198,125/12185,0.872348105,0.999618129,0.761031183,TRAIP,1,BP
GO:0014706,striated muscle tissue development,2/198,218/12185,0.872973566,0.999618129,0.761031183,CENPF/CDK1,2,BP
GO:0051962,positive regulation of nervous system development,2/198,220/12185,0.876240202,0.999618129,0.761031183,ASPM/XRCC2,2,BP
GO:0120031,plasma membrane bounded cell projection assembly,5/198,463/12185,0.876564836,0.999618129,0.761031183,IFT25/POC1A/PLK4/ANLN/KIF24,5,BP
GO:0045619,regulation of lymphocyte differentiation,1/198,128/12185,0.878533281,0.999618129,0.761031183,FANCD2,1,BP
GO:0044403,biological process involved in symbiotic interaction,2/198,222/12185,0.879429622,0.999618129,0.761031183,CDK1/TRIM59,2,BP
GO:0032006,regulation of TOR signaling,1/198,131/12185,0.884420205,0.999618129,0.761031183,FAM83D,1,BP
GO:0035265,organ growth,1/198,131/12185,0.884420205,0.999618129,0.761031183,CDK1,1,BP
GO:0043065,positive regulation of apoptotic process,4/198,393/12185,0.886079368,0.999618129,0.761031183,TOP2A/MYBL2/ECT2/MELK,4,BP
GO:0071396,cellular response to lipid,4/198,393/12185,0.886079368,0.999618129,0.761031183,KIF18A/H2AZ1/CCNA2/HMGB2,4,BP
GO:0010821,regulation of mitochondrion organization,1/198,132/12185,0.886318728,0.999618129,0.761031183,AURKA,1,BP
GO:0010720,positive regulation of cell development,3/198,313/12185,0.887588231,0.999618129,0.761031183,ASPM/AURKA/XRCC2,3,BP
GO:0030031,cell projection assembly,5/198,473/12185,0.887720832,0.999618129,0.761031183,IFT25/POC1A/PLK4/ANLN/KIF24,5,BP
GO:2001233,regulation of apoptotic signaling pathway,3/198,314/12185,0.888866806,0.999618129,0.761031183,RTKN2/HELLS/HMGB2,3,BP
GO:0007249,canonical NF-kappaB signal transduction,2/198,229/12185,0.890006744,0.999618129,0.761031183,TRIM59/ECT2,2,BP
GO:0006352,DNA-templated transcription initiation,1/198,134/12185,0.890023188,0.999618129,0.761031183,E2F2,1,BP
GO:0071248,cellular response to metal ion,1/198,135/12185,0.891830126,0.999618129,0.761031183,ECT2,1,BP
GO:0043434,response to peptide hormone,3/198,317/12185,0.892625297,0.999618129,0.761031183,CDC6/BRIP1/CCNA2,3,BP
GO:0048284,organelle fusion,1/198,136/12185,0.893607523,0.999618129,0.761031183,CDK1,1,BP
GO:0051494,negative regulation of cytoskeleton organization,1/198,136/12185,0.893607523,0.999618129,0.761031183,TPX2,1,BP
GO:1901136,carbohydrate derivative catabolic process,1/198,136/12185,0.893607523,0.999618129,0.761031183,HMMR,1,BP
GO:1902904,negative regulation of supramolecular fiber organization,1/198,136/12185,0.893607523,0.999618129,0.761031183,TPX2,1,BP
GO:0035051,cardiocyte differentiation,1/198,137/12185,0.89535586,0.999618129,0.761031183,CDK1,1,BP
GO:0045637,regulation of myeloid cell differentiation,1/198,137/12185,0.89535586,0.999618129,0.761031183,HMGB2,1,BP
GO:0001666,response to hypoxia,2/198,233/12185,0.895659557,0.999618129,0.761031183,BRIP1/CCNA2,2,BP
GO:0002009,morphogenesis of an epithelium,4/198,403/12185,0.897315238,0.999618129,0.761031183,STIL/KIF20B/TIMELESS/SAPCD2,4,BP
GO:0043068,positive regulation of programmed cell death,4/198,403/12185,0.897315238,0.999618129,0.761031183,TOP2A/MYBL2/ECT2/MELK,4,BP
GO:0009617,response to bacterium,3/198,322/12185,0.898638187,0.999618129,0.761031183,MACROD2/NAALADL2/HMGB2,3,BP
GO:0006979,response to oxidative stress,3/198,323/12185,0.899803995,0.999618129,0.761031183,CDK1/FANCD2/ECT2,3,BP
GO:0061138,morphogenesis of a branching epithelium,1/198,140/12185,0.900431199,0.999618129,0.761031183,TIMELESS,1,BP
GO:0043087,regulation of GTPase activity,2/198,237/12185,0.901042419,0.999618129,0.761031183,ARHGAP11A/ECT2,2,BP
GO:0071216,cellular response to biotic stimulus,1/198,141/12185,0.902067946,0.999618129,0.761031183,HMGB2,1,BP
GO:0009165,nucleotide biosynthetic process,2/198,239/12185,0.903636158,0.999618129,0.761031183,RRM1/RRM2,2,BP
GO:0001837,epithelial to mesenchymal transition,1/198,142/12185,0.903677922,0.999618129,0.761031183,FAM83D,1,BP
GO:0006909,phagocytosis,1/198,142/12185,0.903677922,0.999618129,0.761031183,XKR5,1,BP
GO:1901654,response to ketone,1/198,142/12185,0.903677922,0.999618129,0.761031183,NASP,1,BP
GO:0006469,negative regulation of protein kinase activity,1/198,145/12185,0.90835154,0.999618129,0.761031183,PLK1,1,BP
GO:0001933,negative regulation of protein phosphorylation,2/198,244/12185,0.909846611,0.999618129,0.761031183,PLK1/PBK,2,BP
GO:0043488,regulation of mRNA stability,1/198,146/12185,0.909858716,0.999618129,0.761031183,CARHSP1,1,BP
GO:1990138,neuron projection extension,1/198,146/12185,0.909858716,0.999618129,0.761031183,AURKA,1,BP
GO:0003205,cardiac chamber development,1/198,147/12185,0.911341229,0.999618129,0.761031183,CNTRL,1,BP
GO:0016311,dephosphorylation,2/198,246/12185,0.912224757,0.999618129,0.761031183,CDKN3/CDCA2,2,BP
GO:0031929,TOR signaling,1/198,148/12185,0.912799481,0.999618129,0.761031183,FAM83D,1,BP
GO:0048167,regulation of synaptic plasticity,1/198,148/12185,0.912799481,0.999618129,0.761031183,CDC20,1,BP
GO:0036293,response to decreased oxygen levels,2/198,247/12185,0.913391767,0.999618129,0.761031183,BRIP1/CCNA2,2,BP
GO:0002449,lymphocyte mediated immunity,1/198,150/12185,0.915644775,0.999618129,0.761031183,EXO1,1,BP
GO:0001763,morphogenesis of a branching structure,1/198,151/12185,0.917032588,0.999618129,0.761031183,TIMELESS,1,BP
GO:1901605,alpha-amino acid metabolic process,1/198,151/12185,0.917032588,0.999618129,0.761031183,ARHGAP11B,1,BP
GO:0043086,negative regulation of catalytic activity,3/198,340/12185,0.917864166,0.999618129,0.761031183,PIF1/PLK1/MAD2L1,3,BP
GO:0043123,positive regulation of canonical NF-kappaB signal transduction,1/198,152/12185,0.918397683,0.999618129,0.761031183,ECT2,1,BP
GO:1902905,positive regulation of supramolecular fiber organization,1/198,153/12185,0.919740429,0.999618129,0.761031183,PSRC1,1,BP
GO:0010038,response to metal ion,2/198,253/12185,0.920094991,0.999618129,0.761031183,CDK1/ECT2,2,BP
GO:0009743,response to carbohydrate,1/198,154/12185,0.921061189,0.999618129,0.761031183,CDT1,1,BP
GO:0031345,negative regulation of cell projection organization,1/198,154/12185,0.921061189,0.999618129,0.761031183,KIF24,1,BP
GO:0072593,reactive oxygen species metabolic process,1/198,154/12185,0.921061189,0.999618129,0.761031183,FOXM1,1,BP
GO:0045216,cell-cell junction organization,1/198,156/12185,0.923638184,0.999618129,0.761031183,ECT2,1,BP
GO:0046651,lymphocyte proliferation,1/198,156/12185,0.923638184,0.999618129,0.761031183,HELLS,1,BP
GO:0043254,regulation of protein-containing complex assembly,3/198,347/12185,0.924402501,0.999618129,0.761031183,PSRC1/KIF14/HJURP,3,BP
GO:0006486,protein glycosylation,1/198,157/12185,0.924895116,0.999618129,0.761031183,POGLUT3,1,BP
GO:0033673,negative regulation of kinase activity,1/198,157/12185,0.924895116,0.999618129,0.761031183,PLK1,1,BP
GO:0043413,macromolecule glycosylation,1/198,157/12185,0.924895116,0.999618129,0.761031183,POGLUT3,1,BP
GO:0043487,regulation of RNA stability,1/198,157/12185,0.924895116,0.999618129,0.761031183,CARHSP1,1,BP
GO:0051235,maintenance of location,2/198,258/12185,0.925306749,0.999618129,0.761031183,GPSM2/ASPM,2,BP
GO:1902074,response to salt,2/198,258/12185,0.925306749,0.999618129,0.761031183,ECT2/CCNA2,2,BP
GO:0002366,leukocyte activation involved in immune response,1/198,158/12185,0.926131462,0.999618129,0.761031183,EXO1,1,BP
GO:0008361,regulation of cell size,1/198,158/12185,0.926131462,0.999618129,0.761031183,IQGAP3,1,BP
GO:0071356,cellular response to tumor necrosis factor,1/198,158/12185,0.926131462,0.999618129,0.761031183,TRAIP,1,BP
GO:0045861,negative regulation of proteolysis,1/198,159/12185,0.927347557,0.999618129,0.761031183,PBK,1,BP
GO:0030308,negative regulation of cell growth,1/198,160/12185,0.92854373,0.999618129,0.761031183,PSRC1,1,BP
GO:0061013,regulation of mRNA catabolic process,1/198,160/12185,0.92854373,0.999618129,0.761031183,CARHSP1,1,BP
GO:0002263,cell activation involved in immune response,1/198,161/12185,0.929720307,0.999618129,0.761031183,EXO1,1,BP
GO:0031334,positive regulation of protein-containing complex assembly,1/198,162/12185,0.930877608,0.999618129,0.761031183,PSRC1,1,BP
GO:0032943,mononuclear cell proliferation,1/198,162/12185,0.930877608,0.999618129,0.761031183,HELLS,1,BP
GO:0006401,RNA catabolic process,2/198,264/12185,0.931139634,0.999618129,0.761031183,CARHSP1/RNASEH2A,2,BP
GO:0042326,negative regulation of phosphorylation,2/198,264/12185,0.931139634,0.999618129,0.761031183,PLK1/PBK,2,BP
GO:1903706,regulation of hemopoiesis,2/198,264/12185,0.931139634,0.999618129,0.761031183,FANCD2/HMGB2,2,BP
GO:0051345,positive regulation of hydrolase activity,3/198,355/12185,0.931292241,0.999618129,0.761031183,ARHGAP11A/ECT2/HMGB2,3,BP
GO:0060326,cell chemotaxis,1/198,163/12185,0.932015945,0.999618129,0.761031183,HMGB2,1,BP
GO:0001818,negative regulation of cytokine production,1/198,165/12185,0.934236964,0.999618129,0.761031183,TRAIP,1,BP
GO:0055001,muscle cell development,1/198,166/12185,0.935320249,0.999618129,0.761031183,CDK1,1,BP
GO:0043408,regulation of MAPK cascade,4/198,447/12185,0.93599661,0.999618129,0.761031183,IQGAP3/FOXM1/FAM83D/PBK,4,BP
GO:0031400,negative regulation of protein modification process,3/198,361/12185,0.936077318,0.999618129,0.761031183,PLK1/MAD2L1/PBK,3,BP
GO:0006470,protein dephosphorylation,1/198,167/12185,0.936385778,0.999618129,0.761031183,CDCA2,1,BP
GO:0070482,response to oxygen levels,2/198,270/12185,0.936541899,0.999618129,0.761031183,BRIP1/CCNA2,2,BP
GO:0045088,regulation of innate immune response,2/198,273/12185,0.939090676,0.999618129,0.761031183,AURKB/HMGB2,2,BP
GO:0032271,regulation of protein polymerization,1/198,170/12185,0.939478702,0.999618129,0.761031183,PSRC1,1,BP
GO:0042113,B cell activation,1/198,171/12185,0.940476056,0.999618129,0.761031183,EXO1,1,BP
GO:0030111,regulation of Wnt signaling pathway,2/198,275/12185,0.940735812,0.999618129,0.761031183,ASPM/DEPDC1B,2,BP
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/198,172/12185,0.941457057,0.999618129,0.761031183,EXO1,1,BP
GO:0006839,mitochondrial transport,1/198,172/12185,0.941457057,0.999618129,0.761031183,ARHGAP11B,1,BP
GO:1903828,negative regulation of protein localization,1/198,172/12185,0.941457057,0.999618129,0.761031183,SAPCD2,1,BP
GO:0007517,muscle organ development,2/198,278/12185,0.943124956,0.999618129,0.761031183,CENPF/CHD2,2,BP
GO:0034612,response to tumor necrosis factor,1/198,174/12185,0.943371059,0.999618129,0.761031183,TRAIP,1,BP
GO:0070085,glycosylation,1/198,176/12185,0.94522279,0.999618129,0.761031183,POGLUT3,1,BP
GO:0009895,negative regulation of catabolic process,2/198,281/12185,0.945422757,0.999618129,0.761031183,MAD2L1/PBK,2,BP
GO:0015980,energy derivation by oxidation of organic compounds,2/198,281/12185,0.945422757,0.999618129,0.761031183,CDK1/CCNB1,2,BP
GO:0051091,positive regulation of DNA-binding transcription factor activity,1/198,178/12185,0.947014266,0.999618129,0.761031183,RTKN2,1,BP
GO:0051650,establishment of vesicle localization,1/198,178/12185,0.947014266,0.999618129,0.761031183,NDE1,1,BP
GO:0097191,extrinsic apoptotic signaling pathway,1/198,178/12185,0.947014266,0.999618129,0.761031183,HMGB2,1,BP
GO:0010001,glial cell differentiation,1/198,179/12185,0.947888021,0.999618129,0.761031183,CDK1,1,BP
GO:0032496,response to lipopolysaccharide,1/198,181/12185,0.949592754,0.999618129,0.761031183,HMGB2,1,BP
GO:0070372,regulation of ERK1 and ERK2 cascade,1/198,181/12185,0.949592754,0.999618129,0.761031183,FAM83D,1,BP
GO:0070661,leukocyte proliferation,1/198,181/12185,0.949592754,0.999618129,0.761031183,HELLS,1,BP
GO:0032102,negative regulation of response to external stimulus,2/198,288/12185,0.950446918,0.999618129,0.761031183,AURKB/PBK,2,BP
GO:0009896,positive regulation of catabolic process,4/198,471/12185,0.951036658,0.999618129,0.761031183,CDC20/DTL/PLK1/AURKA,4,BP
GO:0030162,regulation of proteolysis,4/198,471/12185,0.951036658,0.999618129,0.761031183,CDC20/PLK1/AURKA/PBK,4,BP
GO:0048562,embryonic organ morphogenesis,1/198,184/12185,0.952046366,0.999618129,0.761031183,STIL,1,BP
GO:0050807,regulation of synapse organization,1/198,185/12185,0.952837535,0.999618129,0.761031183,CDC20,1,BP
GO:0007423,sensory organ development,3/198,387/12185,0.953474741,0.999618129,0.761031183,RRM1/MCM2/CCNA2,3,BP
GO:0031347,regulation of defense response,4/198,476/12185,0.953732395,0.999618129,0.761031183,AURKB/FANCD2/HMGB2/PBK,4,BP
GO:0040008,regulation of growth,4/198,476/12185,0.953732395,0.999618129,0.761031183,PSRC1/KIF14/CDK1/CCNB2,4,BP
GO:0050803,regulation of synapse structure or activity,1/198,187/12185,0.95438112,0.999618129,0.761031183,CDC20,1,BP
GO:0050821,protein stabilization,1/198,187/12185,0.95438112,0.999618129,0.761031183,CHEK2,1,BP
GO:0051223,regulation of protein transport,3/198,389/12185,0.954612133,0.999618129,0.761031183,CDK1/KIF20B/ECT2,3,BP
GO:0030217,T cell differentiation,1/198,188/12185,0.955133957,0.999618129,0.761031183,FANCD2,1,BP
GO:0045927,positive regulation of growth,1/198,188/12185,0.955133957,0.999618129,0.761031183,CDK1,1,BP
GO:0002237,response to molecule of bacterial origin,1/198,190/12185,0.956602746,0.999618129,0.761031183,HMGB2,1,BP
GO:0016054,organic acid catabolic process,1/198,190/12185,0.956602746,0.999618129,0.761031183,ARHGAP11B,1,BP
GO:0043414,macromolecule methylation,1/198,190/12185,0.956602746,0.999618129,0.761031183,HELLS,1,BP
GO:0046395,carboxylic acid catabolic process,1/198,190/12185,0.956602746,0.999618129,0.761031183,ARHGAP11B,1,BP
GO:0006898,receptor-mediated endocytosis,1/198,192/12185,0.958023687,0.999618129,0.761031183,HMMR,1,BP
GO:0055086,nucleobase-containing small molecule metabolic process,4/198,485/12185,0.95824505,0.999618129,0.761031183,RRM1/TK1/RRM2/MACROD2,4,BP
GO:0045936,negative regulation of phosphate metabolic process,2/198,301/12185,0.958634182,0.999618129,0.761031183,PLK1/PBK,2,BP
GO:0048588,developmental cell growth,1/198,193/12185,0.9587167,0.999618129,0.761031183,AURKA,1,BP
GO:0051648,vesicle localization,1/198,193/12185,0.9587167,0.999618129,0.761031183,NDE1,1,BP
GO:0010563,negative regulation of phosphorus metabolic process,2/198,302/12185,0.959207478,0.999618129,0.761031183,PLK1/PBK,2,BP
GO:1902105,regulation of leukocyte differentiation,1/198,195/12185,0.960068759,0.999618129,0.761031183,FANCD2,1,BP
GO:0048729,tissue morphogenesis,4/198,489/12185,0.96011791,0.999618129,0.761031183,STIL/KIF20B/TIMELESS/SAPCD2,4,BP
GO:0045926,negative regulation of growth,1/198,198/12185,0.962014676,0.999618129,0.761031183,PSRC1,1,BP
GO:0045765,regulation of angiogenesis,1/198,199/12185,0.962642113,0.999618129,0.761031183,E2F2,1,BP
GO:0002443,leukocyte mediated immunity,1/198,200/12185,0.963259238,0.999618129,0.761031183,EXO1,1,BP
GO:0016049,cell growth,3/198,406/12185,0.963286204,0.999618129,0.761031183,PSRC1/KIF14/AURKA,3,BP
GO:0060560,developmental growth involved in morphogenesis,1/198,201/12185,0.96386622,0.999618129,0.761031183,AURKA,1,BP
GO:1901342,regulation of vasculature development,1/198,201/12185,0.96386622,0.999618129,0.761031183,E2F2,1,BP
GO:0018205,peptidyl-lysine modification,1/198,202/12185,0.964463223,0.999618129,0.761031183,DEK,1,BP
GO:0048568,embryonic organ development,2/198,312/12185,0.964538459,0.999618129,0.761031183,STIL/PLK4,2,BP
GO:0031669,cellular response to nutrient levels,1/198,205/12185,0.966195984,0.999618129,0.761031183,BRIP1,1,BP
GO:0070201,regulation of establishment of protein localization,3/198,413/12185,0.966385532,0.999618129,0.761031183,CDK1/KIF20B/ECT2,3,BP
GO:0048738,cardiac muscle tissue development,1/198,206/12185,0.966754682,0.999618129,0.761031183,CDK1,1,BP
GO:0048762,mesenchymal cell differentiation,1/198,206/12185,0.966754682,0.999618129,0.761031183,FAM83D,1,BP
GO:0050863,regulation of T cell activation,1/198,214/12185,0.970905818,0.999618129,0.761031183,FANCD2,1,BP
GO:0060828,regulation of canonical Wnt signaling pathway,1/198,214/12185,0.970905818,0.999618129,0.761031183,ASPM,1,BP
GO:0045089,positive regulation of innate immune response,1/198,215/12185,0.971387035,0.999618129,0.761031183,HMGB2,1,BP
GO:0002831,regulation of response to biotic stimulus,2/198,328/12185,0.971707639,0.999618129,0.761031183,AURKB/HMGB2,2,BP
GO:1902903,regulation of supramolecular fiber organization,2/198,328/12185,0.971707639,0.999618129,0.761031183,PSRC1/TPX2,2,BP
GO:0006753,nucleoside phosphate metabolic process,3/198,427/12185,0.971862109,0.999618129,0.761031183,RRM1/TK1/RRM2,3,BP
GO:0003007,heart morphogenesis,1/198,217/12185,0.972325839,0.999618129,0.761031183,STIL,1,BP
GO:0006402,mRNA catabolic process,1/198,217/12185,0.972325839,0.999618129,0.761031183,CARHSP1,1,BP
GO:0006520,amino acid metabolic process,1/198,223/12185,0.97496229,0.999618129,0.761031183,ARHGAP11B,1,BP
GO:0002833,positive regulation of response to biotic stimulus,1/198,225/12185,0.975784334,0.999618129,0.761031183,HMGB2,1,BP
GO:0001558,regulation of cell growth,2/198,342/12185,0.976820385,0.999618129,0.761031183,PSRC1/KIF14,2,BP
GO:0002250,adaptive immune response,1/198,229/12185,0.977348721,0.999618129,0.761031183,EXO1,1,BP
GO:0032870,cellular response to hormone stimulus,3/198,444/12185,0.97738346,0.999618129,0.761031183,CDC6/BRIP1/CCNA2,3,BP
GO:0031668,cellular response to extracellular stimulus,1/198,231/12185,0.978092782,0.999618129,0.761031183,BRIP1,1,BP
GO:0009101,glycoprotein biosynthetic process,1/198,232/12185,0.978455642,0.999618129,0.761031183,POGLUT3,1,BP
GO:0060537,muscle tissue development,2/198,349/12185,0.979030885,0.999618129,0.761031183,CENPF/CDK1,2,BP
GO:0043010,camera-type eye development,1/198,235/12185,0.979508731,0.999618129,0.761031183,RRM1,1,BP
GO:0006954,inflammatory response,3/198,457/12185,0.980896215,0.999618129,0.761031183,FANCD2/HMGB2/PBK,3,BP
GO:0042063,gliogenesis,1/198,240/12185,0.981151269,0.999618129,0.761031183,CDK1,1,BP
GO:0048545,response to steroid hormone,1/198,240/12185,0.981151269,0.999618129,0.761031183,HMGB2,1,BP
GO:0051146,striated muscle cell differentiation,1/198,242/12185,0.981770988,0.999618129,0.761031183,CDK1,1,BP
GO:0048638,regulation of developmental growth,1/198,249/12185,0.983784611,0.999618129,0.761031183,CDK1,1,BP
GO:0034655,nucleobase-containing compound catabolic process,2/198,367/12185,0.983821276,0.999618129,0.761031183,CARHSP1/RNASEH2A,2,BP
GO:0032259,methylation,1/198,250/12185,0.984053599,0.999618129,0.761031183,HELLS,1,BP
GO:0060485,mesenchyme development,1/198,250/12185,0.984053599,0.999618129,0.761031183,FAM83D,1,BP
GO:0046649,lymphocyte activation,3/198,471/12185,0.984097424,0.999618129,0.761031183,EXO1/HELLS/FANCD2,3,BP
GO:0010631,epithelial cell migration,1/198,251/12185,0.984318148,0.999618129,0.761031183,ANLN,1,BP
GO:0090132,epithelium migration,1/198,251/12185,0.984318148,0.999618129,0.761031183,ANLN,1,BP
GO:1903311,regulation of mRNA metabolic process,1/198,253/12185,0.984834216,0.999618129,0.761031183,CARHSP1,1,BP
GO:0060070,canonical Wnt signaling pathway,1/198,254/12185,0.985085877,0.999618129,0.761031183,ASPM,1,BP
GO:0090130,tissue migration,1/198,255/12185,0.985333383,0.999618129,0.761031183,ANLN,1,BP
GO:0016055,Wnt signaling pathway,2/198,376/12185,0.985800985,0.999618129,0.761031183,ASPM/DEPDC1B,2,BP
GO:0198738,cell-cell signaling by wnt,2/198,377/12185,0.986005895,0.999618129,0.761031183,ASPM/DEPDC1B,2,BP
GO:0030098,lymphocyte differentiation,1/198,259/12185,0.986283204,0.999618129,0.761031183,FANCD2,1,BP
GO:0007015,actin filament organization,2/198,380/12185,0.986603586,0.999618129,0.761031183,IQGAP3/GAS2L3,2,BP
GO:0044270,cellular nitrogen compound catabolic process,2/198,386/12185,0.987725649,0.999618129,0.761031183,CARHSP1/RNASEH2A,2,BP
GO:0006935,chemotaxis,1/198,266/12185,0.987800449,0.999618129,0.761031183,HMGB2,1,BP
GO:0007600,sensory perception,1/198,266/12185,0.987800449,0.999618129,0.761031183,BIRC5,1,BP
GO:0042330,taxis,1/198,266/12185,0.987800449,0.999618129,0.761031183,HMGB2,1,BP
GO:0006869,lipid transport,1/198,267/12185,0.98800311,0.999618129,0.761031183,XKR5,1,BP
GO:0046700,heterocycle catabolic process,2/198,388/12185,0.988079,0.999618129,0.761031183,CARHSP1/RNASEH2A,2,BP
GO:0001654,eye development,1/198,270/12185,0.988591211,0.999618129,0.761031183,RRM1,1,BP
GO:0150063,visual system development,1/198,270/12185,0.988591211,0.999618129,0.761031183,RRM1,1,BP
GO:0006631,fatty acid metabolic process,1/198,271/12185,0.988780799,0.999618129,0.761031183,ACBD7,1,BP
GO:0031589,cell-substrate adhesion,1/198,271/12185,0.988780799,0.999618129,0.761031183,KIF14,1,BP
GO:0032956,regulation of actin cytoskeleton organization,1/198,271/12185,0.988780799,0.999618129,0.761031183,ECT2,1,BP
GO:0044282,small molecule catabolic process,1/198,272/12185,0.988967252,0.999618129,0.761031183,ARHGAP11B,1,BP
GO:0019439,aromatic compound catabolic process,2/198,394/12185,0.989080853,0.999618129,0.761031183,CARHSP1/RNASEH2A,2,BP
GO:0048880,sensory system development,1/198,273/12185,0.989150622,0.999618129,0.761031183,RRM1,1,BP
GO:0009611,response to wounding,2/198,395/12185,0.989239682,0.999618129,0.761031183,CDK1/AURKA,2,BP
GO:0031349,positive regulation of defense response,1/198,276/12185,0.989682735,0.999618129,0.761031183,HMGB2,1,BP
GO:0071496,cellular response to external stimulus,1/198,277/12185,0.989854271,0.999618129,0.761031183,BRIP1,1,BP
GO:0019221,cytokine-mediated signaling pathway,1/198,279/12185,0.990188875,0.999618129,0.761031183,TRAIP,1,BP
GO:0001819,positive regulation of cytokine production,1/198,281/12185,0.990512499,0.999618129,0.761031183,HMGB2,1,BP
GO:0051090,regulation of DNA-binding transcription factor activity,1/198,285/12185,0.991128224,0.999618129,0.761031183,RTKN2,1,BP
GO:1901361,organic cyclic compound catabolic process,2/198,413/12185,0.991742956,0.999618129,0.761031183,CARHSP1/RNASEH2A,2,BP
GO:1903131,mononuclear cell differentiation,1/198,290/12185,0.991842257,0.999618129,0.761031183,FANCD2,1,BP
GO:0009100,glycoprotein metabolic process,1/198,291/12185,0.991978048,0.999618129,0.761031183,POGLUT3,1,BP
GO:0006091,generation of precursor metabolites and energy,2/198,415/12185,0.991983318,0.999618129,0.761031183,CDK1/CCNB1,2,BP
GO:0043410,positive regulation of MAPK cascade,1/198,296/12185,0.992623998,0.999618129,0.761031183,IQGAP3,1,BP
GO:0051249,regulation of lymphocyte activation,1/198,296/12185,0.992623998,0.999618129,0.761031183,FANCD2,1,BP
GO:0009117,nucleotide metabolic process,2/198,421/12185,0.99266426,0.999618129,0.761031183,RRM1/RRM2,2,BP
GO:0031346,positive regulation of cell projection organization,1/198,299/12185,0.992986446,0.999618129,0.761031183,ANLN,1,BP
GO:0002683,negative regulation of immune system process,1/198,305/12185,0.993659029,0.999618129,0.761031183,AURKB,1,BP
GO:0010876,lipid localization,1/198,305/12185,0.993659029,0.999618129,0.761031183,XKR5,1,BP
GO:0032535,regulation of cellular component size,1/198,307/12185,0.993868642,0.999618129,0.761031183,IQGAP3,1,BP
GO:0048598,embryonic morphogenesis,2/198,434/12185,0.993952013,0.999618129,0.761031183,STIL/KIF20B,2,BP
GO:0032970,regulation of actin filament-based process,1/198,310/12185,0.994170204,0.999618129,0.761031183,ECT2,1,BP
GO:0030855,epithelial cell differentiation,2/198,438/12185,0.994301854,0.999618129,0.761031183,CDK1/PLK4,2,BP
GO:0016050,vesicle organization,1/198,319/12185,0.994989166,0.999618129,0.761031183,KNL1,1,BP
GO:0042110,T cell activation,1/198,319/12185,0.994989166,0.999618129,0.761031183,FANCD2,1,BP
GO:0002252,immune effector process,1/198,325/12185,0.99547047,0.999618129,0.761031183,EXO1,1,BP
GO:0042692,muscle cell differentiation,1/198,331/12185,0.995905755,0.999618129,0.761031183,CDK1,1,BP
GO:0001817,regulation of cytokine production,2/198,473/12185,0.996629205,0.999618129,0.761031183,TRAIP/HMGB2,2,BP
GO:0002694,regulation of leukocyte activation,1/198,343/12185,0.996655369,0.999618129,0.761031183,FANCD2,1,BP
GO:0034329,cell junction assembly,1/198,346/12185,0.996820362,0.999618129,0.761031183,ECT2,1,BP
GO:0050804,modulation of chemical synaptic transmission,1/198,348/12185,0.996925832,0.999618129,0.761031183,CDC20,1,BP
GO:0099177,regulation of trans-synaptic signaling,1/198,349/12185,0.996977254,0.999618129,0.761031183,CDC20,1,BP
GO:0001816,cytokine production,2/198,482/12185,0.997057842,0.999618129,0.761031183,TRAIP/HMGB2,2,BP
GO:0001667,ameboidal-type cell migration,1/198,354/12185,0.997221807,0.999618129,0.761031183,ANLN,1,BP
GO:0031667,response to nutrient levels,1/198,356/12185,0.997314023,0.999618129,0.761031183,BRIP1,1,BP
GO:0032103,positive regulation of response to external stimulus,1/198,364/12185,0.997653411,0.999618129,0.761031183,HMGB2,1,BP
GO:0048812,neuron projection morphogenesis,2/198,497/12185,0.997656612,0.999618129,0.761031183,KIF20B/AURKA,2,BP
GO:0001501,skeletal system development,1/198,367/12185,0.997769372,0.999618129,0.761031183,IFT25,1,BP
GO:0050808,synapse organization,1/198,374/12185,0.998018249,0.999618129,0.761031183,CDC20,1,BP
GO:0050865,regulation of cell activation,1/198,377/12185,0.998116262,0.999618129,0.761031183,FANCD2,1,BP
GO:0009991,response to extracellular stimulus,1/198,380/12185,0.998209451,0.999618129,0.761031183,BRIP1,1,BP
GO:0002521,leukocyte differentiation,1/198,381/12185,0.998239483,0.999618129,0.761031183,FANCD2,1,BP
GO:0007186,G protein-coupled receptor signaling pathway,1/198,389/12185,0.998462378,0.999618129,0.761031183,GPSM2,1,BP
GO:0072521,purine-containing compound metabolic process,1/198,390/12185,0.998488188,0.999618129,0.761031183,MACROD2,1,BP
GO:0001525,angiogenesis,1/198,392/12185,0.998538521,0.999618129,0.761031183,E2F2,1,BP
GO:0090066,regulation of anatomical structure size,1/198,395/12185,0.998610911,0.999618129,0.761031183,IQGAP3,1,BP
GO:0030335,positive regulation of cell migration,1/198,405/12185,0.998827407,0.999618129,0.761031183,KIF20B,1,BP
GO:0050778,positive regulation of immune response,1/198,417/12185,0.999043324,0.999618129,0.761031183,HMGB2,1,BP
GO:2000147,positive regulation of cell motility,1/198,419/12185,0.999075247,0.999618129,0.761031183,KIF20B,1,BP
GO:0040017,positive regulation of locomotion,1/198,426/12185,0.999178857,0.999618129,0.761031183,KIF20B,1,BP
GO:0032787,monocarboxylic acid metabolic process,1/198,427/12185,0.999192684,0.999618129,0.761031183,ACBD7,1,BP
GO:0044283,small molecule biosynthetic process,1/198,433/12185,0.999270911,0.999618129,0.761031183,TK1,1,BP
GO:0048514,blood vessel morphogenesis,1/198,460/12185,0.999539411,0.999618129,0.761031183,E2F2,1,BP
GO:0010608,post-transcriptional regulation of gene expression,1/198,468/12185,0.999598095,0.999618129,0.761031183,CARHSP1,1,BP
GO:0007169,transmembrane receptor protein tyrosine kinase signaling pathway,1/198,469/12185,0.999604887,0.999618129,0.761031183,SHCBP1,1,BP
GO:0045596,negative regulation of cell differentiation,1/198,471/12185,0.999618129,0.999618129,0.761031183,ASPM,1,BP
GO:0017116,single-stranded DNA helicase activity,13/193,23/12494,1.90E-18,3.69E-16,3.16E-16,RFC5/RFC3/RAD51/PIF1/MCM6/MCM5/POLQ/MCM2/RFC4/MCM3/RFC2/MCM4/DSCC1,13,MF
GO:0140657,ATP-dependent activity,39/193,470/12494,3.11E-18,3.69E-16,3.16E-16,KIF2C/RAD54L/ORC1/KIF14/KIF20B/KIF11/HELLS/KIF18A/RFC5/RFC3/RAD51/PIF1/KIF23/BLM/CHD2/CDC6/TOP2A/KIF18B/BRIP1/MCM6/MCM5/KIF15/POLQ/MCM2/SMC4/RFC4/CENPE/TRIP13/KIF20A/KIFC1/MCM3/RFC2/XRCC2/MCM4/DSCC1/ATAD2/KIF24/KIF4A/ERCC6L,39,MF
GO:0008017,microtubule binding,28/193,237/12494,3.31E-17,2.61E-15,2.24E-15,KIF2C/PSRC1/KIF14/CENPF/KIF20B/KIF11/KIF18A/RACGAP1/GAS2L3/DLGAP5/NUSAP1/KIF23/PRC1/NDE1/PLK1/SPAG5/KIF18B/BIRC5/SKA1/SPC24/FAM83D/GTSE1/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,28,MF
GO:0008094,"ATP-dependent activity, acting on DNA",21/193,116/12494,5.54E-17,3.28E-15,2.81E-15,RAD54L/HELLS/RFC5/RFC3/RAD51/PIF1/BLM/CHD2/TOP2A/BRIP1/MCM6/MCM5/POLQ/MCM2/RFC4/MCM3/RFC2/XRCC2/MCM4/DSCC1/ERCC6L,21,MF
GO:0003678,DNA helicase activity,15/193,57/12494,4.92E-15,2.33E-13,2.00E-13,RFC5/RFC3/RAD51/PIF1/BLM/BRIP1/MCM6/MCM5/POLQ/MCM2/RFC4/MCM3/RFC2/MCM4/DSCC1,15,MF
GO:0140097,"catalytic activity, acting on DNA",25/193,226/12494,8.81E-15,3.48E-13,2.98E-13,RAD54L/EXO1/HELLS/POLD3/RFC5/RFC3/POLE2/RAD51/PIF1/BLM/CHD2/TOP2A/BRIP1/MCM6/MCM5/POLQ/MCM2/RFC4/NEIL3/MCM3/RFC2/XRCC2/MCM4/DSCC1/ERCC6L,25,MF
GO:0016887,ATP hydrolysis activity,30/193,346/12494,1.17E-14,3.97E-13,3.40E-13,KIF2C/RAD54L/ORC1/KIF14/KIF20B/KIF18A/RFC5/RFC3/RAD51/PIF1/KIF23/BLM/CHD2/CDC6/KIF18B/BRIP1/MCM6/MCM5/KIF15/MCM2/SMC4/RFC4/TRIP13/KIF20A/KIFC1/MCM3/RFC2/MCM4/ATAD2/ERCC6L,30,MF
GO:0015631,tubulin binding,29/193,330/12494,2.40E-14,7.10E-13,6.09E-13,KIF2C/PSRC1/KIF14/CENPF/KIF20B/KIF11/KIF18A/RACGAP1/GAS2L3/BRCA2/DLGAP5/NUSAP1/KIF23/PRC1/NDE1/PLK1/SPAG5/KIF18B/BIRC5/SKA1/SPC24/FAM83D/GTSE1/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,29,MF
GO:0004386,helicase activity,19/193,140/12494,4.26E-13,1.12E-11,9.62E-12,RAD54L/HELLS/RFC5/RFC3/RAD51/PIF1/BLM/CHD2/BRIP1/MCM6/MCM5/POLQ/MCM2/RFC4/MCM3/RFC2/MCM4/DSCC1/ERCC6L,19,MF
GO:0003777,microtubule motor activity,13/193,53/12494,9.31E-13,2.21E-11,1.89E-11,KIF2C/KIF14/KIF20B/KIF11/KIF18A/KIF23/KIF18B/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,13,MF
GO:0003697,single-stranded DNA binding,16/193,112/12494,1.46E-11,3.16E-10,2.70E-10,RAD54L/MCM10/RAD51AP1/BRCA2/RAD51/BLM/MCM6/CDC45/MCM5/MCM2/SMC4/HMGB2/NEIL3/MCM3/MMS22L/MCM4,16,MF
GO:0003774,cytoskeletal motor activity,13/193,80/12494,2.42E-10,4.79E-09,4.10E-09,KIF2C/KIF14/KIF20B/KIF11/KIF18A/KIF23/KIF18B/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,13,MF
GO:0003688,DNA replication origin binding,6/193,16/12494,8.85E-08,1.61E-06,1.38E-06,ORC1/MCM10/CDC6/CDC45/MCM5/MCM2,6,MF
GO:0003682,chromatin binding,25/193,484/12494,1.12E-07,1.90E-06,1.63E-06,ORC1/UBE2T/CENPF/EXO1/CDK1/HELLS/WDHD1/RAD51/PCLAF/TICRR/CHD2/CDT1/TOP2A/BRIP1/CHAF1A/CENPA/NCAPH/CHAF1B/CDC45/POLQ/SMC4/H2AZ1/GMNN/ATAD2/PHF19,25,MF
GO:0000217,DNA secondary structure binding,7/193,37/12494,1.31E-06,2.07E-05,1.77E-05,CLSPN/RAD51AP1/BLM/HMGB2/NEIL3/XRCC2/HMGB3,7,MF
GO:0008574,plus-end-directed microtubule motor activity,5/193,15/12494,2.21E-06,3.28E-05,2.81E-05,KIF14/KIF20B/KIF11/KIF18A/KIF18B,5,MF
GO:0043138,3'-5' DNA helicase activity,4/193,14/12494,4.89E-05,0.000682329,0.000584897,BLM/MCM6/MCM5/MCM2,4,MF
GO:0106310,protein serine kinase activity,15/193,321/12494,0.000137589,0.001777989,0.001524103,CDC7/NEK2/CDK1/CIT/BUB1B/PKMYT1/PLK1/AURKB/BUB1/AURKA/CHEK2/PLK4/TTK/PBK/MELK,15,MF
GO:0000400,four-way junction DNA binding,4/193,18/12494,0.000142539,0.001777989,0.001524103,BLM/HMGB2/XRCC2/HMGB3,4,MF
GO:0042393,histone binding,12/193,230/12494,0.000238517,0.002826422,0.002422827,NASP/H2AX/NCAPD2/CHD2/UHRF1/HJURP/CHAF1B/MCM2/DEK/NCAPG2/ATAD2/PHF19,12,MF
GO:0070182,DNA polymerase binding,4/193,21/12494,0.000268855,0.003034215,0.002600949,RAD51/FANCI/CDT1/FANCD2,4,MF
GO:0003684,damaged DNA binding,6/193,68/12494,0.000621265,0.006692717,0.005737039,H2AX/BLM/POLQ/HMGB2/NEIL3/FANCG,6,MF
GO:0004674,protein serine/threonine kinase activity,15/193,376/12494,0.000738393,0.00760866,0.006522192,CDC7/NEK2/CDK1/CIT/BUB1B/PKMYT1/PLK1/AURKB/BUB1/AURKA/CHEK2/PLK4/TTK/PBK/MELK,15,MF
GO:0008301,"DNA binding, bending",3/193,14/12494,0.001165135,0.01150571,0.009862767,TOP2A/HMGB2/HMGB3,3,MF
GO:0140658,ATP-dependent chromatin remodeler activity,4/193,35/12494,0.001987047,0.018837201,0.016147368,RAD54L/HELLS/CHD2/ERCC6L,4,MF
GO:0035173,histone kinase activity,3/193,20/12494,0.003408583,0.031070544,0.026633866,CDK1/BUB1/AURKA,3,MF
GO:0004712,protein serine/threonine/tyrosine kinase activity,4/193,41/12494,0.003576464,0.031393402,0.026910622,AURKB/AURKA/TTK/PBK,4,MF
GO:0140612,DNA damage sensor activity,3/193,21/12494,0.003931871,0.033280479,0.028528237,RAD51/UHRF1/XRCC2,3,MF
GO:0003887,DNA-directed DNA polymerase activity,3/193,23/12494,0.005118404,0.041829716,0.035856697,POLD3/POLE2/POLQ,3,MF
GO:0004672,protein kinase activity,15/193,472/12494,0.006519815,0.051506541,0.044151732,CDC7/NEK2/CDK1/CIT/BUB1B/PKMYT1/PLK1/AURKB/BUB1/AURKA/CHEK2/PLK4/TTK/PBK/MELK,15,MF
GO:0034061,DNA polymerase activity,3/193,28/12494,0.008948426,0.068412157,0.058643332,POLD3/POLE2/POLQ,3,MF
GO:0004869,cysteine-type endopeptidase inhibitor activity,2/193,10/12494,0.009846021,0.070712335,0.060615059,BIRC5/PTTG1,2,MF
GO:0051880,G-quadruplex DNA binding,2/193,10/12494,0.009846021,0.070712335,0.060615059,PIF1/BLM,2,MF
GO:0061631,ubiquitin conjugating enzyme activity,3/193,31/12494,0.011870527,0.080665155,0.06914668,UBE2T/UBE2S/UBE2C,3,MF
GO:0140666,annealing activity,2/193,11/12494,0.011912576,0.080665155,0.06914668,RAD54L/BLM,2,MF
GO:0030527,structural constituent of chromatin,3/193,35/12494,0.016525468,0.10585232,0.090737276,H2AX/CENPA/H2AZ1,3,MF
GO:0140299,small molecule sensor activity,3/193,35/12494,0.016525468,0.10585232,0.090737276,RAD51/UHRF1/XRCC2,3,MF
GO:0061650,ubiquitin-like protein conjugating enzyme activity,3/193,37/12494,0.019184048,0.11964788,0.102562918,UBE2T/UBE2S/UBE2C,3,MF
GO:0050699,WW domain binding,2/193,15/12494,0.021840736,0.130736547,0.112068193,KIF20B/CDC25C,2,MF
GO:0019894,kinesin binding,3/193,39/12494,0.02206524,0.130736547,0.112068193,PRC1/KIF18B/FAM83D,3,MF
GO:0140664,ATP-dependent DNA damage sensor activity,2/193,17/12494,0.027724785,0.160262784,0.137378269,RAD51/XRCC2,2,MF
GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,3/193,43/12494,0.028496333,0.160800733,0.137839403,CCNB2/CCNA2/CCNB1,3,MF
GO:0070840,dynein complex binding,2/193,18/12494,0.030878406,0.170190286,0.145888186,GPSM2/CENPF,2,MF
GO:0051010,microtubule plus-end binding,2/193,21/12494,0.041126275,0.221521073,0.189889261,KIF2C/KIF18A,2,MF
GO:0016799,"hydrolase activity, hydrolyzing N-glycosyl compounds",2/193,28/12494,0.069041709,0.363619665,0.31169707,MACROD2/NEIL3,2,MF
GO:0005096,GTPase activator activity,7/193,234/12494,0.071069011,0.366159907,0.313874581,DEPDC1/IQGAP3/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2/DEPDC1B,7,MF
GO:0016891,"RNA endonuclease activity, producing 5'-phosphomonoesters",2/193,29/12494,0.073424861,0.370248766,0.317379577,EXO1/RNASEH2A,2,MF
GO:0030332,cyclin binding,2/193,31/12494,0.082448404,0.407088995,0.348959254,CDK1/NDC80,2,MF
GO:0043015,gamma-tubulin binding,2/193,34/12494,0.096572687,0.467096468,0.400398038,RACGAP1/BRCA2,2,MF
GO:0042162,telomeric DNA binding,2/193,35/12494,0.101424034,0.480749922,0.412101865,PIF1/BLM,2,MF
GO:0016893,"endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",2/193,36/12494,0.106341507,0.494175241,0.423610133,EXO1/RNASEH2A,2,MF
GO:0035064,methylated histone binding,3/193,75/12494,0.109717701,0.500059523,0.428654177,UHRF1/NCAPG2/PHF19,3,MF
GO:0140034,methylation-dependent protein binding,3/193,77/12494,0.116313568,0.520119161,0.445849425,UHRF1/NCAPG2/PHF19,3,MF
GO:0005200,structural constituent of cytoskeleton,3/193,80/12494,0.12647799,0.555097843,0.475833372,TUBA1B/LMNB2/LMNB1,3,MF
GO:0016779,nucleotidyltransferase activity,4/193,129/12494,0.139188046,0.560311165,0.480302264,POLD3/PRIM1/POLE2/POLQ,4,MF
GO:0046982,protein heterodimerization activity,6/193,227/12494,0.139866028,0.560311165,0.480302264,H2AX/TOP2A/CENPA/AURKA/H2AZ1/CENPW,6,MF
GO:0061733,peptide-lysine-N-acetyltransferase activity,2/193,43/12494,0.1423588,0.560311165,0.480302264,BRCA2/ESCO2,2,MF
GO:0008353,RNA polymerase II CTD heptapeptide repeat kinase activity,1/193,10/12494,0.14421511,0.560311165,0.480302264,CDK1,1,MF
GO:0032356,oxidized DNA binding,1/193,10/12494,0.14421511,0.560311165,0.480302264,BLM,1,MF
GO:0035252,UDP-xylosyltransferase activity,1/193,10/12494,0.14421511,0.560311165,0.480302264,POGLUT3,1,MF
GO:0042285,xylosyltransferase activity,1/193,10/12494,0.14421511,0.560311165,0.480302264,POGLUT3,1,MF
GO:0035251,UDP-glucosyltransferase activity,1/193,11/12494,0.157445363,0.583039861,0.499785446,POGLUT3,1,MF
GO:0140852,histone ubiquitin ligase activity,1/193,11/12494,0.157445363,0.583039861,0.499785446,UHRF1,1,MF
GO:0140996,histone H3 kinase activity,1/193,11/12494,0.157445363,0.583039861,0.499785446,AURKA,1,MF
GO:0034212,peptide N-acetyltransferase activity,2/193,47/12494,0.163946348,0.585534685,0.501924024,BRCA2/ESCO2,2,MF
GO:0140993,histone modifying activity,5/193,189/12494,0.168649936,0.585534685,0.501924024,CDK1/BRCA2/UHRF1/BUB1/AURKA,5,MF
GO:0003906,DNA-(apurinic or apyrimidinic site) endonuclease activity,1/193,12/12494,0.170472123,0.585534685,0.501924024,NEIL3,1,MF
GO:0016888,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters",1/193,12/12494,0.170472123,0.585534685,0.501924024,EXO1,1,MF
GO:0097027,ubiquitin-protein transferase activator activity,1/193,12/12494,0.170472123,0.585534685,0.501924024,CDC20,1,MF
GO:0005540,hyaluronic acid binding,1/193,13/12494,0.183298504,0.603357575,0.517201918,HMMR,1,MF
GO:0019104,DNA N-glycosylase activity,1/193,13/12494,0.183298504,0.603357575,0.517201918,NEIL3,1,MF
GO:0061575,cyclin-dependent protein serine/threonine kinase activator activity,1/193,13/12494,0.183298504,0.603357575,0.517201918,CCNB1,1,MF
GO:0010484,histone H3 acetyltransferase activity,1/193,14/12494,0.195927571,0.627497761,0.537895039,BRCA2,1,MF
GO:0043274,phospholipase binding,1/193,14/12494,0.195927571,0.627497761,0.537895039,LMNB1,1,MF
GO:0000062,fatty-acyl-CoA binding,1/193,15/12494,0.208362345,0.649761523,0.556979676,ACBD7,1,MF
GO:1901567,fatty acid derivative binding,1/193,15/12494,0.208362345,0.649761523,0.556979676,ACBD7,1,MF
GO:0004708,MAP kinase kinase activity,1/193,16/12494,0.220605799,0.66613459,0.571014772,PBK,1,MF
GO:0005092,GDP-dissociation inhibitor activity,1/193,16/12494,0.220605799,0.66613459,0.571014772,GPSM2,1,MF
GO:0008080,N-acetyltransferase activity,2/193,58/12494,0.225627187,0.66613459,0.571014772,BRCA2/ESCO2,2,MF
GO:0004521,RNA endonuclease activity,2/193,59/12494,0.231337178,0.66613459,0.571014772,EXO1/RNASEH2A,2,MF
GO:0000979,RNA polymerase II core promoter sequence-specific DNA binding,1/193,17/12494,0.232660863,0.66613459,0.571014772,H2AZ1,1,MF
GO:0140994,RNA polymerase II CTD heptapeptide repeat modifying activity,1/193,17/12494,0.232660863,0.66613459,0.571014772,CDK1,1,MF
GO:0004713,protein tyrosine kinase activity,3/193,108/12494,0.233351549,0.66613459,0.571014772,TTK/PBK/MELK,3,MF
GO:0016835,carbon-oxygen lyase activity,2/193,60/12494,0.237056399,0.66613459,0.571014772,POLQ/NEIL3,2,MF
GO:0008409,5'-3' exonuclease activity,1/193,18/12494,0.244530419,0.66613459,0.571014772,EXO1,1,MF
GO:0046527,glucosyltransferase activity,1/193,18/12494,0.244530419,0.66613459,0.571014772,POGLUT3,1,MF
GO:0120227,acyl-CoA binding,1/193,18/12494,0.244530419,0.66613459,0.571014772,ACBD7,1,MF
GO:0051536,iron-sulfur cluster binding,2/193,63/12494,0.25425331,0.674705578,0.578361877,BRIP1/KIF4A,2,MF
GO:0051540,metal cluster binding,2/193,63/12494,0.25425331,0.674705578,0.578361877,BRIP1/KIF4A,2,MF
GO:0061608,nuclear import signal receptor activity,1/193,19/12494,0.256217308,0.674705578,0.578361877,KPNA2,1,MF
GO:0008139,nuclear localization sequence binding,1/193,20/12494,0.267724327,0.687797056,0.589583974,KPNA2,1,MF
GO:0042056,chemoattractant activity,1/193,20/12494,0.267724327,0.687797056,0.589583974,HMGB2,1,MF
GO:0008186,"ATP-dependent activity, acting on RNA",2/193,67/12494,0.277217741,0.687797056,0.589583974,PIF1/BRIP1,2,MF
GO:0008327,methyl-CpG binding,1/193,21/12494,0.27905423,0.687797056,0.589583974,UHRF1,1,MF
GO:0016895,"DNA exonuclease activity, producing 5'-phosphomonoesters",1/193,21/12494,0.27905423,0.687797056,0.589583974,EXO1,1,MF
GO:0030165,PDZ domain binding,2/193,68/12494,0.282955739,0.687797056,0.589583974,KIF14/CIT,2,MF
GO:0001965,G-protein alpha-subunit binding,1/193,22/12494,0.290209728,0.687797056,0.589583974,GPSM2,1,MF
GO:0004529,DNA exonuclease activity,1/193,22/12494,0.290209728,0.687797056,0.589583974,EXO1,1,MF
GO:0008093,cytoskeletal anchor activity,1/193,22/12494,0.290209728,0.687797056,0.589583974,GAS2L3,1,MF
GO:0010485,histone H4 acetyltransferase activity,1/193,22/12494,0.290209728,0.687797056,0.589583974,BRCA2,1,MF
GO:0004866,endopeptidase inhibitor activity,2/193,70/12494,0.294418869,0.690864079,0.592213046,BIRC5/PTTG1,2,MF
GO:0016410,N-acyltransferase activity,2/193,71/12494,0.300141554,0.697387728,0.597805158,BRCA2/ESCO2,2,MF
GO:0043425,bHLH transcription factor binding,1/193,24/12494,0.312008156,0.704949079,0.604286797,NCAPG2,1,MF
GO:0008047,enzyme activator activity,9/193,476/12494,0.315467645,0.704949079,0.604286797,CDC20/DEPDC1/IQGAP3/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2/DEPDC1B/CCNB1,9,MF
GO:0044389,ubiquitin-like protein ligase binding,6/193,299/12494,0.316114218,0.704949079,0.604286797,UBE2T/TUBA1B/UBE2C/AURKA/CHEK2/CCNB1,6,MF
GO:0030414,peptidase inhibitor activity,2/193,74/12494,0.317260192,0.704949079,0.604286797,BIRC5/PTTG1,2,MF
GO:0097718,disordered domain specific binding,1/193,25/12494,0.322656306,0.704949079,0.604286797,RRM1,1,MF
GO:0030695,GTPase regulator activity,8/193,422/12494,0.328156967,0.704949079,0.604286797,DEPDC1/GPSM2/IQGAP3/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2/DEPDC1B,8,MF
GO:0060589,nucleoside-triphosphatase regulator activity,8/193,422/12494,0.328156967,0.704949079,0.604286797,DEPDC1/GPSM2/IQGAP3/RACGAP1/ARHGAP11B/ARHGAP11A/ECT2/DEPDC1B,8,MF
GO:0004693,cyclin-dependent protein serine/threonine kinase activity,1/193,26/12494,0.333140493,0.704949079,0.604286797,CDK1,1,MF
GO:0055106,ubiquitin-protein transferase regulator activity,1/193,26/12494,0.333140493,0.704949079,0.604286797,CDC20,1,MF
GO:0097472,cyclin-dependent protein kinase activity,1/193,26/12494,0.333140493,0.704949079,0.604286797,CDK1,1,MF
GO:0019887,protein kinase regulator activity,4/193,190/12494,0.337948551,0.708794748,0.607583329,CIT/CCNB2/CCNA2/CCNB1,4,MF
GO:0004725,protein tyrosine phosphatase activity,2/193,79/12494,0.345563013,0.718407316,0.615823282,CDKN3/CDC25C,2,MF
GO:0000287,magnesium ion binding,4/193,194/12494,0.352003153,0.725432584,0.621845386,PRIM1/PIF1/PLK1/TOP2A,4,MF
GO:0016407,acetyltransferase activity,2/193,82/12494,0.362365625,0.737637389,0.632307422,BRCA2/ESCO2,2,MF
GO:0004842,ubiquitin-protein transferase activity,7/193,380/12494,0.372284185,0.737637389,0.632307422,UBE2T/DTL/UHRF1/UBE2S/UBE2C/TRAIP/TRIM59,7,MF
GO:0061135,endopeptidase regulator activity,2/193,84/12494,0.373478498,0.737637389,0.632307422,BIRC5/PTTG1,2,MF
GO:0003899,DNA-directed 5'-3' RNA polymerase activity,1/193,30/12494,0.373487285,0.737637389,0.632307422,PRIM1,1,MF
GO:0042169,SH2 domain binding,1/193,30/12494,0.373487285,0.737637389,0.632307422,SHCBP1,1,MF
GO:0004715,non-membrane spanning protein tyrosine kinase activity,1/193,31/12494,0.383188582,0.738726034,0.633240616,MELK,1,MF
GO:0140142,nucleocytoplasmic carrier activity,1/193,31/12494,0.383188582,0.738726034,0.633240616,KPNA2,1,MF
GO:0005547,"phosphatidylinositol-3,4,5-trisphosphate binding",1/193,32/12494,0.392740423,0.738726034,0.633240616,RACGAP1,1,MF
GO:0031492,nucleosomal DNA binding,1/193,32/12494,0.392740423,0.738726034,0.633240616,H2AZ1,1,MF
GO:0034062,5'-3' RNA polymerase activity,1/193,32/12494,0.392740423,0.738726034,0.633240616,PRIM1,1,MF
GO:0097747,RNA polymerase activity,1/193,32/12494,0.392740423,0.738726034,0.633240616,PRIM1,1,MF
GO:0016798,"hydrolase activity, acting on glycosyl bonds",2/193,89/12494,0.400906094,0.748147592,0.641316834,MACROD2/NEIL3,2,MF
GO:0019213,deacetylase activity,1/193,34/12494,0.411404871,0.756166847,0.648190991,MACROD2,1,MF
GO:0019207,kinase regulator activity,4/193,211/12494,0.411584487,0.756166847,0.648190991,CIT/CCNB2/CCNA2/CCNB1,4,MF
GO:0001046,core promoter sequence-specific DNA binding,1/193,36/12494,0.429498539,0.765347021,0.656060293,H2AZ1,1,MF
GO:0004520,DNA endonuclease activity,1/193,36/12494,0.429498539,0.765347021,0.656060293,EXO1,1,MF
GO:0019205,nucleobase-containing compound kinase activity,1/193,36/12494,0.429498539,0.765347021,0.656060293,TK1,1,MF
GO:0030291,protein serine/threonine kinase inhibitor activity,1/193,36/12494,0.429498539,0.765347021,0.656060293,CIT,1,MF
GO:0048487,beta-tubulin binding,1/193,37/12494,0.438336778,0.770175365,0.66019918,RACGAP1,1,MF
GO:0019787,ubiquitin-like protein transferase activity,7/193,407/12494,0.440779476,0.770175365,0.66019918,UBE2T/DTL/UHRF1/UBE2S/UBE2C/TRAIP/TRIM59,7,MF
GO:0001223,transcription coactivator binding,1/193,38/12494,0.447038793,0.770175365,0.66019918,CIT,1,MF
GO:0004402,histone acetyltransferase activity,1/193,39/12494,0.455606673,0.770175365,0.66019918,BRCA2,1,MF
GO:0016755,aminoacyltransferase activity,7/193,414/12494,0.458419174,0.770175365,0.66019918,UBE2T/DTL/UHRF1/UBE2S/UBE2C/TRAIP/TRIM59,7,MF
GO:0042826,histone deacetylase binding,2/193,100/12494,0.459140293,0.770175365,0.66019918,KPNA2/GMNN,2,MF
GO:0005048,signal sequence binding,1/193,40/12494,0.464042475,0.770175365,0.66019918,KPNA2,1,MF
GO:0008138,protein tyrosine/serine/threonine phosphatase activity,1/193,40/12494,0.464042475,0.770175365,0.66019918,CDKN3,1,MF
GO:0004519,endonuclease activity,2/193,101/12494,0.464273557,0.770175365,0.66019918,EXO1/RNASEH2A,2,MF
GO:0043014,alpha-tubulin binding,1/193,41/12494,0.472348224,0.770175365,0.66019918,RACGAP1,1,MF
GO:0004540,RNA nuclease activity,2/193,103/12494,0.474454022,0.770175365,0.66019918,EXO1/RNASEH2A,2,MF
GO:0017124,SH3 domain binding,2/193,103/12494,0.474454022,0.770175365,0.66019918,CIT/PTTG1,2,MF
GO:0051082,unfolded protein binding,2/193,103/12494,0.474454022,0.770175365,0.66019918,CHAF1A/CHAF1B,2,MF
GO:0051539,"4 iron, 4 sulfur cluster binding",1/193,42/12494,0.480525916,0.774155749,0.66361119,BRIP1,1,MF
GO:0005080,protein kinase C binding,1/193,43/12494,0.488577514,0.774155749,0.66361119,TOP2A,1,MF
GO:0038024,cargo receptor activity,1/193,43/12494,0.488577514,0.774155749,0.66361119,HMMR,1,MF
GO:0140030,modification-dependent protein binding,3/193,171/12494,0.494262805,0.774155749,0.66361119,UHRF1/NCAPG2/PHF19,3,MF
GO:0016763,pentosyltransferase activity,1/193,44/12494,0.496504953,0.774155749,0.66361119,POGLUT3,1,MF
GO:0030544,Hsp70 protein binding,1/193,44/12494,0.496504953,0.774155749,0.66361119,CDK1,1,MF
GO:0004857,enzyme inhibitor activity,4/193,248/12494,0.535819427,0.827469081,0.709311715,CIT/PIF1/BIRC5/PTTG1,4,MF
GO:0051087,protein-folding chaperone binding,2/193,116/12494,0.537680331,0.827469081,0.709311715,CDK1/BIRC5,2,MF
GO:0061134,peptidase regulator activity,2/193,118/12494,0.54693537,0.833566917,0.714538818,BIRC5/PTTG1,2,MF
GO:0043539,protein serine/threonine kinase activator activity,1/193,51/12494,0.548676958,0.833566917,0.714538818,CCNB1,1,MF
GO:0001618,virus receptor activity,1/193,54/12494,0.569355585,0.848662098,0.727478503,CDK1,1,MF
GO:0004536,DNA nuclease activity,1/193,54/12494,0.569355585,0.848662098,0.727478503,EXO1,1,MF
GO:0140272,exogenous protein binding,1/193,54/12494,0.569355585,0.848662098,0.727478503,CDK1,1,MF
GO:0016796,"exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",1/193,56/12494,0.582614897,0.857638078,0.73517277,EXO1,1,MF
GO:0043621,protein self-association,1/193,56/12494,0.582614897,0.857638078,0.73517277,GPSM2,1,MF
GO:0003725,double-stranded RNA binding,1/193,57/12494,0.589091447,0.861818968,0.738756655,TUBA1B,1,MF
GO:0097110,scaffold protein binding,1/193,58/12494,0.595468013,0.865803184,0.74217195,CIT,1,MF
GO:0017022,myosin binding,1/193,59/12494,0.601746131,0.869596542,0.745423641,IQGAP3,1,MF
GO:0002039,p53 binding,1/193,61/12494,0.614013047,0.876633086,0.75145541,BLM,1,MF
GO:0031491,nucleosome binding,1/193,61/12494,0.614013047,0.876633086,0.75145541,H2AZ1,1,MF
GO:0003724,RNA helicase activity,1/193,65/12494,0.63743051,0.896025853,0.768079012,BRIP1,1,MF
GO:0031625,ubiquitin protein ligase binding,4/193,283/12494,0.640214953,0.896025853,0.768079012,UBE2T/TUBA1B/AURKA/CHEK2,4,MF
GO:0004197,cysteine-type endopeptidase activity,1/193,67/12494,0.648603635,0.896025853,0.768079012,ESPL1,1,MF
GO:0061630,ubiquitin protein ligase activity,4/193,287/12494,0.651131662,0.896025853,0.768079012,UHRF1/UBE2C/TRAIP/TRIM59,4,MF
GO:0140098,"catalytic activity, acting on RNA",5/193,358/12494,0.652435723,0.896025853,0.768079012,EXO1/PRIM1/PIF1/BRIP1/RNASEH2A,5,MF
GO:0004860,protein kinase inhibitor activity,1/193,68/12494,0.654061066,0.896025853,0.768079012,CIT,1,MF
GO:0017018,myosin phosphatase activity,1/193,68/12494,0.654061066,0.896025853,0.768079012,CDKN3,1,MF
GO:0019210,kinase inhibitor activity,1/193,70/12494,0.664724249,0.902522508,0.773647986,CIT,1,MF
GO:0004721,phosphoprotein phosphatase activity,2/193,147/12494,0.666419574,0.902522508,0.773647986,CDKN3/CDC25C,2,MF
GO:0016829,lyase activity,2/193,149/12494,0.673650634,0.906784077,0.777301029,POLQ/NEIL3,2,MF
GO:0005516,calmodulin binding,2/193,150/12494,0.677218488,0.906784077,0.777301029,IQGAP3/ASPM,2,MF
GO:0004527,exonuclease activity,1/193,75/12494,0.689973195,0.918672176,0.787491583,EXO1,1,MF
GO:0061659,ubiquitin-like protein ligase activity,4/193,305/12494,0.697508546,0.923516902,0.791644513,UHRF1/UBE2C/TRAIP/TRIM59,4,MF
GO:0019902,phosphatase binding,2/193,160/12494,0.711178351,0.936384828,0.802674981,NEK2/CARHSP1,2,MF
GO:0140104,molecular carrier activity,1/193,82/12494,0.722174568,0.945609794,0.810582679,KPNA2,1,MF
GO:0005506,iron ion binding,1/193,83/12494,0.726494606,0.946039679,0.810951179,RRM2,1,MF
GO:0004722,protein serine/threonine phosphatase activity,1/193,84/12494,0.730747812,0.946378314,0.811241459,CDKN3,1,MF
GO:0051015,actin filament binding,2/193,173/12494,0.750827243,0.955673674,0.8192095,IQGAP3/GAS2L3,2,MF
GO:0031490,chromatin DNA binding,1/193,91/12494,0.758733417,0.955673674,0.8192095,H2AZ1,1,MF
GO:0004518,nuclease activity,2/193,176/12494,0.759288286,0.955673674,0.8192095,EXO1/RNASEH2A,2,MF
GO:0016747,"acyltransferase activity, transferring groups other than amino-acyl groups",2/193,176/12494,0.759288286,0.955673674,0.8192095,BRCA2/ESCO2,2,MF
GO:0003730,mRNA 3'-UTR binding,1/193,92/12494,0.762487706,0.955673674,0.8192095,CARHSP1,1,MF
GO:0140678,molecular function inhibitor activity,4/193,336/12494,0.7667496,0.955673674,0.8192095,CIT/PIF1/BIRC5/PTTG1,4,MF
GO:0031267,small GTPase binding,3/193,259/12494,0.767355863,0.955673674,0.8192095,IQGAP3/BIRC5/ECT2,3,MF
GO:1901681,sulfur compound binding,2/193,180/12494,0.770184269,0.955673674,0.8192095,ACBD7/RRM2,2,MF
GO:0043130,ubiquitin binding,1/193,96/12494,0.776932531,0.956738019,0.820121864,TOP2A,1,MF
GO:0008194,UDP-glycosyltransferase activity,1/193,98/12494,0.783823745,0.956738019,0.820121864,POGLUT3,1,MF
GO:0030295,protein kinase activator activity,1/193,98/12494,0.783823745,0.956738019,0.820121864,CCNB1,1,MF
GO:0001221,transcription coregulator binding,1/193,99/12494,0.78718951,0.956738019,0.820121864,CIT,1,MF
GO:0002020,protease binding,1/193,103/12494,0.80013918,0.967515233,0.82936016,BRCA2,1,MF
GO:0019209,kinase activator activity,1/193,105/12494,0.806316933,0.970036107,0.831521069,CCNB1,1,MF
GO:0003779,actin binding,4/193,361/12494,0.81311404,0.973272866,0.834295639,IQGAP3/KIF18A/GAS2L3/ANLN,4,MF
GO:0030674,protein-macromolecule adaptor activity,4/193,370/12494,0.827861346,0.9781898,0.838510466,DTL/POLD3/GAS2L3/NDC80,4,MF
GO:0031072,heat shock protein binding,1/193,113/12494,0.829185231,0.9781898,0.838510466,CDK1,1,MF
GO:0051020,GTPase binding,3/193,290/12494,0.829604008,0.9781898,0.838510466,IQGAP3/BIRC5/ECT2,3,MF
GO:0032182,ubiquitin-like protein binding,1/193,116/12494,0.837050168,0.982083613,0.841848267,TOP2A,1,MF
GO:0019903,protein phosphatase binding,1/193,120/12494,0.846979082,0.985178406,0.844501143,NEK2,1,MF
GO:0045296,cadherin binding,3/193,301/12494,0.848001666,0.985178406,0.844501143,CCNB2/CIP2A/ANLN,3,MF
GO:0016791,phosphatase activity,2/193,220/12494,0.857485665,0.991337086,0.849780403,CDKN3/CDC25C,2,MF
GO:0005539,glycosaminoglycan binding,1/193,134/12494,0.877222213,0.997744759,0.8552731,HMMR,1,MF
GO:0008234,cysteine-type peptidase activity,1/193,136/12494,0.881026752,0.997744759,0.8552731,ESPL1,1,MF
GO:0016853,isomerase activity,1/193,136/12494,0.881026752,0.997744759,0.8552731,TOP2A,1,MF
GO:0140297,DNA-binding transcription factor binding,4/193,409/12494,0.881070612,0.997744759,0.8552731,CENPF/HMGB2/GMNN/NCAPG2,4,MF
GO:0016758,hexosyltransferase activity,1/193,139/12494,0.886514751,0.997744759,0.8552731,POGLUT3,1,MF
GO:1901981,phosphatidylinositol phosphate binding,1/193,140/12494,0.888287528,0.997744759,0.8552731,RACGAP1,1,MF
GO:0033218,amide binding,2/193,261/12494,0.914649,0.999108461,0.856442074,ACBD7/KPNA2,2,MF
GO:0042578,phosphoric ester hydrolase activity,2/193,284/12494,0.93650566,0.999108461,0.856442074,CDKN3/CDC25C,2,MF
GO:0003714,transcription corepressor activity,1/193,178/12494,0.938644581,0.999108461,0.856442074,GMNN,1,MF
GO:0001228,"DNA-binding transcription activator activity, RNA polymerase II-specific",2/193,292/12494,0.942783658,0.999108461,0.856442074,E2F2/MYBL2,2,MF
GO:0001216,DNA-binding transcription activator activity,2/193,296/12494,0.945697961,0.999108461,0.856442074,E2F2/MYBL2,2,MF
GO:0042277,peptide binding,1/193,193/12494,0.951593876,0.999108461,0.856442074,KPNA2,1,MF
GO:0005085,guanyl-nucleotide exchange factor activity,1/193,196/12494,0.953836939,0.999108461,0.856442074,ECT2,1,MF
GO:0048018,receptor ligand activity,1/193,198/12494,0.955274557,0.999108461,0.856442074,HMGB2,1,MF
GO:0016757,glycosyltransferase activity,1/193,201/12494,0.957347893,0.999108461,0.856442074,POGLUT3,1,MF
GO:0030546,signaling receptor activator activity,1/193,202/12494,0.95801753,0.999108461,0.856442074,HMGB2,1,MF
GO:0004175,endopeptidase activity,1/193,219/12494,0.967926305,0.999108461,0.856442074,ESPL1,1,MF
GO:0030545,signaling receptor regulator activity,1/193,223/12494,0.969896644,0.999108461,0.856442074,HMGB2,1,MF
GO:0035091,phosphatidylinositol binding,1/193,225/12494,0.970836174,0.999108461,0.856442074,RACGAP1,1,MF
GO:0003712,transcription coregulator activity,3/193,449/12494,0.971810149,0.999108461,0.856442074,HMGB2/TRIP13/GMNN,3,MF
GO:0001227,"DNA-binding transcription repressor activity, RNA polymerase II-specific",1/193,236/12494,0.975505607,0.999108461,0.856442074,MXD3,1,MF
GO:0050839,cell adhesion molecule binding,3/193,466/12494,0.977096137,0.999108461,0.856442074,CCNB2/CIP2A/ANLN,3,MF
GO:0001217,DNA-binding transcription repressor activity,1/193,244/12494,0.978426904,0.999108461,0.856442074,MXD3,1,MF
GO:0003713,transcription coactivator activity,1/193,244/12494,0.978426904,0.999108461,0.856442074,HMGB2,1,MF
GO:0008233,peptidase activity,2/193,367/12494,0.978993901,0.999108461,0.856442074,FAM111B/ESPL1,2,MF
GO:0003924,GTPase activity,1/193,265/12494,0.984548886,0.999108461,0.856442074,TUBA1B,1,MF
GO:0003729,mRNA binding,1/193,283/12494,0.988398483,0.999108461,0.856442074,CARHSP1,1,MF
GO:0005525,GTP binding,1/193,300/12494,0.991152644,0.999108461,0.856442074,TUBA1B,1,MF
GO:0019001,guanyl nucleotide binding,1/193,309/12494,0.992336378,0.999108461,0.856442074,TUBA1B,1,MF
GO:0032561,guanyl ribonucleotide binding,1/193,309/12494,0.992336378,0.999108461,0.856442074,TUBA1B,1,MF
GO:0005543,phospholipid binding,1/193,364/12494,0.996821557,0.999108461,0.856442074,RACGAP1,1,MF
GO:0005509,calcium ion binding,1/193,443/12494,0.999108461,0.999108461,0.856442074,MELK,1,MF
GO:0098687,chromosomal region,64/198,358/12707,6.22E-51,1.07E-48,7.07E-49,CDCA8/CDC20/KIF2C/ORC1/NUF2/NEK2/CENPF/ZWINT/CDK1/HELLS/KIF18A/INCENP/H2AX/RAD51AP1/NCAPD2/SKA3/BRCA2/BUB1B/KNL1/RAD51/OIP5/PIF1/ZWILCH/BLM/NDE1/PLK1/CDT1/AURKB/SPAG5/TOP2A/BIRC5/NDC80/SKA1/SPC24/CENPO/CENPA/BUB1/MCM6/SPC25/SGO2/HJURP/DSN1/AURKA/CHEK2/MCM5/CENPM/SGO1/MCM2/SMC4/NCAPG/CENPE/MAD2L1/CENPU/CENPK/CCNB1/CENPH/MCM3/TTK/CENPW/ESCO2/MCM4/DSCC1/ERCC6L/CENPI,64,CC
GO:0000793,condensed chromosome,54/198,247/12707,1.43E-47,1.23E-45,8.15E-46,CDC20/KIF2C/NUF2/NEK2/CENPF/ZWINT/MKI67/KIF18A/INCENP/H2AX/NCAPD2/SKA3/BRCA2/BUB1B/KNL1/RAD51/ZWILCH/BLM/NDE1/PLK1/CDT1/AURKB/SPAG5/TOP2A/BIRC5/NDC80/SKA1/SPC24/CENPO/CENPA/NCAPH/BUB1/SPC25/SGO2/HJURP/DSN1/AURKA/CENPM/FANCD2/SGO1/SMC4/NCAPG/CENPE/MAD2L1/HMGB2/CENPU/CENPK/CCNB1/CENPH/TTK/CENPW/NCAPG2/ERCC6L/CENPI,54,CC
GO:0000775,"chromosome, centromeric region",50/198,233/12707,1.69E-43,9.66E-42,6.39E-42,CDCA8/CDC20/KIF2C/NUF2/NEK2/CENPF/ZWINT/HELLS/KIF18A/INCENP/NCAPD2/SKA3/BUB1B/KNL1/OIP5/ZWILCH/NDE1/PLK1/CDT1/AURKB/SPAG5/TOP2A/BIRC5/NDC80/SKA1/SPC24/CENPO/CENPA/BUB1/SPC25/SGO2/HJURP/DSN1/AURKA/CENPM/SGO1/SMC4/NCAPG/CENPE/MAD2L1/CENPU/CENPK/CCNB1/CENPH/TTK/CENPW/ESCO2/DSCC1/ERCC6L/CENPI,50,CC
GO:0000779,"condensed chromosome, centromeric region",43/198,175/12707,5.03E-40,2.16E-38,1.43E-38,CDC20/KIF2C/NUF2/NEK2/CENPF/ZWINT/KIF18A/INCENP/NCAPD2/SKA3/BUB1B/KNL1/ZWILCH/NDE1/PLK1/CDT1/AURKB/SPAG5/BIRC5/NDC80/SKA1/SPC24/CENPO/CENPA/BUB1/SPC25/SGO2/HJURP/DSN1/AURKA/CENPM/SGO1/NCAPG/CENPE/MAD2L1/CENPU/CENPK/CCNB1/CENPH/TTK/CENPW/ERCC6L/CENPI,43,CC
GO:0000776,kinetochore,40/198,165/12707,5.95E-37,2.05E-35,1.35E-35,CDC20/KIF2C/NUF2/NEK2/CENPF/ZWINT/KIF18A/INCENP/SKA3/BUB1B/KNL1/ZWILCH/NDE1/PLK1/CDT1/AURKB/SPAG5/BIRC5/NDC80/SKA1/SPC24/CENPO/BUB1/SPC25/SGO2/HJURP/DSN1/AURKA/CENPM/SGO1/CENPE/MAD2L1/CENPU/CENPK/CCNB1/CENPH/TTK/CENPW/ERCC6L/CENPI,40,CC
GO:0005819,spindle,54/198,390/12707,1.60E-36,4.60E-35,3.04E-35,CDCA8/CDC20/KIF2C/CDC7/GPSM2/PSRC1/ASPM/KIF14/NEK2/CENPF/CDK1/KIF20B/KIF11/KIF18A/INCENP/RACGAP1/ESPL1/SKA3/BORA/DLGAP5/CEP128/BUB1B/NUSAP1/ZWILCH/KIF23/PRC1/NDE1/PLK1/SHCBP1/AURKB/SPAG5/CDC6/KIF18B/BIRC5/SKA1/CKAP2L/TPX2/DSN1/FAM83D/AURKA/SGO1/KIF15/POC1A/ECT2/TACC3/CENPE/MAD2L1/CCNB1/KIF20A/HMMR/KIFC1/TTK/CNTRL/KIF4A,54,CC
GO:0072686,mitotic spindle,30/198,165/12707,8.11E-24,1.99E-22,1.32E-22,CDC7/GPSM2/ASPM/CDK1/KIF20B/KIF11/KIF18A/RACGAP1/ESPL1/SKA3/DLGAP5/NUSAP1/KIF23/PRC1/PLK1/AURKB/SPAG5/CDC6/KIF18B/SKA1/CKAP2L/TPX2/FAM83D/AURKA/ECT2/TACC3/CENPE/MAD2L1/KIFC1/CNTRL,30,CC
GO:0000228,nuclear chromosome,31/198,196/12707,1.10E-22,2.37E-21,1.56E-21,ORC1/NEK2/MCM10/INCENP/POLA2/POLD3/H2AX/NCAPD2/TIMELESS/PRIM1/BRCA2/POLE2/WDHD1/RAD51/BLM/PLK1/GINS2/TOP2A/BIRC5/NCAPH/MCM6/GINS1/CDC45/MCM5/MCM2/SMC4/NCAPG/MCM3/MMS22L/NCAPG2/MCM4,31,CC
GO:0000940,outer kinetochore,14/198,20/12707,1.12E-21,2.14E-20,1.41E-20,NUF2/CENPF/ZWINT/SKA3/BUB1B/KNL1/PLK1/NDC80/SKA1/SPC24/BUB1/SPC25/DSN1/CCNB1,14,CC
GO:0000922,spindle pole,27/198,162/12707,1.81E-20,3.12E-19,2.06E-19,CDC20/GPSM2/PSRC1/ASPM/NEK2/CENPF/KIF20B/KIF11/DLGAP5/CEP128/PRC1/NDE1/PLK1/AURKB/SPAG5/CDC6/CKAP2L/TPX2/DSN1/FAM83D/AURKA/SGO1/POC1A/TACC3/MAD2L1/CCNB1/CNTRL,27,CC
GO:0005874,microtubule,34/198,380/12707,8.33E-17,1.30E-15,8.61E-16,KIF2C/PSRC1/ASPM/KIF14/NEK2/CDK1/KIF20B/KIF11/KIF18A/INCENP/TUBA1B/RACGAP1/GAS2L3/SKA3/NUSAP1/ZWILCH/KIF23/PRC1/NDE1/PLK1/AURKB/SPAG5/KIF18B/BIRC5/SKA1/TPX2/AURKA/GTSE1/KIF15/CENPE/KIF20A/KIFC1/KIF24/KIF4A,34,CC
GO:0005657,replication fork,17/198,66/12707,1.21E-16,1.74E-15,1.15E-15,MCM10/POLA2/POLD3/H2AX/TIMELESS/PRIM1/RFC5/RFC3/WDHD1/PIF1/BLM/UHRF1/RFC4/MCM3/MMS22L/RFC2/XRCC2,17,CC
GO:0030496,midbody,25/198,191/12707,2.02E-16,2.67E-15,1.76E-15,CDCA8/PSRC1/ASPM/KIF14/NEK2/CENPF/CDK1/KIF20B/CEP55/INCENP/RACGAP1/KIF23/PRC1/PLK1/SHCBP1/AURKB/SPAG5/BIRC5/AURKA/ECT2/CENPE/KIF20A/ANLN/CNTRL/KIF4A,25,CC
GO:0051233,spindle midzone,13/198,35/12707,2.35E-15,2.89E-14,1.91E-14,CDCA8/KIF14/KIF20B/KIF18A/INCENP/RACGAP1/PRC1/PLK1/AURKB/CDC6/KIF18B/AURKA/CENPE,13,CC
GO:0071162,CMG complex,8/198,11/12707,4.78E-13,5.49E-12,3.63E-12,GINS2/MCM6/GINS1/CDC45/MCM5/MCM2/MCM3/MCM4,8,CC
GO:0031261,DNA replication preinitiation complex,8/198,12/12707,1.42E-12,1.52E-11,1.01E-11,GINS2/MCM6/GINS1/CDC45/MCM5/MCM2/MCM3/MCM4,8,CC
GO:0005876,spindle microtubule,14/198,77/12707,1.11E-11,1.13E-10,7.45E-11,PSRC1/CDK1/KIF11/KIF18A/SKA3/ZWILCH/PRC1/PLK1/AURKB/KIF18B/SKA1/AURKA/CENPE/KIF4A,14,CC
GO:0005875,microtubule associated complex,17/198,130/12707,1.65E-11,1.57E-10,1.04E-10,CDCA8/KIF2C/KIF14/KIF20B/KIF11/KIF18A/INCENP/KIF23/NDE1/AURKB/KIF18B/BIRC5/AURKA/KIF15/KIF20A/KIFC1/KIF4A,17,CC
GO:0005871,kinesin complex,11/198,41/12707,2.09E-11,1.89E-10,1.25E-10,KIF2C/KIF14/KIF20B/KIF11/KIF18A/KIF23/NDE1/KIF18B/KIF15/KIF20A/KIFC1,11,CC
GO:0000794,condensed nuclear chromosome,12/198,54/12707,2.84E-11,2.44E-10,1.61E-10,NEK2/INCENP/H2AX/NCAPD2/BRCA2/RAD51/BLM/PLK1/NCAPH/SMC4/NCAPG/NCAPG2,12,CC
GO:0097431,mitotic spindle pole,9/198,37/12707,3.85E-09,3.16E-08,2.09E-08,GPSM2/ASPM/KIF20B/PLK1/AURKB/SPAG5/FAM83D/AURKA/CNTRL,9,CC
GO:0000939,inner kinetochore,7/198,19/12707,8.63E-09,6.74E-08,4.46E-08,CENPO/CENPM/CENPU/CENPK/CENPH/CENPW/CENPI,7,CC
GO:0045171,intercellular bridge,11/198,74/12707,1.77E-08,1.32E-07,8.74E-08,CDCA8/CDC7/KIF20B/CEP55/PRC1/CDC6/SKA1/TPX2/FAM83D/CENPE/KIF20A,11,CC
GO:1990023,mitotic spindle midzone,6/198,13/12707,2.08E-08,1.49E-07,9.85E-08,KIF20B/KIF18A/PRC1/AURKB/KIF18B/CENPE,6,CC
GO:0043596,nuclear replication fork,8/198,33/12707,3.00E-08,2.06E-07,1.36E-07,MCM10/POLA2/POLD3/TIMELESS/PRIM1/WDHD1/MCM3/MMS22L,8,CC
GO:0000781,"chromosome, telomeric region",14/198,145/12707,5.72E-08,3.78E-07,2.50E-07,ORC1/CDK1/H2AX/RAD51AP1/BRCA2/RAD51/PIF1/BLM/MCM6/CHEK2/MCM5/MCM2/MCM3/MCM4,14,CC
GO:0072687,meiotic spindle,5/198,11/12707,3.74E-07,2.38E-06,1.57E-06,ASPM/INCENP/BORA/AURKA/CNTRL,5,CC
GO:0010369,chromocenter,5/198,12/12707,6.33E-07,3.89E-06,2.57E-06,CDCA8/INCENP/OIP5/AURKB/ESCO2,5,CC
GO:0000795,synaptonemal complex,5/198,19/12707,8.50E-06,4.72E-05,3.12E-05,INCENP/BRCA2/RAD51/BLM/PLK1,5,CC
GO:0042575,DNA polymerase complex,5/198,19/12707,8.50E-06,4.72E-05,3.12E-05,POLA2/POLD3/PRIM1/POLE2/MCM3,5,CC
GO:0099086,synaptonemal structure,5/198,19/12707,8.50E-06,4.72E-05,3.12E-05,INCENP/BRCA2/RAD51/BLM/PLK1,5,CC
GO:0031616,spindle pole centrosome,4/198,12/12707,2.57E-05,0.000133793,8.84E-05,DLGAP5/NDE1/AURKB/AURKA,4,CC
GO:0043601,nuclear replisome,4/198,12/12707,2.57E-05,0.000133793,8.84E-05,POLA2/POLD3/PRIM1/MCM3,4,CC
GO:0000152,nuclear ubiquitin ligase complex,6/198,43/12707,5.00E-05,0.000248927,0.00016453,CDC20/BRCA2/BUB1B/RAD51/UBE2S/UBE2C,6,CC
GO:0030894,replisome,4/198,14/12707,5.07E-05,0.000248927,0.00016453,POLA2/POLD3/PRIM1/MCM3,4,CC
GO:0090543,Flemming body,5/198,29/12707,7.65E-05,0.000365494,0.000241575,KIF14/CEP55/RACGAP1/KIF23/CNTRL,5,CC
GO:0000792,heterochromatin,7/198,72/12707,0.0001255,0.000583404,0.000385603,HELLS/INCENP/WDR76/UHRF1/CENPA/H2AZ1/ESCO2,7,CC
GO:0005680,anaphase-promoting complex,4/198,20/12707,0.000227837,0.001031262,0.000681617,CDC20/BUB1B/UBE2S/UBE2C,4,CC
GO:0005814,centriole,9/198,142/12707,0.000378772,0.001670484,0.001104114,STIL/CEP55/CEP128/PLK1/TOP2A/AURKA/POC1A/PLK4/KIF24,9,CC
GO:0070938,contractile ring,3/198,10/12707,0.000412494,0.001773725,0.001172352,KIF20B/PRC1/ANLN,3,CC
GO:0032153,cell division site,6/198,63/12707,0.000430861,0.001807514,0.001194685,CEP55/RACGAP1/NDE1/ECT2/PLK4/ANLN,6,CC
GO:0001741,XY body,3/198,11/12707,0.000560683,0.002242732,0.001482344,H2AX/PLK4/ESCO2,3,CC
GO:0045120,pronucleus,3/198,11/12707,0.000560683,0.002242732,0.001482344,CENPF/AURKA/CCNA2,3,CC
GO:0032154,cleavage furrow,5/198,45/12707,0.000643173,0.002514224,0.001661788,CEP55/RACGAP1/NDE1/ECT2/PLK4,5,CC
GO:0005721,pericentric heterochromatin,4/198,27/12707,0.000757823,0.002896569,0.001914501,HELLS/INCENP/CENPA/ESCO2,4,CC
GO:0043073,germ cell nucleus,5/198,48/12707,0.000868042,0.003245723,0.002145276,H2AX/RAD51/TOP2A/AURKA/TRIP13,5,CC
GO:0090734,site of DNA damage,7/198,107/12707,0.001406232,0.005146212,0.003401413,H2AX/TIMELESS/RAD51/WDR76/TRAIP/MMS22L/ESCO2,7,CC
GO:1990752,microtubule end,4/198,32/12707,0.001461274,0.005236231,0.003460912,KIF2C/ASPM/SPAG5/KIF18B,4,CC
GO:0001673,male germ cell nucleus,4/198,39/12707,0.003070675,0.010778697,0.00712423,H2AX/RAD51/TOP2A/TRIP13,4,CC
GO:0005828,kinetochore microtubule,3/198,20/12707,0.003493633,0.012018098,0.007943418,KIF18A/ZWILCH/CENPE,3,CC
GO:1990391,DNA repair complex,3/198,22/12707,0.004612809,0.015556924,0.010282422,BRCA2/FANCI/FANCD2,3,CC
GO:0034451,centriolar satellite,6/198,100/12707,0.004705668,0.015564903,0.010287696,PLK1/SPAG5/SKA1/TACC3/CENPU/CNTRL,6,CC
GO:0035371,microtubule plus-end,3/198,23/12707,0.005244513,0.017019929,0.011249402,KIF2C/SPAG5/KIF18B,3,CC
GO:0005881,cytoplasmic microtubule,5/198,74/12707,0.005899077,0.018789653,0.01241911,KIF2C/KIF18A/TUBA1B/KIF18B/GTSE1,5,CC
GO:0034399,nuclear periphery,7/198,140/12707,0.006312324,0.019740359,0.013047484,CENPF/BLM/LMNB2/UHRF1/LMNB1/CENPW/KIF4A,7,CC
GO:0000307,cyclin-dependent protein kinase holoenzyme complex,4/198,48/12707,0.006516989,0.020016465,0.013229977,CDK1/CCNB2/CCNA2/CCNB1,4,CC
GO:0035861,site of double-strand break,5/198,77/12707,0.006970326,0.021033266,0.013902036,H2AX/TIMELESS/RAD51/MMS22L/ESCO2,5,CC
GO:0000235,astral microtubule,2/198,10/12707,0.010012255,0.028701799,0.018970589,KIF18A/KIF18B,2,CC
GO:0005818,aster,2/198,10/12707,0.010012255,0.028701799,0.018970589,KIF18A/KIF18B,2,CC
GO:0120103,centriolar subdistal appendage,2/198,10/12707,0.010012255,0.028701799,0.018970589,CEP128/CNTRL,2,CC
GO:0016363,nuclear matrix,6/198,118/12707,0.010347644,0.029176964,0.019284652,CENPF/BLM/UHRF1/LMNB1/CENPW/KIF4A,6,CC
GO:0000803,sex chromosome,3/198,30/12707,0.011102312,0.030799962,0.02035738,H2AX/PLK4/ESCO2,3,CC
GO:0005652,nuclear lamina,2/198,12/12707,0.014387322,0.039279672,0.025962084,LMNB2/LMNB1,2,CC
GO:0061695,"transferase complex, transferring phosphorus-containing groups",9/198,262/12707,0.021668103,0.058233026,0.038489393,CDK1/POLA2/POLD3/PRIM1/POLE2/CCNB2/CCNA2/CCNB1/MCM3,9,CC
GO:0031965,nuclear membrane,8/198,270/12707,0.06087385,0.161081572,0.106467624,DTL/CENPF/CEP128/BRIP1/KPNA2/LMNB2/LMNB1/NRM,8,CC
GO:0036064,ciliary basal body,5/198,144/12707,0.074648349,0.194538123,0.128580889,CENPF/SPAG5/AURKA/CDC45/POC1A,5,CC
GO:0000786,nucleosome,3/198,65/12707,0.08074606,0.207288393,0.13700824,H2AX/CENPA/H2AZ1,3,CC
GO:0099738,cell cortex region,2/198,33/12707,0.093152581,0.235621233,0.155734965,GPSM2/SAPCD2,2,CC
GO:1902554,serine/threonine protein kinase complex,4/198,112/12707,0.097664152,0.243452668,0.160911188,CDK1/CCNB2/CCNA2/CCNB1,4,CC
GO:0031461,cullin-RING ubiquitin ligase complex,5/198,165/12707,0.115627331,0.28411287,0.18778574,CDC20/DTL/BUB1B/UBE2S/UBE2C,5,CC
GO:0045111,intermediate filament cytoskeleton,3/198,81/12707,0.132396975,0.320736334,0.211992191,RAD51/LMNB2/LMNB1,3,CC
GO:0005635,nuclear envelope,10/198,431/12707,0.136526292,0.326146142,0.215567829,DTL/CENPF/RRM1/CEP128/BRIP1/KPNA2/LMNB2/MAD2L1/LMNB1/NRM,10,CC
GO:1902911,protein kinase complex,4/198,128/12707,0.139520155,0.32873242,0.217277242,CDK1/CCNB2/CCNA2/CCNB1,4,CC
GO:0005637,nuclear inner membrane,2/198,45/12707,0.155193357,0.354522375,0.234323234,LMNB1/NRM,2,CC
GO:0031074,nucleocytoplasmic transport complex,1/198,11/12707,0.158710598,0.354522375,0.234323234,KPNA2,1,CC
GO:0043240,Fanconi anaemia nuclear complex,1/198,11/12707,0.158710598,0.354522375,0.234323234,FANCG,1,CC
GO:0099569,presynaptic cytoskeleton,1/198,11/12707,0.158710598,0.354522375,0.234323234,RAD51,1,CC
GO:0044615,nuclear pore nuclear basket,1/198,12/12707,0.171830896,0.37384219,0.247092757,MAD2L1,1,CC
GO:0000791,euchromatin,2/198,49/12707,0.177309684,0.37384219,0.247092757,UHRF1/H2AZ1,2,CC
GO:0000151,ubiquitin ligase complex,7/198,295/12707,0.177845912,0.37384219,0.247092757,CDC20/DTL/BRCA2/BUB1B/RAD51/UBE2S/UBE2C,7,CC
GO:0031464,Cul4A-RING E3 ubiquitin ligase complex,1/198,13/12707,0.184747594,0.37384219,0.247092757,DTL,1,CC
GO:0035253,ciliary rootlet,1/198,13/12707,0.184747594,0.37384219,0.247092757,SPAG5,1,CC
GO:0043186,P granule,1/198,13/12707,0.184747594,0.37384219,0.247092757,CARHSP1,1,CC
GO:0045495,pole plasm,1/198,13/12707,0.184747594,0.37384219,0.247092757,CARHSP1,1,CC
GO:0060293,germ plasm,1/198,13/12707,0.184747594,0.37384219,0.247092757,CARHSP1,1,CC
GO:0005882,intermediate filament,2/198,51/12707,0.188545366,0.377090731,0.249239896,LMNB2/LMNB1,2,CC
GO:0055029,nuclear DNA-directed RNA polymerase complex,3/198,97/12707,0.192564717,0.380702659,0.251627216,POLA2/PRIM1/MCM3,3,CC
GO:0016328,lateral plasma membrane,2/198,53/12707,0.199875783,0.390666303,0.258212734,GPSM2/IQGAP3,2,CC
GO:0000428,DNA-directed RNA polymerase complex,3/198,100/12707,0.204533852,0.390886917,0.25835855,POLA2/PRIM1/MCM3,3,CC
GO:0016605,PML body,3/198,100/12707,0.204533852,0.390886917,0.25835855,RAD51/BLM/CHEK2,3,CC
GO:0030880,RNA polymerase complex,3/198,103/12707,0.216669902,0.409529924,0.270680733,POLA2/PRIM1/MCM3,3,CC
GO:0005938,cell cortex,6/198,262/12707,0.22516287,0.42095667,0.278233295,GPSM2/IQGAP3/ECT2/ANLN/MELK/SAPCD2,6,CC
GO:0030992,intraciliary transport particle B,1/198,17/12707,0.234440542,0.43358896,0.286582666,IFT25,1,CC
GO:0017053,transcription repressor complex,2/198,65/12707,0.268986325,0.492187743,0.325313808,DEPDC1/GMNN,2,CC
GO:0001669,acrosomal vesicle,2/198,72/12707,0.30943652,0.560242963,0.370295227,RACGAP1/KNL1,2,CC
GO:0030990,intraciliary transport particle,1/198,24/12707,0.314259176,0.56304769,0.372149024,IFT25,1,CC
GO:0080008,Cul4-RING E3 ubiquitin ligase complex,1/198,31/12707,0.385793403,0.684087271,0.452150706,DTL,1,CC
GO:0099568,cytoplasmic region,4/198,211/12707,0.41796703,0.733574787,0.484859712,GPSM2/CENPF/SAPCD2/KIF4A,4,CC
GO:0005923,bicellular tight junction,2/198,98/12707,0.453215346,0.787404439,0.520438674,ECT2/SAPCD2,2,CC
GO:0070160,tight junction,2/198,103/12707,0.478975715,0.823838229,0.54451976,ECT2/SAPCD2,2,CC
GO:1990204,oxidoreductase complex,2/198,104/12707,0.484038985,0.824304014,0.544827623,RRM1/RRM2,2,CC
GO:0097542,ciliary tip,1/198,43/12707,0.491569514,0.828921142,0.547879335,IFT25,1,CC
GO:0005929,cilium,8/198,495/12707,0.509143492,0.850220199,0.561957047,IFT25/CENPF/CEP128/SPAG5/AURKA/CDC45/POC1A/CNTRL,8,CC
GO:0043296,apical junction complex,2/198,120/12707,0.560764632,0.92741843,0.612981582,ECT2/SAPCD2,2,CC
GO:0015030,Cajal body,1/198,57/12707,0.592273377,0.970200198,0.641258393,OIP5,1,CC
GO:1904115,axon cytoplasm,1/198,58/12707,0.598655185,0.971402753,0.642053227,KIF4A,1,CC
GO:0030864,cortical actin cytoskeleton,1/198,64/12707,0.634911874,0.999651856,0.660724605,ANLN,1,CC
GO:0005901,caveola,1/198,65/12707,0.640629461,0.999651856,0.660724605,KIF18A,1,CC
GO:0035578,azurophil granule lumen,1/198,65/12707,0.640629461,0.999651856,0.660724605,DSN1,1,CC
GO:0005758,mitochondrial intermembrane space,1/198,74/12707,0.688239756,0.999651856,0.660724605,CDC25C,1,CC
GO:0016607,nuclear speck,5/198,377/12707,0.703759949,0.999651856,0.660724605,H2AX/OIP5/RMI2/SMC4/NCAPG2,5,CC
GO:0120111,neuron projection cytoplasm,1/198,78/12707,0.707332417,0.999651856,0.660724605,KIF4A,1,CC
GO:0044853,plasma membrane raft,1/198,79/12707,0.711920918,0.999651856,0.660724605,KIF18A,1,CC
GO:0031970,organelle envelope lumen,1/198,83/12707,0.729570131,0.999651856,0.660724605,CDC25C,1,CC
GO:0070603,SWI/SNF superfamily-type complex,1/198,87/12707,0.746143188,0.999651856,0.660724605,DEK,1,CC
GO:0000932,P-body,1/198,90/12707,0.757906189,0.999651856,0.660724605,CARHSP1,1,CC
GO:0005643,nuclear pore,1/198,90/12707,0.757906189,0.999651856,0.660724605,MAD2L1,1,CC
GO:0030863,cortical cytoskeleton,1/198,91/12707,0.761705395,0.999651856,0.660724605,ANLN,1,CC
GO:0032838,plasma membrane bounded cell projection cytoplasm,2/198,178/12707,0.768945944,0.999651856,0.660724605,CENPF/KIF4A,2,CC
GO:0005930,axoneme,1/198,100/12707,0.793336291,0.999651856,0.660724605,CENPF,1,CC
GO:0005884,actin filament,1/198,101/12707,0.796582061,0.999651856,0.660724605,GAS2L3,1,CC
GO:0097014,ciliary plasm,1/198,101/12707,0.796582061,0.999651856,0.660724605,CENPF,1,CC
GO:0005766,primary lysosome,1/198,114/12707,0.834436497,0.999651856,0.660724605,DSN1,1,CC
GO:0042582,azurophil granule,1/198,114/12707,0.834436497,0.999651856,0.660724605,DSN1,1,CC
GO:0090575,RNA polymerase II transcription regulator complex,2/198,215/12707,0.85188996,0.999651856,0.660724605,E2F2/MXD3,2,CC
GO:0009898,cytoplasmic side of plasma membrane,1/198,125/12707,0.860932741,0.999651856,0.660724605,RACGAP1,1,CC
GO:0005911,cell-cell junction,4/198,398/12707,0.871966864,0.999651856,0.660724605,IQGAP3/CDCA3/ECT2/SAPCD2,4,CC
GO:0005775,vacuolar lumen,1/198,131/12707,0.873560086,0.999651856,0.660724605,DSN1,1,CC
GO:0005667,transcription regulator complex,4/198,400/12707,0.874436829,0.999651856,0.660724605,E2F2/DEPDC1/MXD3/GMNN,4,CC
GO:1904949,ATPase complex,1/198,134/12707,0.879439128,0.999651856,0.660724605,DEK,1,CC
GO:0001650,fibrillar center,1/198,138/12707,0.886856858,0.999651856,0.660724605,DSN1,1,CC
GO:0030426,growth cone,1/198,145/12707,0.898761622,0.999651856,0.660724605,KIF20B,1,CC
GO:0030427,site of polarized growth,1/198,149/12707,0.904995826,0.999651856,0.660724605,KIF20B,1,CC
GO:0016324,apical plasma membrane,2/198,252/12707,0.90689798,0.999651856,0.660724605,ASPM/SAPCD2,2,CC
GO:0043025,neuronal cell body,3/198,346/12707,0.909467441,0.999651856,0.660724605,RRM1/TPX2/AURKA,3,CC
GO:0098562,cytoplasmic side of membrane,1/198,158/12707,0.917661176,0.999651856,0.660724605,RACGAP1,1,CC
GO:0001726,ruffle,1/198,159/12707,0.91896033,0.999651856,0.660724605,KIF18A,1,CC
GO:0005912,adherens junction,1/198,161/12707,0.921497768,0.999651856,0.660724605,CDCA3,1,CC
GO:0005759,mitochondrial matrix,4/198,456/12707,0.928725335,0.999651856,0.660724605,CDK1/ARHGAP11B/RAD51/CCNB1,4,CC
GO:0016323,basolateral plasma membrane,1/198,176/12707,0.938170784,0.999651856,0.660724605,AURKA,1,CC
GO:0044297,cell body,3/198,396/12707,0.94906126,0.999651856,0.660724605,RRM1/TPX2/AURKA,3,CC
GO:0030424,axon,4/198,488/12707,0.949270101,0.999651856,0.660724605,KIF20B/TPX2/AURKA/KIF4A,4,CC
GO:0045177,apical part of cell,2/198,305/12707,0.953372274,0.999651856,0.660724605,ASPM/SAPCD2,2,CC
GO:0009925,basal plasma membrane,1/198,199/12707,0.957148914,0.999651856,0.660724605,AURKA,1,CC
GO:0150034,distal axon,1/198,206/12707,0.9616786,0.999651856,0.660724605,KIF20B,1,CC
GO:0045121,membrane raft,1/198,209/12707,0.96347094,0.999651856,0.660724605,KIF18A,1,CC
GO:0098857,membrane microdomain,1/198,210/12707,0.964049653,0.999651856,0.660724605,KIF18A,1,CC
GO:0045178,basal part of cell,1/198,212/12707,0.965179854,0.999651856,0.660724605,AURKA,1,CC
GO:0036464,cytoplasmic ribonucleoprotein granule,1/198,216/12707,0.967335284,0.999651856,0.660724605,CARHSP1,1,CC
GO:0043292,contractile fiber,1/198,216/12707,0.967335284,0.999651856,0.660724605,DEK,1,CC
GO:0034774,secretory granule lumen,1/198,223/12707,0.970792672,0.999651856,0.660724605,DSN1,1,CC
GO:0060205,cytoplasmic vesicle lumen,1/198,225/12707,0.971711835,0.999651856,0.660724605,DSN1,1,CC
GO:0031983,vesicle lumen,1/198,226/12707,0.972160566,0.999651856,0.660724605,DSN1,1,CC
GO:0035770,ribonucleoprotein granule,1/198,233/12707,0.975109473,0.999651856,0.660724605,CARHSP1,1,CC
GO:0005788,endoplasmic reticulum lumen,1/198,237/12707,0.976652774,0.999651856,0.660724605,POGLUT3,1,CC
GO:0014069,postsynaptic density,1/198,259/12707,0.983587264,0.999651856,0.660724605,AURKA,1,CC
GO:0032279,asymmetric synapse,1/198,272/12707,0.986676707,0.999651856,0.660724605,AURKA,1,CC
GO:0099572,postsynaptic specialization,1/198,276/12707,0.987505327,0.999651856,0.660724605,AURKA,1,CC
GO:0015629,actin cytoskeleton,2/198,421/12707,0.990514754,0.999651856,0.660724605,GAS2L3/ANLN,2,CC
GO:0098984,neuron to neuron synapse,1/198,297/12707,0.991083979,0.999651856,0.660724605,AURKA,1,CC
GO:0098978,glutamatergic synapse,1/198,333/12707,0.995007093,0.999651856,0.660724605,AURKA,1,CC
GO:0019866,organelle inner membrane,2/198,481/12707,0.995967991,0.999651856,0.660724605,LMNB1/NRM,2,CC
GO:0031252,cell leading edge,1/198,359/12707,0.996718855,0.999651856,0.660724605,KIF18A,1,CC
GO:0005769,early endosome,1/198,361/12707,0.996823242,0.999651856,0.660724605,KIFC1,1,CC
GO:0098552,side of membrane,1/198,387/12707,0.997914362,0.999651856,0.660724605,RACGAP1,1,CC
GO:0005925,focal adhesion,1/198,395/12707,0.998167975,0.999651856,0.660724605,KIF23,1,CC
GO:0030055,cell-substrate junction,1/198,404/12707,0.99841678,0.999651856,0.660724605,KIF23,1,CC
GO:0098793,presynapse,1/198,427/12707,0.998910238,0.999651856,0.660724605,RAD51,1,CC
GO:0030425,dendrite,1/198,471/12707,0.999467693,0.999651856,0.660724605,ZWINT,1,CC
GO:0097447,dendritic tree,1/198,471/12707,0.999467693,0.999651856,0.660724605,ZWINT,1,CC
GO:0009986,cell surface,1/198,491/12707,0.999615984,0.999651856,0.660724605,HMMR,1,CC
GO:0098794,postsynapse,1/198,497/12707,0.999651856,0.999651856,0.660724605,AURKA,1,CC
